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 Immune system response to pathogens is mediated by triggering of receptor-
ligand interactions such as the T cell receptor (TCR) engaging with peptide-major 
histocompatibility complex (pMHC) expressed on infected cells, which can be facilitated 
by the CD4 coreceptor. However, detecting CD4-pMHC binding has been elusive due to 
its purported weak affinity. Additionally, there are no models that describe cooperativity 
between more than two molecules. To address these limitations, the first aim of this thesis 
was to characterize CD4-pMHC binding and mathematically model trimolecular 
cooperativity. Using an ultra-sensitive micropipette adhesion frequency assay and 
biomembrane force probe, the complete set of CD4-pMHC kinetics was experimentally 
detected for the first time. Surprisingly, when controlled mixtures of TCR and CD4 were 
probed against pMHC, binding frequency was greatly enhanced clearly demonstrating 
synergy between TCR, pMHC and CD4. These results were used to develop the first 
documented analytical solutions for trimolecular cooperativity, which imply a 
conformational change in TCR-bound pMHC that greatly enhances CD4 binding. A cell 
system corroborated the model by confirming that the ratio between TCR and CD4 
dictates synergy observed in binding kinetics and intracellular signaling, suggesting that 
CD4 is not a passive facilitator of activation as previously thought. 
 As T cells travel to sites of inflammation, the trimolecular complex is exposed 
reactive oxygen species (ROS) generated by other immune cells also seeking to clear 
pathogen. ROS has been suggested to inhibit T cell function, especially in cancer 
microenvironments, but in other scenarios, it has been shown to improve T cell function. 
The dual-role of ROS has long convoluted study of its effect on immune cells which has 
notoriously limited clinical intervention. Therefore, the second aim of this thesis was to 
monitor TCR-pMHC binding in response to ROS in real-time using a novel modification 
of the micropipette assay, in order to deconvolute how the many molecules involved in 
 xvii 
binding are each affected. TCR-pMHC binding was reduced by introduction of ROS but 
could be partially rescued by the coreceptor. The degree of rescue was modulated by the 
surrounding cholesterol content of the membrane as well as the catalytic activity of 
proximal kinases. By parsing out molecules in a holistic in situ system, it was concluded 
that TCR-pMHC binding is weakened due to the disruption of the trimolecular complex 
by ROS. 
 Similar to T cells, the macrophage TLR4 receptor requires other surface receptors 
to robustly recognize its ligand LPS, and the relationship between oxidative stress and 
macrophage function is mired with conflicting results. Correspondingly, the framework 
developed in the first two aims of this thesis was applied to a third aim which sought to 
understand how macrophage function can be both enhanced and impaired by ROS. 
Unique morphological changes of macrophages induced by LPS engagement were 
dependent on ROS and correlated well with previously described inhibition of 
macrophage phagocytosis. At the same time, ROS enhanced cytokine secretion by 
macrophages and TLR4-LPS binding did not display differences between ROS-treated 
and untreated cells. Lastly, actin reorganization appeared to be reduced when treated with 
ROS. These data suggest that unlike T cell activation which is dependent on TCR-pMHC 
binding, macrophage function is diverse in its regulation as exemplified by ROS 
improving TLR4 signaling but also inhibiting movement by disrupting actin. 
 Overall, by introducing biophysical and biochemical contexts to receptor-ligand 
interactions in tandem, a better understanding of how our immune system sensitively 
detects pathogens was achieved. The novel results described herein inform rational 
design of therapeutic interventions including protein engineering enhancement of antigen 
recognition as well as acute and compartmentalized antioxidant protection.
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CHAPTER 1  INTRODUCTION 
1.1 Specific immune response by T cells 
 The human immune system orchestrates robust defenses against pathogens that 
begin with ‘innate’ responses and can trigger the expansion of a specific ‘adaptive’ 
response. An innate response is readily available to be exerted upon recognition of an 
abnormal entity, intracellularly or extracellularly, and is based in recognizing general 
molecular patterns1-3. An adaptive response recognizes a unique molecular feature but 
requires a period of priming before it can be executed. Such a response is necessary to 
overcome pathogens of significant mutational diversity and rapid infection transmission 
which surpasses the rate at which the innate immune response can maintain resistance1. A 
central arm of the adaptive immune response is made up of T cells, which are 
programmed to specifically recognize the unique molecular features and only act to 
eliminate the cells they derive from as opposed to features from host cells1,3.  
 Activation of T cells begins with tissue resident dendritic cells (DCs) scavenging 
the site of infection and engulfing foreign antigen which leads to DC maturation and 
involves fragments, or peptides, of the antigen being presented on the surface of the DC, 
just as they are presented on infected host cells3,4. Upon activation, DCs migrate into 
peripheral lymph nodes where they encounter antigen inexperienced naïve T cells. DCs 
and naïve T cells will exchange information through a vast array of physically interacting 
surface-bound receptors which ultimately serve to mature naïve T cells into ‘effector’ T 
cells and stimulate their rapid proliferation3,5,6. Vast numbers of effector T cells are 
attracted to the infection site through action of chemokines and adhesion receptors, 
extravasate into the tissue space, and recognize infected cells by the peptide matching the 
one presented on the DC that had previously activated the T cells, affording a specific 
attack targeted only to infected cells and not to uninfected host cells3,7-10. T cells can 
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either directly destroy infected cells by means of toxic granules or they can recruit and 
activate other immune cells to exert the same function3.  
 As the infection is gradually eliminated, the majority of antigen-specific T cells 
undergo controlled self-destruction to avoid damaging host cells and tissue, only leaving 
a small fraction which differentiate into ‘memory T cells’3,11. Upon secondary infection, 
these memory T cells activate much more rapidly than they previously did as naïve cells 
and are preferentially localized in non-lymphoid tissues and can therefore more readily 
respond to the same infection11,12. Recognition of, and response to foreign peptide on 
DCs and eventually the infected cells, is mediated by the T cell receptor. 
1.1.1 T cell receptor 
 Specific immune responses by T cells are predicated on recognizing molecular 
features that are not present in the make-up of healthy host cells and tissues. Recognizing 
host antigen will cause T cells to target self, a disease established as autoimmunity which 
has deadly consequences13. In addition to being programmed to recognize only foreign 
antigen through processes called positive and negative selection14, T cell receptor (TCR) 
recognition is distinct from innate germline encoded receptors such as Toll-like-receptors 
(TLRs), in that TLRs broadly recognize what are known as ‘pathogen-associated 
molecular patterns’ (PAMPS) as opposed to a peptide. For example, TLR3 would 
recognize double-stranded RNA as a pattern as opposed to the nucleotide sequence 
within the double-stranded RNA3. In contrast, TCR can distinguish even one amino acid 
difference between otherwise identical peptides anchored within major histocompatibility 
complexes (MHC)- the combination of which will hereon be referred to as the peptide-
major histocompatibility complex, or pMHC- with consequences extending to T cell 
function and fate15,16. Class-I pMHCs have been reported to anchor peptides between 8 
and 15 amino acids long (mostly 9) and can therefore be represented by tremendous 
number of permutations. Class-II pMHC can yield even greater diversity since the 
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peptides loaded can vary between 11 and 30 amino acids long. Adding to the diversity are 
many different alleles of MHC specific to an individual17. The diversity from pattern 
recognition of germline encoded receptors would not suffice in recognizing such diverse 
ligands, and rather relies on recognition by the TCR whose diversity is based in genetic 
recombination3.   
1.1.1.1 T cell receptor diversity 
 Antibodies, or immunoglobulin (Ig), can recognize virtually any substance by the 
three-dimensional set of amino acids it binds to on the substance called an epitope3. 
Diversity of Igs is concentrated in their variable domains which are encoded by separate 
gene segments in the germline called V, D, and J. The process of randomly joining 
together different genes from each of these segments is called VDJ recombination and is 
capable of producing a theoretical limit of 1011 antibodies with different recognition3.  
1.1.1.1.1 T cell receptor development 
 Production of TCR diversity uses the same mechanism as Ig diversity. Most TCR 
are made up of an α chain and a β chain, yielding the αβ T cell receptor (hereon the αβ T 
cell receptor will be referred to as TCR). These chains are encoded in the germline as 52 
V segments, 2 D segments, and 13 J segments for the β chain, and about 70 V segments, 
no D segments, and 61 J segments for the α chain. By randomly joining together these 
segments for each of the α and β chains, and eventually pairing the α and β chains 
together, a theoretical diversity of 1018 to 1020 is estimated3. However, this diversity 
limited by the number of T cells in one individual, as well as the antigens that the 
individual encounters in their lifetime yielding a realized diversity of 106 to 107 different 
TCR18. Nevertheless, the TCR is capable of recognizing a large repertoire of pMHC. 
 The process of expressing a TCR with a specific recognition occurs in the thymus. 
Progenitor cells from the bone marrow arrive in the thymus without TCR expression and 
undergo several developmental stages3. Now residing in the thymus, the progenitor is 
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referred to as a thymocyte, and expresses a functional pre-TCR that is made up of the 
VDJ-diversified β chain and a pre-α chain. Only thymocytes expressing functional β and 
pre-α are allowed to survive in a process called positive selection3,14. VJ-diversified α 
chains are then expressed and paired with the β chains completing the TCR. At this point, 
cells that express TCR that react strongly to self-antigen are programmed for destruction, 
in a process termed negative selection, to avoid autoimmunity14. Upon completion of this 
stage, T cells are released from the thymus into circulation and can begin to reside in 
peripheral lymph nodes where they will encounter DCs for activation and effector 
function3. While each peripheral T cell clone expresses a unique TCR, the TCR can still 
recognize more than one peptide, a form of cross-reactivity. Therefore, the T cell must be 
able to discriminate between similar peptides (even with only one amino acid difference) 
to propagate variable signaling15. The discriminatory power is present even in thymocytes 
since the reactivity with self-antigen between positive and negative must be different. If 
the degree of recognition is the same, T cells that survive through positive selection 
would all be programmed for death in negative selection3. The discriminatory power 
between different stages of the TCR development19 or in the peripheral where T cells 
discriminate between different foreign antigen20,21, is suggested to be attributed to 
propagation of conformational changes within the structure of the TCR and proteins 
associated with it22-24. 
1.1.1.1.2 T cell receptor structure 
 Two polypeptide chains make up the TCR heterodimer, an α and β chain which 
both span: ectodomains made up of variable and constant regions that are joined by a 
disulfide bond, transmembrane domains, and cytosolic domains that are too short for 
signaling25,26. The variable regions of α and β chains are similar to the structure of the 
fragment antigen-binding (Fab) domains of antibodies which are also known as 
Immunoglobulin (Ig). The similarities in three-dimensional structures imply similarities 
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in their functionality of binding antigen. A difference is that Ig Fab binds to antigen in a 
concave topology while the topology between the αβ variable domains bind to a 
relatively flat surface on pMHC25,26. Binding to the peptide is largely mediated by 
complementarity determining regions (CDR) formed by both variable regions of α and β 
chains, in particular the hypervariable CDR325,26. Moving proximally to the membrane 
from the variable region are the αβ constant domains. These also have sequence 
homology to the Ig constant domain especially in the region where the disulfide bond 
forms between α and β chains25,26. A major difference in the constant β compared to the 
Ig constant region is a well-structured 12 amino acid insertion termed the FG loop which 
may have functional importance in amplifying differences in peptides27. Finally, the TCR 
transmembrane domain is primarily where association with CD3 proteins is driven, by 
evolutionarily conserved and charged residues28. These CD3 transmembrane proteins are 
responsible for signal transfer from the TCR variable region to intracellular proteins28.  
1.1.1.2 CD3 association with TCR 
 Upon ligation of a specific pMHC, information is transferred by the TCR through 
the surface of the T cell, which is a process known as ‘TCR triggering’. However, TCR 
does not possess an intracellular signaling domain28. Thus, how the TCR is able to 
transmit signals from the pMHC to intracellular signaling molecules has been a topic of 
intense investigation for decades. It is well accepted that several CD3 polypeptide chains 
play a central role in transmitting this signal, due to its constitutive association with 
TCR28. There are four different CD3 proteins, CD3γ, CD3δ, CD3ε, and CD3ζ. CD3γ, 
CD3δ, and CD3ε each consist of a single Ig ectodomain, a transmembrane domain, and 
single immunoreceptor tyrosine-based activation motif (ITAM)27,28. CD3ζ has a short 
ectodomain, a transmembrane domain, and a relatively longer cytosolic domain with 
three ITAMS27,28. These proteins present themselves as dimers, more specifically 
heterodimers of CD3εγ and CD3εδ, and homodimers of CD3ζζ, and non-covalently 
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associate with TCR at a 1:1:1:1 ratio forming the TCR-CD3 quaternary complex27,28. 
Altogether 10 ITAMS are associated with the TCR. These motifs act as molecular 
switches, whereby upon phosphorylation, they manifest an activation state and can serve 
as adaptors for signaling molecules which perpetuate a signaling cascade. 
Phosphorylation is mediated by kinases and dephosphorylation is mediated by 
phosphatases. A dynamic balance between these actions ensure that signal is only 
propagated when appropriate29. Another way that CD3 ITAMs phosphorylation can be 
modulated is due to their positive basic residues that are electrostatically buried in the 
negatively charged inner leaflet of the cell membrane, rendering the ITAMs inaccessible 
to phosphorylation by kinases30-33. A body of work theorizes that these chains are 
released as a physical consequence of TCR-pMHC binding causing the ITAMs to be 
susceptible to phosphorylation thereby initiating the signaling cascade27,34,35.  
1.1.1.3 Measuring T cell receptor binding kinetics 
 Activation of T cells does not occur without TCR triggering36. Even in their 
resting state before activation which leads to effector function, TCR are thought to be 
‘tickled’ by low affinity self-peptides to maintain a basal level of activation to prevent a 
state of inactivity37,38. Self-peptides do not fully activate the T cell because this would 
lead to autoimmunity, but rather remain primed due to cross-reactivates that were present 
in thymocyte development38. One method to quantify the variable effects peptides on T 
cells through the TCR is to observe T cell effector function. For example, by measuring 
cytokines secreted by T cells or the extent of proliferation of T cells, ‘potency’ of 
different peptide can be the tested39,40. However, these methods do not directly provide 
any information about how the pMHC is binding to the TCR, thereby preventing 
rationale design of peptides to modulate T cell function. 
1.1.1.3.1 3D kinetics 
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 In circulation, metabolites and proteins are constantly associating and dissociating 
as part of chemical reactions. For example, enzymes associate with proteins in solution to 
greatly accelerate chemical reactions. To measure this reaction, isothermal calorimetry 
can measure thermodynamic changes from gradually titrating one species to another, 
which can yield the affinity constant for the bimolecular interaction41. Another scenario is 
when cells respond to soluble proteins through their surface bound receptors. A well-
studied example is receptor tyrosine kinases such as surface bound epidermal growth 
factor receptor ligated by soluble epidermal growth factor which induces dimerization. 
Binding between receptor and ligand is a dynamic process, however, which occurs with 
on- and off-rates of the ligand to and from its receptor and can be modeled by an affinity 
constant just as with isothermal calorimetry42. Quantitative measurements of this type of 
binding can be mimicked by surface plasmon resonance (SPR). 
 In this experiment a receptor is anchored in the desired orientation on a surface of 
a flow chamber. Along the surface is a surface plasmon field which is very sensitive to 
physical changes along this nanometer-scale thick plane. The ligand is then flowed over 
the receptor coated surface to allow association which is detected by an increase in 
plasmon resonance response units. Association is continued until saturation of response 
units, at which flow is continued without ligand to allow dissociation of bound 
complexes. This decrease in bound ligand is also detected and finally from all these real 
time measurements, on- and off-rates as well as an affinity constant can be calculated43,44. 
SPR has been widely utilized to study various TCR association with their cognate pMHC, 
and from these studies a positive correlation between peptide potency as measured by cell 
effector function, and TCR affinity to pMHC have been established44,45. Kinetics such as 
on- and off-rates are important to detail because their ratio, the affinity constant measured 
by SPR, do not always predict peptide potency46.   
1.1.1.3.2 2D kinetics 
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 A third scenario of information transfer exists whereby two membranes that are in 
sub-micron proximity to each other spatially afford an interaction between two opposing 
surface bound receptors29. This is the case for the TCR-pMHC interaction along with a 
large body of molecules between T cells and Antigen Presenting Cell (APC) such as 
DCs. In fact, within this junction exists an organized supramolecular activation complex 
(SMAC) between interacting opposing molecules6. Since the SMAC was only apparent 
after minutes of T cell-APC interaction, it is thought that the SMAC represents a climax 
in the T cell activation state6. Therefore, measuring interactions that are physically 
constrained by membranes are of high relevance to T cell immunobiology. In order to 
study kinetics between surface bound receptors, micropipette-based 2D binding assay 
have been developed47. 
 In this experiment, two cells are aspirated onto opposing micropipettes exposing 
their surfaces to each other. One cell is the live target cell with the receptor of interest 
expressed on its surface. The other cell is a surrogate APC, a red blood cell (RBC), with 
the ligand of interest chemically conjugated onto its membrane. The main purpose of 
using RBCs as surrogate APCs is to magnify binding events. Upon bringing the cells into 
contact with one another and separating them, a binding event may occur, visualized by 
deformation of the RBC membrane. Assuming binding events occur at low frequency, the 
adhesion frequency can be fitted to a probabilistic model that plots adhesion frequency 
against contact time between cells to extract an effective affinity constant and off-rate for 
the bimolecular reaction47. This assay revealed a much more positive association over a 
larger range of values between peptide potency and affinity constant between TCR and 
pMHC21. Interestingly, the assay suggested that bimolecular on-rate is a stronger 
determinant of peptide potency as opposed to what was previously thought to be off-
rate21. Thus, the micropipette adhesion frequency assay proved to be an effective method 
to measure of TCR-pMHC binding kinetics. 
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 A refinement of the micropipette adhesion frequency assay was developed to 
track the fluctuations of the ultrasensitive red blood cell membrane by using what is 
known as a biomembrane force probe (BFP)48. Here, single-molecule scale bond 
formation and dissociation between TCR and pMHC is visually tracked as the target cell 
is pulled away from the BFP at a predefined force. A seminal study using this assay 
found that an accumulation of bonds lasting above a threshold lifetime, occurring within 
a window of a minute reliably led to intracellular calcium flux in live T cells- a switch-
like indicator of T cell activation20. Overall, micropipette-based 2D binding assays have 
provided a more direct relationship between TCR-pMHC binding kinetics and T cell 
activation, for specific peptide systems, than the same measurements made using SPR19-
21,49,50. Studies using the BFP have also supported the concept of a catch-slip-bond. One 
type of protein-protein association is a slip-bond which will present shorter interacting 
bond lifetimes if the molecules are pulled apart by an external force51. A catch-slip-bond 
is a counter-intuitive type of association whereby forces on the interacting molecules 
pulling the bond apart will yield longer bond lifetimes until even higher forces will 
finally drive the bond to dissociate as in the slip-bond51. These bonds were first directly 
observed using atomic force microscopy measuring bonds between P-selectin and P-
selectin glycoprotein ligand-1 and were purported to be a mechanism supporting 
leukocyte surface rolling under shear forces52. Using the BFP, various TCR were shown 
to associate with pMHC through catch-slip bonds. In these studies, catch-slip-bonds were 
suggested to be a mechanism for amplifying discrimination between pMHC19,20,53, even 
discriminating between pMHC with similar affinities measured by SPR, but opposite 
potency effects50. 
1.1.2 T cell coreceptors 
 Function of T cells were discovered to vary between targeted killing of infected 
cells or robust secretion of cytokines54. Expressed on the surface of these different 
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effector cells were also mutually exclusive proteins- CD8 and CD4, respectively3,54,55. 
These markers were therefore aptly used for identification purposes. Even in the thymus, 
CD8 and CD4 expression occurred in stages and was useful in understanding stages of T 
cell development- first double negative thymocytes which express neither CD4 or CD8, 
then double positive which express both proteins, and finally split between two sets of 
single positive cells14. These surface markers were eventually found to serve functional 
purposes toward TCR triggering based on the two different classes of MHC, class-I and 
class-II54.  
1.1.2.1 CD8 coreceptor 
 CD8-positive T cells were found to be strongly associated with APCs that 
expressed the class-I MHC. This led to the suggestion that CD8 could bind to MHC-I, 
which was indeed found to be the case. It was determined that in the class-I interaction, 
TCR binds to the peptide groove while CD8 binds to MHC56. The CD8 coreceptor is 
encoded by two genes, CD8α and CD8β. Both expressed proteins are made up of a single 
Ig-like domain followed by stalk regions, a transmembrane domain, and a short cytosolic 
tail27. On T cells, these proteins exist mostly as CD8αβ heterodimers but CD8αα 
homodimers also exist27. Using SPR, both dimers were found to bind to MHC-I at 
affinity values ranging from 50-200 µM, which is between one and two orders of 
magnitude weaker than many TCR-pMHC interactions57. Using 2D binding assays, the 
CD8-MHC interaction was found to have an affinity of 5 x 10-6 µm4, which is almost two 
orders of magnitude weaker than the model OT1 TCR- OVA pMHC interaction21,58. Due 
to this large difference in binding affinities, the CD8-MHC interaction has been 
suggested to not play a significant role in stabilizing TCR-pMHC interactions, rather 
largely to recruit kinases to the TCR-CD3 ITAMs via its cytosolic association with 
kinases, specifically one called Lck27,59. Despite this consensus, CD8 has been shown to 
contribute to a ‘two-stage binding’ represented by an enhanced adhesion frequency after 
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a delay of 1 second contact time for the OVA system60. While the role of CD8 in 
propagating signal by recruitment of Lck to ITAMs is generally accepted, the role of 
stabilization of TCR-pMHC by CD8-MHC toward prolonging bond lifetimes has been 
relatively less explored19,61. 
1.1.2.2 CD4 coreceptor 
 Analogous to the CD8 case, CD4-positive T cells were found to be strongly 
associated with APCs expressing the class II pMHC 3,54. By overexpressing CD4 on cells, 
previous studies found the cells adhering to B cells expressing class-II MHC after 
washing, clearly demonstrating binding between CD4 and MHC class II62. More recently, 
it was shown that blocking CD4 can abrogate T cell signaling to a point that would 
require 30-fold as many TCR-pMHC interactions to recover the same level of signaling63. 
Peptides in class-II MHC are usually much longer than those anchored in class-I, ranging 
between 11-30 residues in length17,64. Despite this longer length, the peptide presented in 
class-I are more amenable to scanning by TCR because the peptide ends are confined by 
the groove which causes the peptide to bulge out of the groove. Peptides ends in class-II 
MHC extend out of the groove and are relatively unstructured64. The stability of peptides 
in class-II can also be weaker than in peptides in class-I65,66. To overcome this limitation, 
previous studies have used a peptide covalently bound to the MHC-II groove when 
interrogating interactions between TCR and pMHC49,67. Stability of peptide in MHC 
plays a critical role in TCR recognition because altering anchor residues have shown to 
greatly modulate binding affinity to TCR, as well as the peptide potency68. The 
measurement that has remained elusive, however, is binding kinetics between CD4 and 
MHC-II class-II. 
1.1.2.2.1 CD4, CD8, and ternary complex structures 
 In contrast to TCR, CD4 and CD8 are invariant structures and were therefore 
assumed to interact with conserved regions of polymorphic MHC molecules. Since the 
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CD8αα homodimer CD loop binds to the MHC-I α3 membrane proximal domain with a 
well-structured hydrogen-bond network, it was inferred that CD8-MHC-I binding does 
not require a conformational change27. CD4 is made up of four Ig-like domains (D1 
through D4), a short membrane proximal stalk region, a transmembrane helix, and a 
cytosolic tail which binds to Lck just like CD869. A distinct feature of CD4 is its angled 
orientation. When CD4 dimerizes, a ‘butterfly’ profile is observed with an angle at the 
D1D2 to D3D4 junction of 140°69. Unlike CD8-MHC-I binding, CD4-MHC-II binding 
was not found to be antibody-like and instead occurs CD4 D1 domain wedging between 
two membrane proximal α2 and β2 domains of MHC-II27. Using a superimposition of the 
CD4-MHC-II complex on TCR-pMHC-II structures, a ternary complex structure was 
predicted. This technique illustrated a V-shape ternary interaction, with TCR and CD4 
binding to MHC-II with their respective membrane proximal regions being clearly distant 
and not interacting27. The shape of the ternary complex was directly shown by Mariuzza 
and colleagues using CD4 that possessed much greater affinity to MHC-II, accomplished 
by yeast display70. TCR-pMHC-CD4 displayed the V-shape with approximately 70 Å 
distance between the membrane proximal Cα/Cβ module of TCR and the CD4 D4 
domain70. It was suggested that this distance provides ample space for CD3εγ/εδ/ζζ 
subunits to organize around TCR along with association with the coreceptor for ITAM 
phosphorylation28,70. These models likely capture the geometry of the ternary complex 
but defining the role of CD4 in TCR triggering is incomplete without measuring binding 
between CD4 and MHC-II. 
1.1.2.2.2 Remarkably low affinity binding of CD4 to pMHC 
 In contrast to binding between CD8 and MHC-I, measurements for CD4-MHC-II 
are controversial. The first measurements were made by Reinherz and colleagues using 
SPR and determined that human CD4 binding to mouse MHC class-II occurred with a KD 
of 200 µM, which is on the same order of magnitude with some CD8-MHC-I 
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measurements71. An unsuccessful attempt at recapitulating these results using human 
CD4 and human MHC class-II interaction concentrations as high as 2 mM was conducted 
by Davis and colleagues72. Further attempts were made by Mariuzza and colleagues who 
used concentrations as high as 400 µM with no detectable binding between CD4 and 
MHC class-II, which is in stark contrast to binding between their mutant CD4 and MHC 
class-II which occurred with a KD of 8 µM and is on the same order of magnitude as 
many TCR-pMHC interactions73. Instead of SPR, two dimensional assays were also 
unable to detect a significant difference between bimolecular TCR-pMHC interaction and 
the trimolecular TCR-pMHC-CD4 interaction49,74. Most recently, Davis and colleagues 
repeated this experiment using soluble CD4 at concentrations up to 2.5 mM at 4°C 
without any detectable binding75. However, by constraining molecules to two-
dimensional interactions, they successfully used the CD4 coated beads to pull down cells 
expressing MHC-II. To corroborate these findings, cells expressing MHC-II clearly 
displayed binding to CD4 (400-4,000 molecules/µm2) and CD2 (400 molecules/µm2) 
functionalized lipid bilayers, as seen by accumulation of fluorophore conjugated CD4 and 
CD2 under MHC-II expressing cells75.  Using the Zhu-Golan approach76 they estimate 
the CD4-MHC-II KD to be up to three orders of magnitude weaker than TCR-pMHC 
interactions76. These two-dimensional results are reminiscent of seminal work 
discovering that CD4 can mediate adhesion62. However, due to the very low affinity 
interaction of CD4-MHC-II not contributing significantly to TCR-pMHC interactions 
based on their calculations, Davis and colleagues concluded that the primary role of CD4 
was to deliver Lck to ITAMs, consistent with previous studies59,75. Still, it remains 
unclear how blocking CD4 could abrogate T cell signaling so significantly63.  
1.1.3 Lck kinase 
 Kinases are enzymes that catalyze the transfer of a phosphate from an ATP to a 
functional group of a molecule. With the addition of a phosphate group, the functional 
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group (such as a tyrosine) can be made conformationally accessible for association with 
specific adaptor molecules and in some cases subsequently phosphorylate other 
molecules. Such as process is termed a signaling cascade which can be reversible by 
enzymatic action of phosphatases which catalyze the removal of phosphates. 
Hematopoietic cells express a family of kinases called Src kinases that are specialized for 
various roles77. T cells primarily express Lck and Fyn from the Src family, but only 
express Lck consistently throughout their development and lifespan77.  
1.1.3.1 Lck structure and function 
 Lck is a 56 kDa protein made up of an N-terminal covalent attachment site for 
saturated fatty acids, a unique region which mediates association with CD4 and CD8 via 
a ‘zinc clasp’, a Src-homology 3 (SH3) domain, an SH2 domain, a tyrosine kinase 
domain, and a C-terminal regulatory domain77,78. Phosphorylation at the C-terminal 
domain at tyrosine 505 (Y505) of Lck causes intramolecular binding with its own SH2 
domain, resulting in an autoinhibited ‘closed’ form78. Y505 can be dephosphorylated by 
the ubiquitous CD45 phosphatase, which will relax Lck into an ‘open’ conformation79. 
Once open, phosphorylation of the catalytic tyrosine kinase domain at tyrosine 394 
(Y394) lends the kinase to become ‘active’ and is at that point, capable of 
phosphorylating the CD3 ITAMs79. It is thought that phosphorylation of Y505 is 
mediated by another kinase, Csk, and phosphorylation of Y394 is mediated by tans-
autophosphorylation77,79. Thus, this kinase which is critical for signal propagation from 
TCR-pMHC interactions exists in a dynamic equilibrium with many other signaling 
molecules. 
1.1.3.2 Lck association with CD4 and CD8 
 By means of its fatty-acid modified N-terminal end, Lck is anchored in the inner 
leaflet of T cells. Proximity to the membrane allows for direct imaging of Lck along with 
other surface bound receptors. Using these methods, it was found that CD4, TCR, and 
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Lck can colocalize prior to SMAC formation80,81. While Lck propagates signal from 
TCR-pMHC interactions, there is no direct evidence of TCR directly affecting Lck 
activation state79,82. In fact, it is estimated that 40% of Lck in T cells are constitutively 
active and this number does not correlate with TCR or CD4 engagement but does 
correlate with CD3ζ phosphorylation79, suggesting that Lck exists in a dynamic 
equilibrium between active and inactive Lck is maintained in resting T cells82. More 
recently, it was shown that the conformational states of Lck can determine their self-
clustering capacity with only active Lck inducing clustering82. Interestingly, Lck has been 
found to bind the intracellular portions of CD4 at a higher affinity than CD883. Using a 
thymocyte system that expressed a coreceptor chimera with a CD8 ectodomain and a 
CD4 cytosolic domain, it was determined that increased association with Lck can lead to 
more efficient TCR triggering84. Thus, while there is no evidence for TCR-pMHC 
influencing Lck activation state, Lck may play a critical role in increasing the efficiency 
of TCR-pMHC scanning for antigen.  
1.2 T cell receptor machinery interactions with oxidative environment 
 Sites of inflammation are made up of a host of immune cells secreting pro-
inflammatory cytokines and chemicals. A major family of chemicals that are secreted by 
these innate immune cells to destroy pathogens are reactive oxygen species (ROS)85,86. 
This group of chemicals rapidly and irreversibly oxidize biopolymers such that they 
disassemble, destroying lipid membranes, nucleic acids, and proteins87. Indeed, 
significant cytotoxic potential in inflammation is attributed to ROS by detecting overly 
oxidized biomarkers on host cells from scenarios of inflammation87,88. Ubiquitous in cells 
and tissue, however, are antioxidants which protect the host from damage88. The balance 
between the presence of ROS and antioxidant capacity can be a predictor of severity for 
various diseases such as asthma87,89 and diabetes90. When the balance tilts in favor of 
oxidants over antioxidants, a state of oxidative stress is created confined by defined 
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spatio-temporal boundaries, which could be organism systemic or localized in specific 
tissues87,91.  
1.2.1 Reactive Oxygen Species 
 Based in the antimicrobial action of phagocytes and the presence of oxidized 
biomarkers in various diseases85,86, the consensus was that bursts of extracellular ROS are 
considered to be harmful to host cells88. However, the paradigm of ROS effects in the 
field of immunology has shifted to one where ROS is also indispensable for many 
cellular functions as part of intracellular signaling91,92.  
1.2.1.1 Chemical action of ROS 
 Oxidation is defined by a loss of electrons while reduction is defined by a gain of 
electrons. ROS can be extremely volatile radicals such as the hydroxyl radical which 
reacts with biopolymers at diffusion-controlled rates and the superoxide anion radical 
which has a half-life of milliseconds87, or non-radicals such as hydrogen peroxide which 
is a relatively stable molecule91. DNA oxidation is a major contributor to genome 
instability and can lead to mutagenesis. Damage can be made to all four bases, as well as 
the deoxyribose, however the most susceptible to damage is guanine93. A lesion in 
guanine can cause it to pair with adenine instead of cysteine and can cause transverse 
mutations after replication91,93. Lipids are easily oxidized by radicals and are commonly 
used as biomarkers for oxidation91, while H2O2 can freely diffuse through the some 
membranes due to their uncharged nature87 or use aquaporins to transverse less 
permeable membranes94. As for proteins, radicals can damage multiple side-chain and 
backbone sites95. However, less reactive ROS display selectivity in the residues 
targeted91. Modification by oxidation can result in increased side-chain hydrophilicity 
which could result in altered conformations as well as altered interactions with binding 
partners95. In the case of mild H2O2, thiols in cysteine residues are oxidized resulting in 
sulfenic acid. This process of sulfenylation is reversible and can serve as a molecular 
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switch to change the conformation and interactions of a protein. Formation of a disulfide 
bond, glutathionylation, S-nitrosylation, S-acylation, and sulfenylamide formation are 
other reversible thiol oxidative modifications and play roles in protein signal transduction 
akin to and at times associated with tyrosine phosphorylation96,97. This vast array of 
modifications is exerted by ROS from a variety of sources. 
1.2.1.2 Sources of ROS and redox signaling 
 Recognizing that ROS does not only have detrimental effects was rooted in the 
fact that mitochondria creates ROS as byproducts of cellular respiration92. To produce 
ATP, oxygen is the terminal electron acceptor for the NAD/NADH redox pair, and 
oxygen is reduced to water87. However, it is estimated that 2% of the oxygen consumed 
by this process can create byproducts of superoxide and H2O2
98. Superoxide is produced 
by complex I and II of the mitochondria and released into the mitochondrial matrix. Here 
it is converted into H2O2 which can then freely diffuse into the cytosol
99. These were 
thought to be unwanted, but inevitable byproducts of metabolism. This perspective 
changed when H2O2 was found to be critical for processes such proliferation, 
differentiation, and migration through cysteine modifications100,101. Another major source 
of intracellular ROS is the NADPH oxidase (Nox) complex which is expressed by many 
cell types but in particular, is the mode by which neutrophils, monocytes, and 
macrophages produce millimolar concentrations of ROS for the respiratory burst targeted 
towards pathogens92. In response to recognition of infection by TLRs102, the integral 
membrane catalytic subunit joins with regulatory subunits, and produce superoxide in a 
closed compartment called the phagosome, which protects the rest of the cell from 
damage92,103. Prior to release toward the pathogen, superoxide is converted to a variety of 
ROS, such as H2O2 or peroxynitrite which is a reactive nitrogen species even more 
reactive than superoxide86,103. Damage by ROS is largely compartmentalized and along 
with the action antioxidants, are maintained at tolerable levels at the single-cell scale. 
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 In the event of an infection and recruitment of many inflammatory cells to a site 
which concomitantly produce ROS, deleterious effects are more likely. While cells will 
consume ROS using their antioxidants and create a ROS gradient across plasma 
membranes104, excess ROS at concentrations produced by NOXs can cause mutations or 
even lead to apoptosis and necrosis105,106. Homeostasis encapsulates all of the oxidative 
processes mentioned above through production of antioxidants and action of repair 
mechanisms, but it also includes equilibrium with oxidative environments external to the 
organism. A perpetual source of oxidants is in air that is inhaled into the lungs, which is 
well-suited for such a challenge since alveolus possess the high concentrations of 
glutathione, the predominant nonprotein thiol in cells87. When antioxidants are 
overwhelmed, an altered equilibrium can develop by various adaptations toward ROS, 
where the presence of high concentrations of ROS are systemic and chronic. Such altered 
equilibria exist for airway diseases87,89, alcohol abuse107, and cancer108,109. In the case of 
cancer, DNA mutations by ROS can lead activation of oncogenes and further stable 
production of ROS110. However, some studies have found that antioxidants can contribute 
to the maintenance and progression of this allostatic state110,111, clearly demonstrating the 
complex nature of ROS regulation in cancer. 
1.2.2 Effects of ROS specific to TCR triggering 
 In studying effector T cells, which exert their function at sites of inflammation 
(and therefore oxidation), it is imperative to take into consideration how ROS may 
influence their efficacy in battling infected cells.   
1.2.2.1 T cell receptor redox biology 
 Despite there being no documented cases of TCR αβ-chains sensitivity to 
oxidation by ROS, it is well documented T cell activation is closely related to ROS 
signaling96. Early studies found that introduction of antioxidants inhibited proliferation 
and cytokine signaling by stimulated T cells112-115. Conflicting studies later found that 
 19 
ROS stimulated T cell proliferation, in particular conditions116,117. The controversy of 
whether ROS suppresses or enhances T cell function remains fully understood and likely 
varies between different T cell developmental stages and the sensitivity of individual 
molecules of the TCR signaling cascade. A wealth of studies has found that in response 
to TCR triggering by anti-CD3 crosslinking, T cells generate ROS within 15 
minutes118,119, but it was later determined that this ROS burst by Nox is not necessary for 
expression of activation markers120. Another source of ROS in T cells following TCR 
triggering is the mitochondria. Since studies found that T cells undergo much higher 
glycolytic flux during T cell activation121,122, Sena and colleagues examined the 
mitochondrial metabolism. They found that the mitochondria consumed oxygen more 
rapidly and produced ROS which was sufficient to support T cell activation99. 
Interestingly, it was found that the mitochondria translocates under the TCR123 and 
localized ROS production enhances phosphorylation of signaling proteins like Lck within 
1 minute of TCR triggering124. The relationship between ROS and TCR is complex and 
requires consideration of molecules associated with TCR in order to fully understand its 
impact on T cell activation. 
1.2.2.2 Coreceptor and Lck redox biology 
 Along with the discovery that CD4 bound to MHC-II was the characterization of 
relatively higher binding affinity between CD4 and the HIV-1 envelope protein 
gp120125,126. Once bound to CD4, gp120 undergoes a conformational change which 
allows interaction with chemokine receptors on the T cell surface, CCR5 and CXCR4127. 
This step causes another conformational change in viral envelope which leads to fusion 
of the viral membrane with the host plasma membrane and release of viral particle 
contents into the host cytoplasm128. Transmission of HIV-1 infection leads to tremendous 
loss of CD4+ T cell numbers, and consequently severely impaired immune function. A 
body of research has found that HIV-positive patients present glutathione antioxidant 
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deficiency compared to control subjects 129-131. The redox state of CD4+ T cells is 
important to consider because a disulfide bond in the D4 domain can mediate homodimer 
formation132 which has been reported to be important for TCR-pMHC signaling133,134. 
However, this cell driven process can also leave the reduced form of CD4 to be 
susceptible to HIV-1135. Indeed, it was shown that the reduced monomeric CD4 is the 
preferred ligand for HIV-1, as opposed to the oxidized form135, and this interferes with 
formation of CD4 homodimers, which subsequently impairs signaling136.  
 An analogous redox characterization has not been conducted for CD8, but both 
coreceptors associate with Lck which possesses cysteines critical to their function which 
are known to be sensitive to oxidation. By mutating cysteines C378, C465, and C476 to 
alanine, Lck displayed impaired kinase activity including trans-autophosphorylation137. In 
this vein, specifically oxidizing Lck impaired its association with CD4, but this occurred 
at oxidant concentration greater than what was required to inhibit CD3 ITAM 
phosphorylation138. In contrast, others have found that oxidation of free sulfhydryl groups 
led to phosphorylation of both the Lck catalytic Y394 and the inhibitory Y505139. While 
the conformation of Lck may be modulated by cysteines, as seen even in HIV-1 
patients140, their activation state is likely indirectly modulated by ROS through 
phosphatases like CD45 or SHP-1 whose activity has been shown to be reversibly 
impaired upon oxidation141,142. These large number of possible modifications on Lck and 
its regulatory phosphatases in response to ROS cause investigation of CD3 ITAMs in an 
oxidative environment to be convoluted. A more direct measure of ROS influence on 
TCR triggering could reconcile these seemingly contradictory findings. 
1.2.2.3 Membrane cholesterol and actin redox biology 
 TCR, CD4, CD8, and Lck are anchored in a membrane made up of not only 
various phospholipids but microdomains of cholesterol. Relatively large aggregates of 
cholesterol and sphingolipids called lipid rafts have long been part of the ‘fluid mosaic’ 
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model of the cell membrane143, and are areas of higher density of surface proteins144. 
TCR and its associated proteins were found to be in clusters of cholesterol145-147, and 
removal or oxidation of cholesterol would inhibit TCR-mediated signaling148 and 
binding21,149. Similarly, inhibition of actin polymerization can inhibit TCR-pMHC 
binding21. While TCR clusters have only been shown to indirectly interact with actin150, 
associated signaling molecules further downstream have a direct link151. Oxidation of 
cofilin, which regulates actin disassembly and assembly is sufficient to cause T cell 
hyporesponsiveness152,153. Interestingly, lipid rafts and actin seem to regulate each other. 
Despite actin not linking directly to lipid rafts, disruption of cholesterol will alter actin 
organization144. Correspondingly, TCR-stimulated raft clustering depends on the 
reorganization of actin cytoskeleton154. This relationship is likely centered on the TCR 
machinery which can associate with both actin and cholesterol. Recently, disrupting TCR 
binding to cholesterol using a naturally occurring analog, cholesterol sulfate, inhibited 
CD3 ITAM phosphorylation155. Overall, the environment surrounding TCR heavily 
influences its signaling capacity. 
1.3 Macrophage Immunobiology 
 Macrophages are myeloid derived cells that are present in most tissues throughout 
the body156. They are differentiated from monocytes either from circulation, residing in 
tissues, or in bone marrow. It is imperative to note that macrophages can vary vastly in 
their functions between different anatomical compartments156. For example, while lung 
interstitial macrophages and Kupffer cells in the liver are both highly phagocytic157, they 
overexpress different surface markers that may play specialized roles for their local tissue 
microenvironment158. Due to their plasticity, macrophages thus represent a model cell 
system to study how aspects of the environment can have profound effects on cell 
function.  
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1.3.1 Macrophage function 
 Macrophage effector functions span roles across homeostasis, development, and 
innate and adaptive immunity159. The large diversity of function is exemplified in the 
case of alveolar macrophages which is involved in surfactant homeostasis160, lung injury 
repair, and even lung tissue development159. Furthermore, these macrophages serve as 
both an innate immune cells by phagocytosing particulate161, and an adaptive immune 
cells by presenting antigen to activate T cells in lung draining lymph nodes162, albeit at a 
relatively weaker efficiency163,164. In support of achieving these functions, macrophages 
undergo activation which is generally defined as antigen-dependent microbicidal activity 
in response to an infection165. Early work separated the differentiated states of activated 
macrophages, or polarizations, into two separate types: M1 and M2.  
1.3.1.1 Polarization 
 The categorization of activated macrophages into M1 and M2 macrophages 
stemmed from prior work in distinguishing Th1 and Th2 type inflammation responses165. 
This dichotomy has enabled comprehensive enumeration of the receptors that can 
activate macrophages, the intracellular signaling cascades that follow, and ultimately the 
proteins that are secreted by or expressed on macrophages166. Briefly, macrophages can 
polarize to the M1 phenotype in response to LPS (which is a major cell wall component 
of gram-negative bacteria), IFN-γ, virus internalization, or GM-CSF while, polarization 
to the M2 phenotype can be induced by IL-4, IgG, IL-10, glucocorticoids, or M-CSF165. 
Since the M1/M2 paradigm was studied in prototypical Th1/Th2 diseases, macrophages 
studied in other pathologies may display a mixed M1/M2 phenotype both in the stimuli 
they respond to and their effector functions, a finding that underscores the limitation in 
the current M1/M2 dichotomy paradigm167.  
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1.3.1.2 Secretions 
 Macrophages will secrete various proteins and small molecules after stimulation 
by LPS. To directly destroy the source of LPS, macrophages can release large amounts of 
H2O2 through superoxide production by NOX complexes
161. LPS stimulation can trigger 
the generation of proinflammatory cytokines like TNFα and IL-6, which increases 
vascular permeability and activates T and B cells, respectively3. Toward the resolution of 
clearance, alveolar macrophages can secrete TGF-β which inhibits DC-mediated 
activation of T cells and can contribute to tissue remodeling159,168. Thus, these cells can 
play both positive and negative regulatory roles. This central role is exemplified in the 
airways where alveolar macrophages make up to 90% of the cellular content159,164,168. 
Upon LPS recognition, macrophages generate chemokines CXCL10, CXCL11, and 
CCL2, which together recruit other immune cells to exert a more diverse repertoire of 
defenses164,165. Interestingly, LPS can serve as an auto-chemokine for peritoneal 
macrophages through production of prostaglandins which would occur on the scale of 
hours169. Altogether, these secretions center the macrophage as a proinflammatory hub. 
1.3.1.3 Phagocytosis 
 Macrophages, along with neutrophils, are referred to as professional phagocytes 
because of their efficiency to engulf objects (cells, pathogens, or debris) larger than 
0.5µm170. Unlike receptor mediated endocytosis and pinocytosis, phagocytosis usually 
functions independent of clathrin and instead relies on actin reorganization. This process 
can be initiated by both Fc and complement receptors, which recognize particulate that 
have been opsonized by antibodies and complement, respectively170. Triggering of these 
receptors leads to a cascade of phosphorylation events and reorganization of the actin 
machinery as seen by their enrichment at point contacts with the object171.  Furthermore, 
internalization mediated by Fc-receptors is closely associated with generation of 
proinflammatory molecules170. Thus, phagocytosis is a critical mechanism for 
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macrophages to clear infection. However, this process can be impaired by oxidative 
environments. 
1.3.2 Development of oxidative stress in alcohol exposed macrophages 
 Excessive alcohol consumption is associated with tremendous clinical 
complications such as increased risk of acute respiratory distress syndrome 
(ARDS)172,173. This disease has a mortality rate of 26%174 and is characterized by the 
activation of systemic inflammatory cascades due to development of pulmonary edema 
caused by inflammation, trauma, or severe pneumonia175. Another example is how 
alcohol use during pregnancy leads to a 34-fold increase in risk of premature delivery107 
and an increased risk of systemic infection known as sepsis176,177. In a guinea pig model, 
in utero ethanol exposure led to oxidative stress in the developing lungs, as measured by 
glutathione content, which was associated with impaired alveolar macrophage function 
and increased risk of pneumonia178-180. Later in a mouse model of in utero ethanol 
exposure, the same group found that alveolar macrophage displayed not only impaired 
differentiation, but also impaired phagocytosis and dysfunctional TGF-β secretion181.  
1.3.2.1 Upregulation of reactive oxygen species in macrophages 
 By exposing both primary and cell line macrophages to ethanol, Nox 1, Nox2, 
Nox4 and associated Phox proteins were expressed at higher levels, which was 
accompanied by greatly increased production of ROS182. With continuous exposure to 
ethanol, the increased in mRNA levels increased up to an apparent saturation point after 
72 hours182. Thus, it is possible that chronic alcohol exposure can shift the immediate 
macrophage environment into a stable state of oxidative stress. In a later study, 
concurrent incubation of ethanol-treated alveolar macrophages with the critical 
antioxidant glutathione downregulated the increase, and this modulation improved 
phagocytosis. These results were corroborated when ethanol fed mice underwent oral 
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administration of glutathione. Therefore, there is a clear relationship between oxidative 
stress and macrophage state and function183. 
1.3.2.2 Association between oxidative stress and TLR4-LPS axis 
 To further understand risk factors associated with ARDS, a mouse model was 
developed which recapitulates the human acute phase184,185. Surprisingly, this mouse 
model was resistant to LPS challenge and it was discovered that a mutation in the TLR4 
receptor was responsible. The impaired TLR4 signaling was also associated with a 
decrease in oxidized phospholipids, suggestive of reduction in ROS presence186. Another 
study found that when production of glutathione was inhibited by gene knockout of Nrf2, 
causing higher intracellular ROS, LPS-mediated TLR4 signaling improved. This was 
confirmed when a double knockout mouse model which also prevented ROS generation 
exhibited similar TLR4 signaling as Nrf2-positive cells187. Recently, a mutual 
relationship was discovered whereby TLR4 deficiency abrogated ROS generation, which 
afforded accumulation of antioxidant capacity, reduced inflammation, decreased TGF-β 
deposition, and ultimately prevented hypertension-induced kidney injury188. Supporting 
studies have found that TLR4 is rapidly shuttled to the membrane upon oxidative stress 
which may serve as a mechanism to prime macrophages for recognizing pathogens189. In 
order to directly determine how oxidative stress influences TLR4 signaling, however, 
TLR4 binding to LPS must be considered. 
1.3.3 TLR4 triggering by LPS 
 Among all the TLRs, TLR4 is the most well-studied and its signaling is triggered 
by LPS ligation, but requires a set of additional proteins190. CD14 was long considered to 
be a receptor for LPS, because antibody blockade of CD14 abrogated TNF-α secretion191. 
However, CD14-LPS binding triggered variable signaling cascades than those from 
TLR4-LPS binding192. While the receptor for LPS was in the process of being 
determined, lipid binding protein (LBP) was shown to be critical in the macrophage 
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response to LPS193. Once TLR4 was confirmed to be the primary receptor for LPS, a 
secreted glycoprotein, MD-2, was shown to associate with TLR4 and confer its 
sensitivity to LPS194,195. Associations between TLR4, LPs, and MD-2 were corroborated 
upon determination of the multi-molecular crystal structure.  Together, they form an M-
shaped multimer made up of two copies of the TLR4-LPS-MD-2 trimolecular 
complex196. Dimerization of the two copies creates a platform for adaptor molecules like 
MyD88197 and TRIF to initiate a signaling cascade. SPR was conducted to measure the 
binding affinities between these various molecules. Using soluble mouse proteins, MD-2-
LPS interactions had a KD of 2 µM; CD14-LPS had a KD of 9 µM, and TLR4-LPS had a 
KD of 14 µM
198. Meanwhile, human LBP was shown to have almost 4 nM affinity to 
LPS199. Interestingly, progressive association such as LBP-LPS-CD14 from CD14-LPS, 
or MD-2-LPS-TLR4 from LPS-TLR4, greatly enhanced association to LPS200. These 
findings support a model where LBP binds to LPS; the LBP-LPS complex binds to CD14 
and is extracted from the bacterial membrane; LPS is transferred to TLR4-MD-2; and the 
TLR4-LPS-MD-2 trimolecular complex undergoes conformational changes to allow the 
cascade inducing dimerization196. Thus, binding studies played a critical role in resolving 
the convoluted complexing of LPS to macrophage receptors. While binding kinetics 
between the TLR4-MD-2 bimolecular complex and LPS have not been reported, recently 
it was found that real-time binding between a damage-associated molecular pattern and 
TLR4 induced macrophage stiffening201. Taken together, binding studies conducted on 
macrophages experiencing oxidative stress could be a powerful approach to more directly 
understand how TLR4 signaling is modulated by ROS.  
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CHAPTER 2  SPECIFIC AIMS AND HYPOTHESES 
 Molecular interactions propagate physical and biochemical signals, ultimately 
resulting in cellular functions. Often, these interactions involve many molecular species 
as a means of specializing signal transduction. Furthermore, protein interactions are 
subject to dynamic soluble extracellular microenvironments. Characterizations of multi-
molecular interactions and an investigation of how biochemical perturbations imposed in 
tandem could influence signal transduction are therefore warranted. To understand this 
central theme, the model TCR-pMHC-CD4 system was employed to characterize 
trimolecular interplay. Next, an analogous CD8 coreceptor system was studied to 
understand how a pathological oxidative environment can influence trimolecular 
interactions. Lastly, framework from the T cell model was used to study the macrophage 
TLR4-LPS system whose signal transduction responds with profound plasticity to 
oxidative environments. 
  
Aim 1: Delineated the role of CD4 co-receptor in T cell receptor triggering  
Hypothesis: CD4 binds to TCR-engaged pMHC-II to prolong lifetime of complex 
Aim 1a: Detected CD4 coreceptor and trimolecular binding  
Aim 1b: Mathematically characterized trimolecular kinetics 
Aim 1c: Distinguished purified kinetics to cellular system kinetics  
Aim 2:  Quantified the effect of H2O2 environment on T cell receptor binding 
Hypothesis:  TCR binding to pMHC-I will be impaired in presence of H2O2. 
Aim 2a: Developed real-time adhesion frequency assay for ROS study 
Aim 2b: Deconvoluted signaling molecules responsible for impaired recognition 
Aim 3:  Determine the role of TLR4-LPS binding in ROS-impaired function  
Hypothesis: TLR4-LPS binding is impaired in an oxidative stress environment  
Aim 3a: Conducted real-time micropipette assay for TLR4-LPS binding under ROS 
Aim 3b: Imaged movement of macrophages in response to LPS under oxidative stress 
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CHAPTER 3  Aim 1 
Delineating the role of CD4 coreceptor in T cell receptor triggering. A fundamental 
piece of information missing in the controversy over the role of CD4 in TCR triggering 
are kinetic measurements of CD4 to MHC-II and an experimentally-determined 
contribution of CD4 to TCR-pMHC-II association. Since  it was found21 that constraining 
the receptor-ligand pair in their respective membranes upon engagement greatly amplifies 
the difference in on-rates for point mutations within the peptide; affinity and on-rate 
measurements correlate more closely to peptide potency than the same measurements 
made by SPR do; and deformations in the ultra-sensitive red blood cell membrane is able 
to detect lower affinity binding events than capable via SPR, the micropipette adhesion 
frequency assay was employed to measure CD4 binding to peptide-human leukocyte 
antigen (pHLA), which is the human analog to pMHC. The same approach was used to 
measure the trimolecular interaction between TCR-pHLA-CD4, and parameters from 
these experiments were inputted into a mathematical model to characterize the 
contribution of CD4 to TCR-pHLA interaction. 
3.1 Methods 
3.1.1 Materials 
 Polylink bead coupling kit and 6µm carboxylated polystyrene beads were 
purchased from Polysciences, Inc. (Warrington, PA). The kit included a polylink 
coupling buffer, polylink wash/storage buffer, and polylink EDAC. Calbiochem brand 
Biotin-PEG-NHS for biotinylation of RBCs were purchased from Millipore Sigma 
(Burlington, MA). Coverslips for micropipette chambers were purchased from Fisher 
Scientific (Hampton, NH). RPMI1640 + glutamine with no calcium or magnesium, 1X 
PBS, L15, and 1X HBSS was purchased from Corning Inc. (Corning, NY). PE 
Quantibrite calibration beads and PE-conjugated antibodies were purchased from BD 
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Biosciences (San Jose, CA). TCR was stained with PE-conjugated anti-human TCR-β1 
chain clone JOVI.1. CD4 was stained with PE-conjugated anti-human CD4 clone OKT4. 
pHLA was stained with PE-conjugated anti-human HLA-DR clone L243. Fluo-4 AM 
was purchased from ThermoFisher (Waltham, MA). Nucleofection kit was purchased 
from Lonza (Morristown, NJ). Plasmids for full-length TCR and CD4 were purchased 
and prepared by Genscript (Piscataway, NJ). Peptides were also purchased from 
Genscript and were loaded onto biotinylated HLA-DR monomers by the Yerkes National 
Institutes of Health Tetramer Core facility (Atlanta, GA). Completed pHLA were stored 
at -20°C in 50% glycerol/PBS and a fresh aliquot was used in each experiment. 
Biotinylated E8 TCR and CD4 were generously gifted by Roy Mariuzza at the University 
of Maryland. Divalent streptavidin was generously gifted by Baoyu Liu at the University 
of Utah. All other reagents were purchased from Sigma Aldrich (St. Louis, MO). 
3.1.1.1 Acquisition of Cells 
 For adhesion frequency experiments, whole blood was isolated by phlebotomists 
from healthy volunteers at the Stamps Health Center at the Georgia Institute of 
Technology according to a Georgia Institute of Technology IRB-approved protocol. For 
BFP experiments, human RBCs were isolated from whole blood of healthy volunteers by 
finger prick according to a Georgia Institute of Technology IRB-approved protocol. TCR 
β-chain deficient Jurkat J.RT3 cells were purchased from ATCC (Manassas, VA). J.RT3 
cells were transfected with the plasmid for full length E8 TCR using retroviral 
transduction. Briefly, plasmid was amplified using a stable E. Coli and amplified DNA 
was isolated. Purified DNA was combined with VSV-G envelope protein and psPAX2 in 
optimum with lipofectamine and cultured with 293T cells. Finally, viral supernatant was 
incubated with J.RT3 cells, surviving cells were taken for Fluorescence activated cell 
sorting (FACS) by BD Aria. Cells were sorted three times to ensure narrow and stable 
surface expression levels of E8 TCR. Subsequently, Jurkat cells with varying surface 
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expression levels were electroporated with plasmid for full length CD4 within 
supplemented media using the Amaxa Nucleofector II (Lonza). After a resting period of 
two days in supplemented media, cells were cultured for one week with periodic 
passaging before taken for FACS by the BD Aria. Cells were sorted three times to ensure 
narrow and stable surface expression levels of CD4 that were consistent between all cell 
lines. 
3.1.1.2 Preparation of Cells and Beads 
3.1.1.2.1 Preparation of RBCs for adhesion frequency 
 Whole blood was isolated by phlebotomists from healthy volunteers at the Stamps 
Health Center at the Georgia Institute of Technology according to a Georgia Institute of 
Technology IRB-approved protocol. Histopaque-1077 was added to the bottom of the 
tube of RBCs and the suspension was centrifuged. Supernatant containing all cells except 
for RBCs were discarded and the RBCs were washed and resuspended in ice cold 1X 
PBS. Following buffer exchange into EAS-45 (2 mM Adenine, 110 mM D-glucose, 55 
mM D-Mannitol, 50 mM Sodium Chloride, 20 mM Sodium Phosphate, 10 mM L-
glutamine), aliquots of RBCs were mixed with biotin-3400-NHS at a pH of 7.2 for 30 
minutes at room temperature. The ratio between RBCs and biotin-3400-NHS were varied 
to increase the site density of biotin on the surface of RBCs. Controlled biotin sites 
allowed for defined sites of biotinylated protein when saturating concentrations of 
proteins were incubated with biotinylated RBCs. 200 µg/mL divalent streptavidin was 
incubated with RBCs for 20 minutes at room temperature. Following exhaustive washing 
of RBCs with ice cold EAS-45, biotinylated OT1-TCR or OVA-MHC-I at a 
concentration of 20 µg/mL were incubated with RBCs for 30 minutes at room 
temperature. RBCs were washed twice with ice cold 1X PBS + 2% BSA and aliquots 
would be taken for site density measurements by flow cytometry.  
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3.1.1.2.2 Preparation of RBCs and beads for Biomembrane Force Probe  
 Freshly isolated human RBCs were biotinylated by covalently linking to biotin-
PEG3500-NHS by 30 min incubation at 25°C. Biotinylated RBCs were then incubated 
with nystatin in N2 buffer (265.2 mM KCl, 38.8 mM NaCl, 0.94 mM KH2PO4, 4.74 mM 
Na2HPO4, 27 mM sucrose; pH 7.2 at 588 mOsm) for 30 min at 0°C. Nystatin-loaded 
biotinylated RBCs were washed twice with and stored in N2 buffer at 4°C for later use in 
BFP experiments. To coat proteins on beads, borosilicate glass beads were mercapto-
propyl silanated and covalently functionalized to monovalent streptavidin-maleimide in 
phosphate buffer saline (pH 6.8) by overnight incubation at 25°C. Streptavidinylated 
beads were then incubated with sub-saturating concentrations of biotinylated pHLA, 
TCR, CD4, or mixtures of protein for 2 hours in HBSS + 2% BSA at 4°C. After coating, 
beads were stored at 0-4°C to improve stability. 
3.1.2 Binding Assay 
3.1.2.1 Micropipette Adhesion Frequency 
3.1.2.1.1 Coating strategy 
 Biotinylated RBCs of a specified site density were incubated with 0.2 mg/mL 
divalent streptavidin for 30 minutes at 4°C, washed exhaustively, then incubated with 20 
µg/mL biotinylated TCR, CD4, or pMHC monomers for 30 minutes at 4°C. For mixture 
coatings, soluble TCR was mixed with CD4 at specified molar ratios and then added to 
washed streptavidinylated RBCs. Table 3 describes optimized ratios of monomer 
concentrations in order to achieve specific ratio of coated proteins as quantified by flow 
cytometry described below.  
3.1.2.1.2 Site density determination 
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 Beads or RBCs were incubated with antibodies corresponding to their protein 
functionalized surfaces for 30 minutes at 25°C using a saturating antibody 
concentrations. Following three washes and resuspension in 1X PBS + 2% BSA, beads 
and RBCs were analyzed using the BD Accuri Flow Cytometer FL2 channel for PE 
excitation and detection. Fluorescence measurements were compared with BD 
Quantibrite PE calibration beads in order to calculate the number of proteins on the 
surface of beads. Briefly, fluorescence from beads of four different sizes and with 
different known number of PE-fluorochromes were used to create a well-fitted (R2 > 
0.97) linear regression between the log of mean fluorescence intensity and the log of PE 
molecule count. The regression was used to back-calculate the fluorescence from PE-
stained beads and RBCs. 
3.1.2.1.3 Micropipette Adhesion Frequency Assay 
 This assay used sub-micron scale manipulation to bring into contact a pair of 
RBCs with ultrasensitive membranes coated with either a receptor or cognate ligand to 
visually amplify the presence of adhesion at the end of the contact of controlled contact 
area and contact time. The repeated motions of impingement and retraction were 
controlled by a piezoelectric actuator. This micropipette apparatus approach is higher 
throughput than the BFP assay in collecting affinity measurements and was therefore 
used initially to measure kinetics between purified proteins coated on the RBCs. Upon 
obtaining kinetic measurements from purified proteins, translating into a cell system 
required using the BFP assay because human RBCs express CD58 which binds to CD2 
which is highly expressed on human derived Jurkat cells. 
 Pipettes were individually forged to under 1 µm in opening diameter to allow the 
biotinylated RBC to aspirate and adopt a surface tension that cannot be seen to fluctuate 
under the microscope. In the field of view were two opposing pipettes- one aspirated an 
RBC with pHLA while the other aspirated an RBC with TCR alone, wtCD4 alone, 
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mtCD4 alone, a mixture between TCR and wtCD4, or a mixture between TCR and 
mtCD4 (Figure 1A). The experiment was conducted under a microscope within a 
chamber containing a non-CO2 dependent L15 media supplemented with HEPES to 
maintain pH and 2% BSA to minimize non-specific adhesions. This media was then 
sealed with mineral oil to prevent changes in osmolarity during the experiment. 
 First, the adhesion frequency must be optimized for contact time and site density 
of interacting proteins. RBCs with various biotin binding sites were used to coat with 
biotinylated protein, and those with 20-30% adhesion frequency at long contact times (4 
seconds was initially assumed to be long because the likelihood of binding 20-30% for 
most adhesion molecule bonds and strong TCR-pMHC bonds such as OT1 TCR:OVA 
pMHC would saturate at 2 seconds) were from then on out used as reference site 
densities. Adhesion frequency was estimated from 50 cyclically repeated contacts of a 
single pair of RBCs and a mean adhesion frequency would be determined from a stated 
number of different RBC pairs. Each cycle would consist of 0.5 seconds of approaching 
over about 10µm until the RBCs are in contact (but not visibly impinging), a defined 
contact time, 0.5 seconds of retraction over 10 µm back to the 0 µm baseline, and 0.5 
seconds of pausing before the next cycle begins. Adhesion events would be recorded in 
binary with ‘1’ indicating an adhesive event and ‘0’ indicating no adhesion. An average 
of values between 50 contacts yields the ‘adhesion frequency’ for a given contact time. 
Then, adhesion frequency curves were constructed by measuring adhesion frequency 
against increasing contact times until saturation would clearly occur (assumed here to not 
be changing in adhesion frequency for three progressively doubling contact times, 
(Figure 1B). A Poisson-based probabilistic model for adhesion kinetics mediated by a 
small number of bonds predicts the average number of bonds formed to be related to the 
adhesion frequency. <n> for a given contact area (assumed to be 3 µm2 between RBCs) is 
related to the concentration of interacting species, the affinity of the interaction, the off-
rate, and the corresponding contact time between cells (Figure 1D). Thus, the 2D 
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effective affinity can be extracted based on adhesion frequency (Figure 1C). After 
saturation contact times were determined for all tested interacting species coatings, only 
the shortest saturating contact times would be used for further experiments comparing 2D 
affinity or <n> values, in order to achieve a higher throughput collection of data.  
 Non-specific controls were conducted for all sets of species coatings. To do so, 
RBCs coated with divalent streptavidin anchored irrelevant protein were brought into 
contact with RBCs coated with proteins of interest. An adhesion frequency curve would 
be obtained for nonspecific adhesion. Then, for each contact time, the distribution of 
nonspecific adhesion frequency would be subtracted from the measured distribution of 
adhesion frequency (Figure 1E). 
3.1.2.2 Biomembrane Force Probe 
3.1.2.2.1 Coating 
 Sub-saturating concentrations were used to coat proteins on the glass BFP beads 
to ensure low adhesion frequency (≤ 20%) is achieved for single-molecule measurements, 
and for there to be sufficient streptavidin site for strong attachment to biotinylated RBC. 
Proteins were incubated with streptavidinylated beads at a concentration of 4 ng/mL in 
HBSS + 2% BSA for 2 hours at 4°C, then washed using ice cold HBSS + 2% BSA.  
3.1.2.2.2 Assay 
 This assay leverages the ultra-sensitive RBC membrane as in micropipette but 
instead of only observing the presence of adhesive events, the deformations are 
quantified by tracking the interface between the RBC membrane and glass bead surface 
using a high-speed camera. These deformations in distance are converted to force using 
the spring constant of the nystatin expanded RBC. The derivation and a characterization 
of spring constant transformation are described elsewhere202,203 and depends on the 
diameter of the micropipette, the size of the RBC, and the size of the interface between 
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RBC and bead. Accordingly, micropipettes to hold the BFP were forged to be between 
1.7 µm and 2.2 µm. Outside this range, the equations used to derive spring constant are 
not applicable. The BFP would be constructed as follows: A micropipette was calibrated 
for zero aspiration for every BFP that was constructed. From this baseline, an RBC was 
firmly aspirated. Then, an opposing pipette aspirating a protein-coated glass bead 
impinged the bead against the apex of the RBC. Finally, the bead was released from its 
pipette to complete the BFP (Figure 2 A and B). What was formerly the bead pipette was 
then free to aspirate the target cell. To calibrate the constant for every BFP used, the 
opening diameter of the RBC-aspirating micropipette is measured, along with the 
diameter of the RBC and the diameter of the contact area between the glass bead and the 
RBC. These values are inserted into a calibration equation described elsewhere202, and an 
aspirating pressure to obtain an RBC spring constant of 0.3 pN/nm is outputted. The 
aspirating pressure is accordingly adjusted in relation to the baseline zero pressure, and at 
this point the BFP assay was ready to be executed. 
 In the BFP assay, nonspecific adhesions were tested first because higher adhesion 
frequencies yield a higher probability of multiple bonds forming simultaneously. Thus, 
the contact time and buffer were optimized to minimize the nonspecific adhesion to 
below 3%. Jurkat cells were taken directly from incubator at 37°C within RPMI1640 + 
10% FBS (hereon abbreviated as R10), concentrated, and then injected into the L15 + 2% 
BSA supplemented chamber media sealed with mineral oil. The cells were allowed to 
equilibrate to the new chamber media for 20 minutes before proceeding with the testing 
of nonspecific adhesions, which was then followed by testing experimental groups. 
 Typically, 15 minutes of repeated cycles of contact between the Jurkat cell (or 
bead) against the BFP were conducted. Careful micromanipulation was constantly 
administered in order to achieve a contact profile that is normal (does not experience 
shearing forces). Common unsuitable force profiles would involve dragging of the 
interface, or lack of contact. Additionally, for a majority of Jurkat cells, adhesion was not 
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detected for the first 30-50 contacts. The 15 minutes of contact included the first 30-50 
cycles of no adhesion. 
 The force spectroscopy mode conducted with BFP was a force-clamp (Figure 2C 
and D). A force value would be predefined at which the molecular bond was maintained. 
As the cell impinged the BFP, the force profile read a negative value indicative of force 
being exerted on the BFP. This force value was maintained at the predefined compression 
force for the duration of the predefined contact time. At the end of the contact time, the 
force profile would rapidly ramp increasingly positive until it reached the clamp force, at 
which it the position of the cell is maintained at until the molecules would reach their 
bond lifetime and dissociate back to the baseline thermal fluctuation force values of the 
RBC. Several hundred events would be collected for each clamp force across many 
different BFP-cell pairs and these values were analyzed. 
 Every single force profile was analyzed. Adhesion frequency was collected as 
described in Section 3.1.2.1 between both the presence and absence of bond formation. 
Successful bond formations were more carefully analyzed using in-house Labview 
programs. Bond lifetime (from the beginning of force clamp value to the instant the bond 
dissociates) and bond stiffness (the force experienced by the bond over an extension of 
the molecular bond) were cataloged. The bond lifetimes are binned by forces and all bond 
lifetimes within each bin are plotted together as survival curves (log of fraction of bonds 
lasting longer than a given bond lifetime) fitted to a two-state model for TCR-pHLA 
bonds and trimolecular bonds, and a one-state model for CD4-HLA bonds. Once a good 
fit is achieved, all lifetimes within each bin are averaged and plotted against their 
respective average force.  
3.1.2.2.3 Stiffness Assay 
 The stiffnesses of molecular bonds were modeled as Hookean spring constants 
which encapsulates the proportionality between the force exerted on a spring and the 
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distance traveled over the exertion (Figure 2 E and F). Stiffness was measured from the 
ramping phase of the BFP test cycle. The difference between the displacements of the 
bead tracking system and the displacements of the piezoelectric actuator-capacitance 
sensor feedback system yielded the distance at which the molecular springs were 
experiencing force. Two straight lines were fitted to the piecewise data: One was fitted to 
the compressive force regime where the bead was slowly ramping away from cell 
impingement (force < 0). The other was fitted to the tensile force regime where the bead 
would ramp away from the cell beyond the point of initial contact (force > 0). In this 
analysis, it is assumed that the magnitude of force on the cell membrane is identical in 
cell compression as it is in tension. Hooke’s law for springs in series is illustrated in 
Figure 2E and F. The slopes from the two fitted lines provided the spring constants for 
the cell and the cell-molecule system, respectively. Thus, the spring constant was derived 
using the equation in Figure 2E and F. An ensemble of molecular spring constant was 
collected as histograms using similar force bins in the average bond lifetime analyses. 
Single or double Gaussian distributions were used to fit the histograms. These histograms 
were then used to estimate the number of molecular bonds that were bimolecular or 
trimolecular in nature. 
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Figure 1. Micropipette Adhesion Frequency Assay (A) Microscopic view of two 
aspirated RBCs each coated with proteins brought into contact with one another by a 
piezoelectric actuator attached to the left micropipette. Scale bar 4 µm. (B) Schematic 
depicting probability of adhesion plotted against varying contact times between cells in 
A. (C) Poisson distribution describing how the average number of events of a defined 
scenario is related the probability of the events occurring.  (D) Equality describing the 
parameters constraining the average number of events that can occur. (E) Calculation to 
subtract nonspecific adhesions from the observed adhesion frequencies to yield the 









3.1.3 Mathematical Characterization 
 The poisson-based model for 2D affinity in adhesion frequency was derived for a 
bimolecular interaction and does not apply for three interacting species. An extension of 
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the model is derived for the trimolecular case and is described here. The trimolecular 
association was modeled using mass action kinetics. Depicted in Figure 3, in pathway 
within a system describes the association of TCR and pHLA and subsequently the 
association with CD4 to yield the trimolecular complex. The trimolecular complex can be 
dissociated in the reverse direction or by dissociating TCR first and subsequently CD4. 
Figure 2. Biomembrane Force Probe assay and analysis. 
(A) Microscopic view of BFP opposite from the target cell which was an RBC or a bead. 
This depicts a scenario where purified pHLA was coated on the glass bead (placed on 
the apex of an RBC), while TCR and CD4 (either individually or as a mixture) was 
coated on the target cell. The target cell moved by a piezoelectric actuator which 
responded to the high-speed tracking of the interface between the RBC and the glass 
bead on the left. Scale bar is 4 µm. (B) Microscopic view of BFP coated with pHLA 
opposite from a Jurkat cell expressing TCR, CD4, or a mixture of both at different ratios. 
The Jurkat cell moved by a piezoelectric actuator which responded to the high-speed 
tracking of the interface between the RBC and the glass bead on the left. Scale bar is 4 
µm. (C) Representative data depicting a BFP assay cycle where no adhesion event 
occurred. The black trace depicts the thermal fluctuation exhibited by the BFP which 
was tracked by the interface between the RBC and the glass bead. The orange trace 
depicts the period when the BFP and the target cell were impinged against one another at 
a predefined force. (D) Representative data depicting a BFP force clamp assay cycle 
where an adhesion event occurred. The black trace depicts the thermal fluctuation 
exhibited by the BFP which was tracked by the interface between the RBC and the glass 
bead. The orange trace depicts the period when the BFP and the target cell were 
impinged against one another at a predefined force. The blue trace depicts the ramping 
phase where the cells remained associated through a single-molecule scale molecular 
bond which was held at a predefined clamp force. The green trace depicts the bond 
lifetime duration two molecules remained associated to each other until dissociation 
which was described by the interaction off-rate. (E) Schematic representing the BFP and 
target cell as a system of Hookean Springs. The upper spring was experiencing a 
compressive force and the stiffness described by this system is equivalent to the stiffness 
of the target cell. The lower system was modeled as two springs in series experiencing a 
tensile force. The black spring represents the stiffness of the target cell, while the blue 
spring represents the stiffness of the bimolecular bond. The equation describing the 
relation between spring constants is displayed. (F) Schematic representing the BFP and 
target cell as a system of Hookean Springs. The system was modeled as two springs in 
series experiencing a tensile force. The black spring represents the stiffness of the target 
cell, while the blue spring represents the stiffness of the trimolecular bond. The 
trimolecular bond, however, was modeled as two springs in parallel. When exerted in 
parallel, two spring constants are additive. The equation describing the relation between 
spring constants is displayed. 
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These two pathways were driven by kinetic on- and corresponding off-rates and exist in 
equilibrium. 
 A more simplified view of the above system separated the two pathways into 
individual ones. Consequently, on- and off-rates describing the first association of the 
mutually exclusive species did not exist (Figure 4). The resulting average number of 
bonds formed between two molecules was derived as in section 3.1.2.1.3, and 
previously21. However, the average number of bonds formed between three different 
species was proportional to the concentration of not two, but all three interacting species, 
the contact area between cells, and the affinities for two different bimolecular 
interactions. The total number of bonds observed during an experimental cycle, was 
therefore described as the sum between trimolecular bonds and any bimolecular bonds 
from the previous reaction step. When no cooperativity was assumed, that is, the on-and 
off-rates of TCR to pHLA does not differ from the on- and off-rates of TCR to pHLA-
CD4; or the on- and off-rates of CD4 to HLA does not differ from the on- and off-rates of 
CD4 to TCR-pHLA, the affinities would between these aforementioned steps did not 
change either. Thus, the trimolecular expressions for average number of bonds formed 
between the two independent pathways were equivalent. This permitted combining the 
two pathways (Figure 4), to describe a uniform case of no cooperativity, whereby the 
total number of bonds observed experimentally was predicted to be the sum of the 
trimolecular bonds and the two separate bimolecular bonds. 
 To characterize a scenario of cooperativity, the following assumptions were made 
(Figure 4). The first was that the on-rate of TCR to pHLA was proportional to the on-rate 
of TCR to pHLA-CD4 by a scalar ‘a’. This scalar encapsulated any influence or 
conformational change that may occur after the first bimolecular bond. The 
corresponding off-rates were assumed to be proportional by a scalar ‘b’. This scalar 
encapsulated any change in dissociation from the trimolecular complex compared to 
dissociation from a bimolecular interaction. Next, the on-rate of CD4 to HLA was 
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proportional to the on-rate of CD4 to TCR-pHLA by a scalar ‘c’. This scalar 
encapsulated any influence or conformational change that may occur after the first 
bimolecular bond. Importantly, the fourth assumption was that the off-rate proportionality 
in this CD4 association pathway, was equivalent to the off-rate proportionality in the 
TCR association pathway. This assumption was made because any change in bond 
lifetime is only afforded by the single trimolecular complex. In other words, the 
branching out into two different pathways which dissociate TCR and CD4 respectively, 
are reciprocally stabilizing. Additionally, the off-rates between different species 
measured in this study as well as those measured previously were similar or at least on 
the same order of magnitude, which were in contrast to measurements made for on-rates 
which have been shown to vary greatly even with one amino acid difference21. These 
assumptions simplified the construction of mass action expressions for the network of 
reactions in Figure 3. As detailed further in Appendix A.2, the kinetic equations were 
constructed by mass action equating the rate of bond formation to associations as positive 
species and dissociations as negative species. These were then translated into vector form 
and were solved for an equilibrium solution were bond formation does not change with 
time. It was determined that the vector describing the difference between the equilibrium 
set of bond formation and the set of bond formation at any time satisfied a homogenous 
differential equation. Therefore, analytical solutions for bond formation between the 
bimolecular species, the trimolecular species, and the total observed bonds was solved. 
Finally, using the scalar a, b, and c assumptions, the solutions were simplified to yield the 




Figure 3. Reactions between TCR, pHLA, and CD4. 
(A) Diagram depicting the equilibrium chemical reactions between the three 
species TCR, pHLA, and CD4 along with their respective kinetic rates. (B) 
Simplified diagram from A depicting CD4 and HLA association first, then 
associating with TCR. (C) Simplified diagram from A depicting TCR and pHLA 





Figure 4. Analytical solutions for bond formations assuming no cooperativity.  
(A) Assumptions and analytical solutions for bond formations depicted in Figure 3A. (B) 
Assumptions and analytical solutions for bond formations depicted in Figure 3B. (C) 
Analytical solutions for bond formations when combining the analytical solutions from A 





3.1.4 Calcium Imaging  
 Cells in R10 were incubated with 5 µM Fluo-4 AM, for 30 minutes in a 37°C 
incubator with 5% CO2. Cells were washed with and resuspended in R10, and further 
incubated for 15 minutes to ensure hydrolysis and activation of dye. Cells were 
subsequently washed with ice cold 1X PBS + 2% BSA (containing calcium and 
magnesium) three times and maintained on ice until ready for imaging. Calcium was 
imaged under an LSM 710 NLO confocal microscope using a 488 nm laser line and a 
Figure 5. Analytical solutions for bond formations with cooperativity. 
Using the stated assumptions, analytical solutions for bimolecular, trimolecular, and total 
number of bonds were derived. 
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63X / 1.4 NA oil-immersion Plan Apochromat objective. The main system consisted of a 
Zeiss 710 confocal scan head mounted on an AxioObserver Z1 inverted microscope stage 
with motorized stage. For calcium flux studies, glass-bottom wells were cleaned with 
ethanol and sodium hydroxide. Tetravalent streptavidin was physioadsorbed on the clean 
surfaces overnight at 4°C, and the surfaces were subsequently passivated with BSA. 
Biotinylated pHLA was allowed to bind to streptavidin for 30 minutes at 4°C and then 
the surfaces thoroughly washed. Cells were injected onto the surface and time lapse 
images were acquired with 30 second intervals over 10 minutes. Images were analyzed 
for the duration of time a cell required to flux upon reaching a stable plane on the surface. 
3.2 Results 
3.2.1 TCR-pHLA interactions bind with thousands-fold higher propensity than 
wild type CD4-HLA interactions.  
 Both the E8TCR:pHLA and CD4:HLA bimolecular interactions have been 
undetectable by SPR measurements. However, upon dimerization, E8-pHLA binding was 
detected by SPR. CD4-HLA binding, in contrast, required immobilization of CD4 on 
beads at a very high concentration to increase avidity. Thus, the E8TCR:pHLA 
interaction was examined first because although single-molecule bonds were not 
achievable by SPR, it is more likely to demonstrate binding than CD4-HLA. Binding 
between E8 and pHLA was readily detected but required a relatively long contact time of 
16 seconds in order to fit data to a plateau regime in contact time compared to the OVA 
peptide which requires only requires up to 5 seconds (Figure 6A). By repeating this 
experiment 3 times with different site densities of E8 and pHLA on the RBCs and 
plotting these values against a poisson transformation of the adhesion frequency, a value 
of 5.036 x 10-4 um4 was obtained (Table 1). This value is on the same order of magnitude 
as those measured for TCR-pHLA interactions between TCR and class-I pHLA. These 
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results demonstrate that binding between E8 and pHLA can be detected using this 
method without multimerization 
 Since interactions between a mutated CD4 and HLA were detectable by SPR, this 
interaction was next tested as a step closer toward detecting wild-type CD4 binding. 
Binding was detected between mCD4 and HLA at a comparable adhesion frequency as 
between E8 and pHLA using a smaller product of receptor-ligand site densities (Figure 
6C). When three different experiments using various values of site densities were plotted 
together, a 2D effective affinity of 2.592 x 10-3 um4 was estimated (Table 1), which is 
more than 5-fold the affinity of the TCR-pHLA interaction used in this system and 
others.  
 Finally, CD4 and HLA binding was not detected until very high site densities 
were employed. Using very high site densities requires RBCs that are highly biotinylated, 
and each biotin site is functionalized with streptavidin. Although streptavidin is 
subsequently coated with biotinylated protein, the high density of coated streptavidin on 
one membrane is sufficient to act as a competitor to streptavidin on the opposing 
membrane thereby resulting in nonspecific binding. To further reduce nonspecific 
adhesion at high streptavidin site densities, 20 µg/mL soluble streptavidin was present in 
the chamber during the experiment, and was done within 10 minutes, before soluble 
streptavidin would replace the coated streptavidin along with the biotinylated protein 
bound to it, resulting in a loss of adhesion frequency. While conditions were optimized to 
ensure minimal loss of adhesion frequency over the course of the 10-minute experiment, 
any value obtained may represent a slight underestimate. Additionally, since the 
experiment could not occur longer than 10 minutes, longer contact times were not tested 
in order to prevent a loss of adhesion frequency as well as to not compromise the number 
of contacts per cell pair. Site densities 3000-times those used in the mCD4 experiment 
were employed to obtain comparable adhesion frequencies. Thus, albeit the use of several 
experimental optimizations beyond those required for detecting TCR-pHLA and mCD4-
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HLA binding, binding between non-multimerized CD4 and HLA was detected for the 
first time (Figure 6E). 
 Several experiments using various site densities were conducted to verify the very 
weak CD4-HLA interaction. When these site densities were plotted against the average 
number of bonds formed, a 2D effective affinity of 8.09 x 10-7 um4 was estimated (Table 
1) which is the lowest value ever reported using the micropipette adhesion frequency 
assay. Using 2D effective affinity as a comparison of strength of binding, the TCR-pHLA 
interaction is about 622-fold stronger while the mCD4-HLA interaction is about 3203-
fold stronger. Considering the micropipette adhesion frequency assay has a larger 
dynamic range in detecting receptor ligand interactions than SPR, these results support 
previous studies that report the CD4-HLA interaction is remarkably weaker.  
 Kinetic rates can be extrapolated from the adhesion frequency. First the fitting is a 
function of the kinetic off-rate. The order of off rates between these sets of interactions is 
mCD4:HLA > TCR:pHLA > wtCD4:HLA with values of 0.67, 0.49, and 0.36, 
respectively. Using the relationship between off-rate and the 2D effective affinity, on-
rates for the interactions were calculated as well. The order of on-rates matched that of 
the off-rates with values of 1.75 x 10-3 um4/s, 2.51 x 10-4 um4/s, and 2.89 x 10-7 um4/s, 
respectively. Comparing these values to each other, the mCD4:HLA interaction has a 
roughly 7-fold higher propensity to bind than the TCR-pHLA interaction, which in turn 
has a roughly 870-fold higher propensity to bind than the wtCD4-HLA interaction. The 
mCD4:HLA interaction has roughly a 6000-fold higher propensity to bind than its wild-
type counterpart. Examining the kinetic rates supports the reasoning that the CD4:HLA 





Table 1: Binding kinetics from adhesion frequency 
Relative densities ACKA (µm4) koff (s-1) Ackon (µm4/s) 
TCR-pHLA 5.036 x 10-4 0.5 2.518 x 10-4 
wtCD4-HLA 8.09 x 10-7 0.4 3.236 x 10-7 





3.2.2 Constraining CD4 and TCR on the same membrane opposed to pHLA 
results in synergy. 
  Colocalized on the T cell membrane with TCR are coreceptors to pMHC, CD4 or 
CD8. By binding the same ligand at different sites, CD8 has been reported to increase the 
adhesion frequency between cells by 3-fold compared to the bimolecular TCR-pMHC 
binding. Such a phenomena has not been reported for CD4:MHC due to the inability to 
distinguish a trimolecular TCR-pMHC-CD4 interaction from the bimolecular TCR-
pMHC interaction. To investigate this synergy using the micropipette system used in 
section 4.2.1, TCR and CD4 were functionalized as a random mixture on the surface of 
one RBC. To minimize the discrepancies in coating strategies, RBCs with identical 
biotinylation sites were used. An assumption was made where this coating strategy 
ensures a constant total number of protein coated on the surface of the RBC, rationalized 
by streptavidin and biotinylated protein coated at high excess and the interaction between 
biotin and streptavidin being among the strongest non-covalent interactions reported.  
 Given a constant total number of proteins, changing the molar ratio between 
soluble TCR and CD4 within a solution to coat RBCs resulted in different ratios of TCR 
and CD4 presented on the RBCs. This coting strategy enabled investigation into the 
contribution of CD4 to TCR binding to pMHC. Beginning at an RBC coating of only 
Figure 6. Micropipette adhesion frequency assay reveals binding of TCR:pHLA, 
mCD4:HLA, and wtCD4:HLA.  
(A) Plot of adhesion frequency against contact time between opposing RBCs. The solid 
curve is a mathematical fitting. (B) Plot of <n>obs against the product of site densities of 
TCR and pHLA. The solid line is the linear regression between three points plotted and 
the value of the slope represents the ACKA in box. Each point is three different 
experiments from the plateau region in panel A. (C, E) Adhesion frequency plot for 
mCD4 and HLA in panel C, and for wtCD4 and HLA in panel E. Each solid curve is a 
separate fitting using different values for site densities corresponding to those used in 
experiment. (D, F) Plot between three experiments to estimate ACKA of mCD4:HLA in 
panel D and wtCD:HLA panel F in panel F. All solid lines are independently conducted 
linear regression. All points represent experiments repeated in triplicate with error bars 
representing standard error. 
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TCR at a site density of 25 TCR molecules per um2, gradually increasing CD4 molecules 
in the coating mixture resulted in progressively lower adhesion frequency (Figure 7A). 
Coating with only TCR exhibited roughly 50% adhesion frequency, while coating with a 
roughly 1.5 TCR/CD4 ratio eventually also matched that adhesion frequency at longer 
contact times than for only TCR. However, a TCR/CD4 ratio of about 0.5 led to an 
adhesion frequency to drop to about 40%. Finally, a ratio of about 0.15 yielded frequency 
of only 20%.  
 When the number of bonds formed were normalized against site densities of 
pHLA and TCR as they were in the bimolecular case of only TCR, the trend reversed 
from that seen in adhesion frequency (Figure 7B). Instead of roughly equivalent curves, 
the 1.5 TCR/CD4 ratio resulted in about 1.5-fold more bonds formed than only TCR. The 
trend continued in reverse order until the TCR/CD4 ratio of 0.15 which exhibited about 
2.5-fold more bonds formed. These normalizations only utilized pHLA and TCR site 
densities. To consider the contribution of CD4, a plot of site densities of all three species 
against the observed number of bonds formed was constructed analogous to those in 
Figure 6. In stark contrast to the overlapping plots in the bimolecular case when different 
site densities are used, three plots representing a different TCR/CD4 ratios did not 
coincide (Figure 7C). Additionally, unlike the bimolecular case which presents the linear 
dependence of average number of bonds on the product of site densities, these three 
separate plots did not exhibit linearity. Finally, the slopes of each curve increased with 
less CD4 mixed on the surface, which is a clear demonstration of increasing synergy 
since the slopes of these curves yield 2D effective affinity in the bimolecular case. It is 
worth noting that the curve where TCR < CD4 is likely an overestimate because only 30 
contacts was used to probe RBCs as opposed to 50 contacts in the other panels, resulting 
in poor resolution despite the experiment conducted in triplicate. This non-linear behavior 
and lack of alignment underscores the complex relationship between the three interacting 
species and will be characterized in section 3.2.4. It can also be seen that the bimolecular 
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case of TCR only results in less observed bonds formed than the case when TCR > CD4. 
Taken together, this TCR-pHLA-CD4 system exhibits synergy in that more bonds are 
formed when a mixture of TCR and CD4 is coated on RBC probed against pHLA 
compared to when only TCR and pHLA are probed against each other. 
 Incorporating a coreceptor to enhance TCR-pMHC binding was previously 
conducted for the CD8 OT-1 system60. The enhancement did not occur until halfway 
through the saturation curve for the otherwise bimolecular case. To examine if such a 
two-stage mechanism occurs for the human CD4 system, the resolution of contact times 
against adhesion frequency was increased. Indeed, an inflection point was observed at 
what would be about halfway through the saturation curve (2-3 seconds) for the 
bimolecular case (Figure 8, black curve). The saturation point for the curve normalized 
by pHLA and TCR site densities occurred at roughly 5 seconds.  
 The increased resolution in the plot of bonds formed clearly illustrates where 
synergy is especially pronounced since the values do not deviate greatly from the 
bimolecular case up to the inflection point. To understand what could be contributing to 
the development of synergy at later contact time points, the mobilization of proteins on 
the surface was limited. In the control case, TCR and CD4 are free to diffuse laterally on 
the RBC surface via their divalent streptavidin linkages to biotinylated cell surface 
proteins. On the opposing cell surface are freely lateral diffusing pHLA molecules. This 
exhibited the same number of bonds formed over time as seen in Figure 7 (Figure 8, 
black curve). In the next experiment, TCR and CD4 were immobilized on the surface of a 
bead at the same ratio, while pHLA was still free to diffuse on the surface of the opposing 
RBC. Strikingly, the synergy seen in the black curve was completely abolished and the 
trimolecular curve coincided with the bimolecular TCR-pHLA curve (Figure 8 red and 
green curves). In a third experiment, TCR and CD4 were free to diffuse but the pHLA 
was immobilized on the surface of a bead. In this case, not only was synergy 
reestablished, but the synergy was greater than in the case where all species were free to 
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diffuse (Figure 8 blue curve). These data demonstrate that the ability for molecules to 
diffuse laterally in the junction between interacting cells plays an important role in 










Figure 7. Demonstration of synergy with presence of CD4.  
(A) Adhesion frequency experiment where CD4 was gradually displacing TCR on the 
surface of the RBC. The arrowhead represents the downward trend in adhesion frequency 
as CD4 was increased with values as seen in the legend per um2. (B) The same 
experiment in A was poisson normalized against only TCR and pHLA site densities. The 
arrowhead represents an upward trend in number of bonds as CD4 is added with values 
seen in the legend per um2. (C) A separate experiment from A and B where the y-axis is 
the number of bonds formed poisson normalized from adhesion frequency and the x-axis 
is the product of site densities of three species. The solid lines are connectors (not 
fittings) between points. The dotted line represents an increasing slope from the three 
curves. The black symbols are on the axis because of the absence of a third species. All 
points represent experiments conducted in triplicate. Solid connecting lines are visual 













3.2.3 Biomembrane force probe demonstrates a trimolecular species 
 Adhesion frequency results demonstrated a striking observation of synergy when 
pHLA interact in trans with TCR and CD4. To pursue the same phenomena in a single-
molecule fashion, BFP was utilized. A bead coated with very low densities of pHLA was 
probed against a bead surface coated with either TCR only or with a mixture of TCR and 
CD4. In the scenario of bond formation, the pHLA bead will be tracked for displacement 
relative to its baseline position. Many cycles of this process were recorded and data 
analyzed for average bond lifetimes against various tensile forces and molecular stiffness. 
Individual data points were displayed together for the bimolecular interaction between 
TCR and pHLA in a plot describing the fraction of bonds that survive by a given lifetime 
(Figure 9A). For very high tensile forces such as 34 pN, it is clear that the survival of 
bonds exhibits an exponential delay. Similar decays are observed for 27 pN, but upon 
tensile forces on bonds of 23 pN, a kink in the distribution occurs around the 1-second 
lifetime bin. A similar kink is observed for the 18 pN distribution. These multi-phase 
distributions are indicative of prolonged survival of bonds consistent with catch-slip 
bonds observed in previous studies using BFP. By the 11 pN distribution, the kink is 
observed to be less pronounced. Averages of these lifetimes were plotted against every 
force bin to accentuate the kinks observed in the distributions (Figure 9B). In the force-
lifetime plots, the prototypical profile for catch-slip bonds were observed for both the 
bimolecular TCR-pHLA interactions as well as the trimolecular TCR-pHLA-CD4 
Figure 8. Mobility of molecules dictates degree of synergy.  
(C) Plots of number of bonds formed normalized by the TCR and pHLA site densities, 
against the contact time between cells. The black curve represents the case where all 
three species, TCR-pHLA-CD4, are freely diffusing laterally. The green curve represents 
the case where only pHLA is freely diffusing while TCR and CD4 are immobilized on a 
bead. The red curve plots the case where two species, TCR-CD4, are freely diffusing. 
The blue curve represents the case where CD4 and TCR are freely diffusing but pHLA is 
immobilized on a bead. The solid lines are connectors (not fittings) between different 
points. Error bars represent standard error.   
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interaction, consistent with suggestions of an additional bond species suggested by 
adhesion frequency results. Strikingly, the average bond lifetimes for the trimolecular 
interaction was almost double the duration for the bimolecular TCR-pHLA interaction. 
As for the bimolecular CD4-HLA interaction, a prototypical slip bond profile was 
observed with average lifetimes similar to those at a low force regime as the TCR-pHLA 
interaction, but much weaker lifetimes at the force bin inducing the peak lifetimes for the 
two other interactions. These results support the idea that a trimolecular interaction is 
enhancing kinetics for a more stabilized bond. An additional approach to analyze the data 
from the BFP assay was to parse out the molecular stiffnesses of each bond by extracting 
differences in extension under force between the optical bead tracking and the piezo-
driven displacements. For the bimolecular TCR-pHLA bonds, a mean stiffness value of 
about 0.255 pN/nm was extracted (Figure 9C). Upon addition of CD4, however, an 
additional population emerged with mean stiffnesses of two populations hovering around 
the same value for the bimolecular interaction, and another at the 0.5 pN/nm bin (Figure 
9D). The findings provide supporting evidence for the development of a third molecular 






3.2.4 Mathematical characterization of synergy 
 Adding CD4 into the system of interaction between TCR and pHLA yields a  
 
drastic increase in number of bonds formed, despite the micropipette measurement 
showing that CD4-HLA 2D affinity is relatively negligible. To understand the 
contribution of CD4 to the formation of bonds, a mass-action based model describing 
trimolecular interactions in the case of no cooperativity was developed (Figure 3). In one 
pathway, TCR and pHLA are in equilibrium with the bimolecular TCR:pHLA complex. 
This complex can then be bound to CD4 and is in equilibrium with the TCR-pHLA:CD4 
trimolecular complex. In a concurrent pathway, CD4 binds to pHLA first and is in 
Figure 9. Single-molecule analysis reveals bond stabilization.  
(A) Survival curves for the bimolecular TCR-pHLA interaction. Each circle indicates one 
bond between TCR and pHLA. Different colors indicate the tensile force at which is 
bond was held to. (B) Average bond lifetimes experienced by a collection of data points 
within prescribed force binds on the x-axis. Solid lines are visual connectors and not 
fittings. (C) Histogram depicting molecular stiffnesses of the bimolecular TCR-pHLA 
interaction. (D) Histogram depicting molecular stiffnesses for bonds formed when TCR, 
pHLA, and CD4 were present in the system. 
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equilibrium with the bimolecular complex of CD4:pHLA. Correspondingly, this 
bimolecular complex can then bind to TCR and this reaction is in equilibrium with a 
TCR-pHLA-CD4 trimolecular complex. Note that the trimolecular complex can 
dissociate into either of the two bimolecular complexes along two different pathways. In 
this model, the assumption is that kon and koff values are not different between TCR 
binding to pHLA and TCR binding to pHLA:CD4. The same assumption applies to when 
CD4 binds to pHLA or TCR:pHLA. Using this model, bond formation and density values 
obtained from experiments where only bimolecular interactions occurred were sufficient 
to model the bond formation prediction if no cooperativity was present. As TCR is 
gradually displaced by TCR on a surface with a constant total number of protein, the 
number of bonds normalized by pHLA decreases completely linearly to the relatively 
negligible case where only CD4-HLA bond formation is occurring. Plotting the data of 
from the experiment using TCR/CD4 mixtures of different ratios (Figure 10), the trend is 
strikingly different (Each column represents the different pHLA density but the same 
TCR/CD4 ratios). First, the points using same values of pHLA yield different upward 
trends from only CD4 to only TCR, demonstrating a nonlinear dependence on pHLA 
density. In other words, all the top points in each column representing one pHLA density 
show a steeper increase than the trajectory for all the bottom points representing another 
pHLA density. The squared error between the no cooperativity prediction and the data 
from mixtures clearly demonstrates that this model does not fit., strongly suggestive of 
cooperativity contributed by the presence of CD4 (Figure 10C).  
 These findings are consistent for various degrees of bond formation. Ranging 
from adhesion frequencies between 1% and 56% which would translate to average bonds 
formed within the contact area from less than 0.01 to 0.78, clear trends were observed 
using a linear interpolation (Figure 11). There was a sharp increase from zero bonds 
formed as soon as TCR is introduced into the system. Extending along one value of TCR, 
the number of bonds per pHLA much more gradually decrease as CD4 is removed from 
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the system, suggesting that CD4 is indeed important to form more bonds despite its very 
weak affinity. Interestingly, there is a clear relationship between bond formation and 
TCR/CD4 ratio. The highest points are all located toward the nbi TCR:pHLA > nbi 
CD4:HLA regime, while the lowest points are toward the nbi TCR:pHLA < nbi CD4:HLA 
regime. Thus, if CD4:HLA bimolecular bonds are allowed to dominate, synergy is not 
likely while if TCR:HLA bonds dominate, the formation of synergy is established.  
 A mathematical model to predict cooperativity between three different molecules 
was subsequently developed (Figure 5). Unlike the linear interpolation the mathematical 
model predicted normalized bond formation as a function of site densities of TCR and 
CD4 (Figure 12). The prediction (surface) successfully predicted the nonlinearity in bond 
formation with increasingly large presence of CD4, and fits with the observed data well. 
The surface is highest at a quadrant where the most CD4 and TCR is present, which is 
expected, but the shape skews toward the TCR axis, which may reflect the dominance in 
binding between TCR and CD4. Most importantly, however, are parameters derived from 
the mathematical model. ‘a’ describes the enhancement of TCR on-rate engagement to 
pHLA between bimolecular and trimolecular complexes, while ‘c’ describes the same 
enhancement for CD4. ‘b’ describes the enhancement in off-rate from the trimolecular 
complex for both TCR and CD4 (Table 2). The value for a was found to be less than 
unity when TCR and CD4 densities were high which indicates that TCR is less likely to 
associate with pHLA that is complexed with CD4. This trend was reversed for the case 
when TCR and CD4 were expressed in comparable densities with pHLA. Meanwhile, the 
value for b was high for both density scenarios, which indicate that CD4 association with 
HLA is always enhanced when TCR and pHLA are already engaged. The value for b was 
always less than unity which indicates that bond lifetimes are always extended when the 
trimolecular bonds are formed. 
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Table 2: Parameter fittings describing TCR-pHLA-CD4 cooperativity 
Relative densities a b c 
TCR ~ pHLA ~ CD4 1.76 x 103 4.39 x 10-1 2.87 x 107 







Figure 11: Dependence of synergy on all bond formation.  
Plot of experimental data points conducted in triplicate. Surface represents a linear 
interpolation between data points. 
Figure 10. Removing bimolecular interactions reveals synergy.  
(A) Simulation of observed bond formation assuming no cooperativity. (B) Plot of data 
points from micropipette adhesion frequency experiment. (C) Plot depicting the squared 
error between the prediction in A and the data points in B. Each color represents different 








3.2.5 Demonstration of synergy in cell system 
 Up to this point, purified proteins have been employed to characterize synergy. To 
apply this framework to a physiological scenario, Jurkat cells were stably transfected 
with the full length E8 TCR and subsequently transfected with the full length wtCD4. 
Figure 12: Mathematical prediction of cooperativity. 
(A, B) Front and side views of surface predicting the normalized number of bonds based 
on TCR and CD4 densities. Red points are experimentally determined. (C, D) Front and 
side views of surface predicting the normalized number of bonds based on TCR and CD4 
densities, specifically for TCR and CD4 densities comparable to pHLA. Red points are 
experimentally determined. These plots were generated in collaboration with Dr. William 
Rittase and Stefano Travaglino 
 63 
The cells were then sorted for surface expression of TCR and CD4 at defined ratios 
(Figure 13 A-D). Each cell line then underwent BFP testing.  
 The average lifetime for the cell line which only expresses TCR with no CD4 
exhibited a catch-slip bond profile with a peak force of about 0.2 seconds around 15pN 
(Figure 13E). Lifetimes for the cell line that only expresses CD4 with no TCR 
demonstrated only a slip-bond profile with a peak force of about 0.3 seconds at the edge 
of the low-force regime of around 5 pN. When the cell expressed more TCR and CD4 on 
its surface, the peak average lifetime reaches up to one second and the profile its catch-
slip. By comparing the different lifetime profiles, the peak force is in the same force bin 
across catch-slip-bond profiles. The slip regime for the catch-slip profiles also decrease 
toward the same low lifetime baseline at high forces. In other words, the profile with the 
longest lifetimes did not sustain those lifetimes at higher forces compared to profiles with 
shorter lifetimes. An important caveat to these results is that these bond lifetimes are 
taken after a contact time of 2 seconds, which is long before the saturation point as seen 
in Figure 6. Additionally, this contact time is also shorter than the time required to reach 
the inflection point observed with synergy in Figure 8. Shorter contact times were 
conducted for these BFP experiments because at longer contact times, adhesion 
frequency was greater than 10% which increases the likelihood of detecting multiple 
bonds forming simultaneously, rather than a single-molecule measurement. 
 Measurements of each single-molecule bond was further dissected to extract 
information about molecular stiffness as in Section 3.2.5. The bimolecular scenarios 
exhibited similar stiffnesses as in the bimolecular interactions studied using the purified 
protein system. Modeled by a single gaussian, the bimolecular TCR-pHLA interaction 
occurred at a mean stiffness of 0.259 pN/nm with over 92% of bonds having stiffnesses 
less than 0.5 pN/nm, a standard deviation of 0.104 pN/nm, and an RSDR of 0.0100 
(Figure 14A). The CD4-HLA interaction occurred at a mean stiffness of 0.112 pN/nm 
with 100% of bonds having stiffnesses less than 0.5 pN/nm, a standard deviation of 0.117 
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pN/nm, and an RSDR of 9.30 x 10-9 (Figure 14C). Histograms of stiffnesses fit well when 
modeled as a gaussian distribution based on the RSDR values. When examining the 
trimolecular case, CD4 and TCR are modeled as springs in parallel both interacting with 
pHLA. When TCR surface expression outnumbered CD4 surface expression on the 
Jurkat cell, a new population of stiffnesses developed with much higher values of 
stiffnesses (Figure 14B). A sum of two gaussians were used to model the global 
population with the overall mean of 0.335 pN/nm, individual means of 0.345 pN/nm and 
0.348 pN/nm, standard deviations of 0.118 pN/nm and 0.112 pN/nm, respectively, and an 
RSDR value of 0.0166. A sum of two gaussians could not be fitted to the case where 
TCR and CD4 surface expression were comparable (Figure 14D), and therefore a single 
gaussian was used with a mean of 0.286 pN/nm, which is greater than the mean from the 
single gaussian modeled for only TCR, a standard deviation of 0.194 pN/nm, and an 
RSDR of 0.0147. Only 79% of bonds had stiffnesses less than 0.5 pN/nm when TCR 
outnumbered CD4 while that frequency was 86% for when TCR and CD4 expression 
were comparable. Despite the inability to fit one scenario to a sum of two gaussians, 
these data demonstrate that a population with stiffer bonds develops at 2-second contact 
times when CD4 is expressed along with TCR.  
 By subtracting the gaussians of the bimolecular cases from the gaussians used to 
model the trimolecular cases, a difference in populations was approximated which was 
rationalized to be the formation of trimolecular bonds (Figure 14E). Roughly 20% of 
bonds were excluded from the bimolecular gaussian for when TCR was greater than 
CD4, while only about 9% of bonds were excluded when TCR was comparable to CD4. 
These excluded populations were then used to extrapolate the mean trimolecular 
stiffnesses. When TCR was greater than CD4, the mean trimolecular stiffness was 
calculated to be 0.454 pN/nm, while when TCR was comparable to CD4, the mean 
trimolecular stiffness was 0.373 pN/nm. This difference was not statistically significant 
by a student t-test. To compare these values to the bimolecular cases, stiffnesses of 
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TCR:pHLA and CD4:HLA were summed to model springs in parallel. The resulting 
predicted stiffness from cell lines only expressing TCR or CD4 interacting with pHLA 
yielded a value of 0.372 pN/nm and was not significantly different from the two 
calculated trimolecular stiffnesses from interactions by cell lines expressing both TCR 
and CD4 (Figure 14F). 
 To determine if these distinguishable biophysical measurements can contribute to 
functional outcomes, intracellular calcium flux in response to pHLA coated on a glass 
surface (Figure 15A) was monitored. Cells were loaded with a fluo-4 calcium dye and 
monitored in 30-second intervals (Figure 15B). Significant increases above baseline 
fluorescence were concluded to represent calcium flux and cells that underwent this 
process were further analyzed. Inclusion of CD4 both shortened the time required for cell 
activation (Figure 15C), and the degree to which cells fluxed calcium (Figure 15D). 
Taken together, these results suggest that stabilization of TCR-pHLA bonds by CD4 has 





Figure 13. Longer lifetimes when CD4 is present. 
(A) Flow cytometry histograms depicting Jurkat cell populations. Red histograms 
represent a population cells that are unstained. Blue histograms represent a population of 
cells stained with a PE-conjugated isotype control. Orange histograms represent cells 
stained with a PE-anti-CD4 antibody. Green histograms represent cells stained with a PE-
anti-TCR antibody. (B) Bond lifetime plots for different cell lines conducting using BFP. 




Figure 14. Stiffness analysis elucidates trimolecular population.  
(A-D) Histograms of bond stiffnesses illustrated by fraction of bonds formed plotted 
against stiffness values for various cell lines with different TCR/CD4 ratios interacted 
with pHLA. Orange solid lines represent robust-fitted gaussians toward the histograms. 
In the case of panel B, a robust-fitted sum of two gaussians was used to fit the histogram. 
(E) Plot depicting the fraction of bonds formed that are bimolecular compared to 
trimolecular using the different cell lines. (F) Plot depicting the mean stiffness values for 
both bimolecular and trimolecular cases. The empty point represents a prediction where 
the two black-filled points were summed to represent two springs in parallel and 
compared to the stiffnesses for trimolecular bonds extrapolated from data. Error bars 











3.3 Discussion and Conclusions 
 The role of CD4 in TCR triggering is incompletely understood largely due to the 
undetermined kinetics of CD4 binding to MHC. Attempts at measuring these kinetics 
conducted with SPR yielded controversial conclusions with some groups not detecting 
binding70,75 while others have measured kinetics similar to those between CD8 and 
MHC71. An alternative approach taken by a few groups measured kinetics using in situ 
methods that analyze the two-dimensional junction between the T cell and the APC. One 
group used a fluorescence clustering approach to detect accumulation of TCR in response 
to an antibody blockade for CD474. Interestingly, while the blockade did not alter the 
Figure 15. TCR and CD4 expressing Jurkat cells exhibit synergy 
(A) Confocal images of uncoated surface (left) or surface coated with pHLA (right). 
Scale bar 10 µm. (B) Pseudocolor images of Jurkat cells loaded with Fluo-4 calcium dye. 
Left image is frame before calcium flux, right image is first frame of flux. Scale bar 10 
µm. (C) Plot depicting time cells on surface required to flux calcium. (D) Plot depicting 
the degree of calcium flux change compared to baseline fluorescent levels. Error bars 
represent standard error. 
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proportion of detectable fluorescence resonance energy transfer (FRET) events which 
represent TCR-pMHC binding, it did reduce the degree of calcium flux in T cells. A 
second group used the micropipette adhesion frequency assay and BFP to determine the 
contribution of CD4 binding to TCR-pMHC two-dimensional kinetics49. Adhesion 
frequency curves that extended to a saturation time of 5 seconds did not differ whether or 
not there was a CD4 antibody blockade. Additionally, by measuring binding between 
TCR and MHC loaded with a noncognate peptide, this study aimed to determine the 
kinetics between CD4 and MHC. However, since binding hovered close to the detection 
limit of the method, adequate data points were not achievable and therefore a 
mathematical fitting for on- and off-rates was not possible. Nevertheless, the group 
estimated that the 2D effective affinity as two orders of magnitude weaker than the 
interaction between CD8 and MHC measured by the same technique. Finally, a third 
group plated MHC expressing cells on lipid bilayers functionalized with CD2 and high 
concentrations of CD4. Measured by accumulation of fluorescently tagged CD4, ratios 
between bound and free CD4 were used to determine an effective 2D affinity (a different 
version than one calculated from micropipette adhesion frequency)75. Affinity values for 
the CD4-MHC interaction were calculated to be two to three orders of magnitude weaker 
than those for typical interactions between T cells and APCs, and was the weakest 
interaction recorded using their method. The affinity values for CD4-MHC between all 
these studies were found to be roughly three orders of magnitude weaker than TCR-
pMHC interactions and were therefore concluded to be too weak to afford stabilization, 
especially since no difference in TCR-pMHC binding was found when CD4 was blocked. 
Nevertheless, the question of how CD4 can contribute so greatly to TCR signaling 
remains.  
 In this study, instead of using systems known to signal through TCR-pMHC 
efficiently, a human TCR-pHLA system known to possess very weak kinetics was 
employed to amplify any possible contribution of CD4. Reminiscent of seminal studies 
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examining the role of CD4, binding was detected between CD4 and MHC and 
surprisingly, the interaction greatly enhanced binding between TCR and pHLA both in 
on- and off-rates. To quantify the contribution of CD4, mathematical models were 
developed and found that inclusion of CD4 in TCR-pMHC binding can improve on-rates 
by up to 6 orders of magnitude and can improve off-rates by up to two-fold. These data 
provide strong evidence for a synergistic role of CD4 in TCR-pMHC binding in addition 
to its role in recruiting Lck to phosphorylate CD3 ITAMs, specifically in the case of a 
weak TCR-pMHC interaction. 
3.3.1 Synergy between TCR, pHLA and CD4 
 To circumvent the outstandingly weak interaction between CD4 and MHC, 
Mariuzza and colleagues employed a yeast display molecular evolution approach to 
mutate the binding site toward much stronger association70. This approach yielded a 
mutant CD4 which spontaneously formed a trimolecular complex crystal with TCR and 
pMHC and provided invaluable structural insights into the potential docking geometries 
between the three molecules. Of particular interest was the 7 nm gap between the 
membrane proximal regions of TCR and CD4 which strongly argues against any 
association between TCR and CD4 and any subsequent model for TCR triggering based 
on that association. The distance was argued to be maintained by the rigidity of CD4 as 
opposed to crystal artifacts, justified by the lack of segmental flexibility between the four 
Ig-like CD4 domains and supported by observations of glycosylation in the D3 and D4 
membrane proximal regions. It was suggested that the gap provides ample space for CD3 
dimers to organize around the TCR and for Lck to link between the CD3 ITAMs and the 
coreceptor28. The TCR-pMHC-CD4 system is therefore an effective model to study 
characterize simultaneous but independent binding events. 
 The bimolecular mtCD4-MHC interaction was expected to be detected since it 
was characterized by SPR, whereas the E8 TCR:TPI HLA DR1 and the wtCD4-HLA 
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DR1 interactions could not be characterized by the same method204. Indeed, binding with 
mtCD4 was readily observed at a 2D effective affinity magnitude slightly higher than 
even the OT1 TCR-OVA interaction, with comparable on- and off-rates. Next, using 
SPR, the TCR-pHLA interaction was not detectable until the TCR was tetramerized to 
increase avidity and flowed over pHLA. In contrast, adhesion frequency was detected at a 
modest affinity roughly 5-fold weaker than the mtCD4-HLA interaction, and a 
comparable off-rate. The on-rate of the TCR-pHLA interaction, however, was almost an 
order of magnitude lower which could explain how single molecule interactions were not 
detectable via SPR. Lastly, in contrast to previous studies, CD4-MHC binding was 
observed without multimerization, albeit with affinity values close to the detection limit 
of the adhesion frequency approach. Nevertheless, kinetics were determined from 
adhesion frequency curves and the on-rate was measured to be almost an order of 
magnitude lower than those measured for CD8-MHC, while the off-rate was comparable. 
The 2D affinity value is similar to the one estimated using the same micropipette 
adhesion frequency method49. Possible reasons why higher resolution was determined in 
this study, sufficient for mathematical fitting to attain on- and off-rates, are that highest 
possible site densities for RBCs was utilized in this study and longer contact times were 
also employed. In the previous study, the longest contact time used to detect binding was 
5 seconds, while 8 seconds was used in the present study. Longer contact times were not 
employed because they greatly increased nonspecific biotin-streptavidin adhesions. It is 
expected that higher resolution of the adhesion frequency curves and more accurate 
mathematical fitting would result from using even longer contact times. The same 
problem did not present itself for the mtCD4-HLA and TCR-pHLA interactions since 
nonspecific adhesion were nearly non-existent for relatively much lower biotinylation of 
RBCs. These data support existing binding studies for mtCD4 and provide an explanation 
for why other interactions were not detectable. 
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 Upon mixing TCR and CD4 on the same surface to interact with pHLA, higher 
than expected adhesion frequency resulted. By titrating increasing amount of CD4 to 
displace TCR on the same biotinylated RBC surface, the adhesion frequency reduced as 
expected, but normalizing by site densities of TCR and HLA yielded values higher than 
the case where only TCR was present on the surface. In other words, more bonds were 
detected between TCR and pHLA once CD4 was included in the system, suggestive of 
CD4 synergizing with TCR-pHLA. To begin exploring the extent to how CD4 was 
contributing to higher detection of bonds, another set of adhesion frequency data was 
plotted against the densities of all three species. Unlike the linear traces presented for the 
bimolecular cases, the relationship between site densities and bond formation was not 
linear, indicative of a nonlinear relationship between HLA against TCR and CD4, since 
for every trace, the values for TCR and CD4 are held constant. This could encapsulate the 
varying degrees to how TCR and CD4 interact with pHLA, but it could also be a 
manifestation of a how a trimolecular complex interplays with bimolecular interactions. 
Additionally, higher bond formation vis a vis the CD4-HLA bimolecular interaction with 
a tremendously low on-rate is suggestive of a significant enhancement of on-rate or 
occupancy since CD4-HLA binding should not even be detectable at the low densities of 
CD4 used in these trimolecular experiments.  
 An interesting feature was an apparent kink otherwise graded adhesion frequency 
curves. To validate this feature, a higher resolution adhesion frequency curve was 
collected and indeed between 2 and 4 seconds was an inflection point in the curve. This 
observation was reminiscent to two-stage binding observed for the OT1 system when 
CD8 was included. Consistent with those observations, adhesion frequency doubled, and 
the kink occurred at the contact time required for roughly half of the maximal adhesion 
frequency. For the OT1 CD8 system, the inflection point occurred at about 1 second, with 
a saturation contact time of about 2 seconds60. What differs between these two systems is 
the shape of the cooperativity inflection, with the CD4 system displaying less of a 
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sinusoidal switch-like inflection as the CD8 system. To understand how this cooperativity 
could occur, TCR and CD4 were coated either on the fluid membranes of RBCs or 
immobilized by the same densities and ratios on beads. Cooperativity was abolished 
when TCR and CD4 were immobilized. One interpretation is that diffusion is required for 
cooperativity since densities were carefully chosen to ensure CD4 and TCR could be in 
close enough proximity to synergize on pHLA together at a population level as 
determined by flow cytometry. However, it is possible that this proximity was not 
ensured at a single-molecule level despite matching of densities between RBC and bead 
experiments70. Nevertheless, this experiment does suggest that diffusion trapping by 
bimolecular interactions to enhance distal bimolecular interactions is not occurring. Next, 
using BFP and very high CD4 densities to surround TCR, longer bond lifetimes were 
detected when CD4 was included compared to when only TCR and pHLA were 
interacting, suggestive of an enhanced molecular bond. This was corroborated with 
molecular stiffness analysis which examined all bonds formed in BFP experiments and 
found that a stiffer species compared to the TCR-pHLA interaction emerged. Taken 
together, these data suggest that a trimolecular species forms between TCR, pHLA, and 
CD4 with kinetics enhanced beyond the sum of any of the bimolecular kinetics.   
 The data presented here could not be fitted to the adhesion frequency 
mathematical model previously used since that expression only describes a bimolecular 
interaction. A system of equations was described in this study to include interaction with 
a third species. To simplify the model, two separate pathways were considered and a 
which describes a case of no cooperativity was developed. It is important to highlight that 
these pathways represent sequential binding in two different hypothesis, where either 
TCR or CD4 bind to pHLA first. Simultaneous binding is also possible, but this model 
assumes a sequence. Additionally, given a single pHLA monomer, it is likely that the 
TCR will bind first since the on-rate for the TCR-pHLA interaction is many orders of 
magnitude greater than that of the CD4-HLA. Nevertheless, when on-rates are assumed 
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to not change between bimolecular complexing and trimolecular complexing, the system 
of equations that describes the trimolecular complex greatly simplifies and should yield a 
linear relationship between bond formation and the product of the three species’ 
densities. As discussed earlier and represented in Figure 6, the linear relationship is not 
the case and there is significant deviation from the observed data closer to higher 
TCR/CD4 density ratios. Fitting data to the trimolecular model yields a closer, albeit not 
ideal, fit to the observed data. What was captured in the model was the nonlinear trend 
toward a point where TCR density is greater than CD4, as seen in the observed data. The 
parameters that were determined from fitting consistently describe tremendous 
enhancement in CD4 binding to HLA after TCR engagement, and a prolonging in both 
TCR-pHLA and CD4-HLA bond lifetimes due to trimolecular bond stabilization. What 
appeared to vary between different sets of data was the nonlinear trend in relation to the 
density of pHLA, which was also seen with earlier micropipette results plotting against 
three species. Thus, the mathematical model successfully describes how three species can 
synergize, but future work must incorporate an additional nonlinear factor encompassing 
the convoluted relationship between pHLA against TCR and CD4. It is possible that such 
a fitting could also describe the kink in the adhesion frequency curves representative of a 
two-stage cooperativity. Indeed, this must be considered because the data points used 
when plotting the observed bond formations are from the well-established saturation 
regime of the adhesion frequency curves which follows the inflection point. 
 Finally, this mathematical framework structured observations of bond formation 
in a Jurkat cell system. The expression of TCR on Jurkats was consistent between TCR 
only and TCR > CD4 cell lines. The TCR expression on the TCR ~ CD4 cell line also 
appeared uniform. However, despite three rounds of sorting, since CD4 was transfected 
into Jurkats after established TCR expression in three different cells lines separately, 
CD4 expression was not consistent or broadly uniform between cell lines. This could 
contribute to the low number of trimolecular bonds formed as determined through 
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stiffness analysis. For example, in the TCR ~ CD4 cell line, most cells did not express 
CD4 higher than isotype control levels. If these cells were used for BFP experiments, the 
data points would be skewed toward a bimolecular TCR-pHLA scenario. A more likely 
explanation for the low number of trimolecular bonds detected, however, is the short 
contact time used in the BFP assay. Instead of the 6 to 8 second contact time threshold 
where adhesion frequency for the trimolecular case appeared to saturate, only 2 seconds 
was used due to excessive nonspecific adhesions beyond 4 seconds. In the BFP assay, 
adhesion frequency must be maintained lower than 20% in order to predict the vast 
majority of bonds formed are single-molecule bonds. At 4 second contact times, the 
adhesion frequency neared 30% and therefore a significant fraction of bonds recorded 
were not between single-molecular interactions. Examining bond lifetimes revealed that 
the bimolecular TCR-pHLA interaction is prolonged under force in the purified system 
compared to the cell system. The difference between these two systems have been 
discussed in previous studies. Some have provided evidence that glycosylation of TCR 
can accelerate dissociation of TCR-pMHC205-207, which is consistent with the results seen 
in this study. In contrast, others have speculated that association between TCR and CD3 
in a cell system can contribute to stabilized force-regulated bond lifetimes21. Both are 
viable explanations of the data but likely rely strongly on the TCR-pHLA pair used. In 
this study, a very weak TCR-pHLA interaction was used with a peak force-regulated 
bond lifetimes of about 0.2 seconds in a cell system. The doubling in bond lifetime for 
the purified system could certainly be explained by less glycosylation, and it is possible 
that the disruption by glycosylation dominated any stabilization by CD3. Comparing the 
zero-force bond lifetimes measured in BFP demonstrate that even without force-
regulation, the was slight stabilization in bond lifetime when CD4 is included with the 
TCR-pHLA interaction. Strikingly, this stabilization was greatly amplified under force by 
up to 5 times, where different catch-slip bond profiles were clearly distinguishable. This 
provided strong evidence that force accelerates trimolecular bond formation. The 
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acceleration was not as pronounced for the Jurkats where TCR and CD4 expression were 
comparable. This can also be attributed to the short contact time. By relating these data 
back to the adhesion frequency curves, a 2 second contact time does not effectively 
distinguish the bimolecular interactions from the trimolecular interactions and was only 
in the beginning of the two-stage inflection point for cooperativity.  The observation of 
longest bond lifetimes occurring when TCR expression was greater than CD4 expression 
suggests that at this short contact time, CD4 is more effectively being included for 
trimolecular bonds than if there was a higher TCR/CD4 ratio. Importantly, the force at 
which the bond profiles progress from catch to slip are consistent between all cell lines. 
This supports the idea that TCR and CD4 bind pHLA and independent sites and that 
dissociation of any component of the trimolecular complex will lead to dissociation of the 
TCR-pHLA portion dictates the detection of bonds by BFP. These data are consistent 
with mathematical modeling that predicted a skewing of greater number of bonds formed 
toward high TCR/CD4 ratio and supports the model that TCR and pHLA bind first, 
followed by stabilization by CD4. Synergy was also demonstrated in functional assays 
where Jurkats were plated on glass surfaces coated with pMHC, where CD4 cooperativity 
not only led to a faster time to flux calcium, but also a higher degree of calcium flux. 
Overall, these data present a strong case for synergy between TCR, pHLA, and CD4 to 
stabilize bond formation between T cell and APC to result in more robust T cell 
signaling. 
3.3.2 Implications for models of T cell triggering 
 TCR triggering is defined in this thesis as the antigen-specific engagement of 
TCR with pMHC resulting in phosphorylation of the CD3 ITAMs. This process is the 
initiating step toward T cell activation and effector functions. Such functions result in 
targeted destruction of abnormal cells expressing relatively miniscule amounts of foreign 
antigen compared to the abundance of self-antigen also expressed, highlighting the 
 77 
exquisite specificity afforded by TCR recognition. This is accomplished despite the 
observation that TCR-pMHC interactions are generally much weaker than interactions 
between cell adhesion molecules such as between integrin and its various ligands, which 
highlights the sensitivity of TCR triggering. To explain these two TCR capabilities, 
various models for TCR triggering have been proposed. These models consider kinetics 
between various components of the TCR machinery as well as their static and dynamic 
physical features208. Processes within the scope of this thesis begin at engagement of 
TCR to pMHC through the point of Lck phosphorylation of CD3 ITAMs. Therefore, only 
models discussing those points will be discussed below. A detailed explanation of the 
receptor-mediated mechanosensing between T cells and APCs that incorporates all other 
published models for TCR triggering is described elsewhere36. 
3.3.2.1 Kinetic proofreading 
 The original concept of kinetic proofreading or kinetic amplification was 
proposed independently by John Hopfield in 1974209 and Jacques Nino in 1979210 to 
address the specificity paradox in biochemical reactions, whereby point differences in the 
makeup of one reactant can be discriminated by the second reactant. This was apparent 
with the unexpectedly low error rate involved in ribosomes recognizing mRNA codons. 
The solution, they proposed, was a multi-step ‘ratchet’ process where progressive 
intermediates ‘proofread’. If the intermediate is proofread to be inappropriate, an exit step 
occurs at a faster rate than the subsequent correct reaction rate down the overall pathway.  
 In the case of TCR, avoiding triggering due to nonspecific stimuli is particularly 
daunting because expressed on the surface of APCs is predominantly self-peptides. 
Similarities between self- and foreign-peptides could therefore result in T cell activation 
and autoimmunity if the only distinguishing factor was the binding interface determined 
by a few amino acids. Therefore, the kinetic proofreading model for TCR triggering211 
relies on the bond lifetime, also known as dwell time, for specific TCR-pMHC 
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interactions. It was postulated that self-peptides that may bind to TCR through 
similarities in binding interface would confer a relatively very short lifetime- since all 
self-reactive TCRs will have been removed by negative selection during thymic 
development- compared to bond lifetimes with foreign peptides. During the bond lifetime 
period of proofreading for self-peptides, irreversible exit steps would occur before signal 
can be transmitted to allow for phosphorylation of CD3 ITAMs, affording specificity of 
activation only to foreign cognate peptides. This model is well accepted to be involved in 
TCR triggering and recent unpublished studies using optogenetics demonstrate that the 
dwell-time of TCR-pMHC interactions is an important determinant for triggering. A 
complementary study using BFP expanded upon this idea by incorporating force-
regulation of bond lifetimes. It was shown by Salaita and colleagues that T cells can exert 
actin-dependent tensile forces on pMHC through the TCR212. This finding is in line with 
early observations that actin retrograde flow contributes to SMAC formation, and more 
recently it was shown that actin arcs can translocate TCR150. Using this strong basis for 
studying bonds under tension, it was found that 10-15 pN tensile forces can prolong bond 
lifetimes for many TCR-pMHC interactions20. In fact, it was recently suggested that the 
induction of catch-bond profiles can predict whether TCR triggering occurs much more 
effectively than affinity values. It is postulated that force pulling through the TCR is 
mechanism for kinetic proofreading which can discriminate between foreign-peptides 
which will exhibit a catch-slip profile when bound to TCR under force, while self-
peptides will exhibit a slip profile. Thus, consistent with optogenetic studies, off-rates can 
be a determining factor to trigger TCR in a kinetic proofreading fashion. 
 What has not been studied is how coreceptors can contribute to proofreading. This 
is largely due to neglection since early studies found that TCR triggering can occur 
without the presence of coreceptors, and that coreceptors alone are insufficient to lead to 
T cell activation208. Additionally, many studies concluded from the weak CD4-MHC 
affinity that the coreceptor could not play a role in stabilizing the TCR-pMHC bond 
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toward more effective triggering84. It is important to note that coreceptors are heavily 
implicated in initiating phosphorylation events via association with Lck and pMHC. 
These events may represent one step in kinetic proofreading whereby bond lifetimes long 
enough to reveal CD3 ITAMs to phosphorylation by coreceptor engaged-Lck could select 
foreign pMHC over self-pMHC, but these steps are extrinsic to the prolonging of the 
bond lifetime itself. The results in the current study make a case for CD4-mediated 
enhancement of bond lifetime. Together with functional experiments which showed that 
inclusion of CD4 promoted the time and degree of calcium flux, coreceptors may play a 
non-negligible role in kinetic proofreading. This role was especially pronounced when 
relatively small amounts of CD4 enhanced bond lifetime up to 5-fold. Within the force-
regulated enhancement may be kinetic proofreading steps to amplify cognate TCR-
pMHC interactions which experience catch-slip bond profiles. A natural question to 
follow is whether coreceptor-mediated enhancement occurs for self-peptides? Unlike the 
TCR, CD4 binding to pMHC is conserved for a given MHC allele and could therefore 
influence both foreign- and self-peptide interactions with TCR. A second model for TCR 
triggering informs this possibility. 
3.3.2.2 Serial triggering and co-agonism 
 Comparison between relatively strong TCR-pMHC interactions with antibody-
antigen interactions reveals that the former is weaker by up to 6 orders of magnitude, 
which prompts the question of how such a weak interaction can trigger a highly 
consequential signaling event when many other receptor-ligand interactions rely on much 
stronger affinities? A serial triggering model that addresses this question of sensitivity 
posits that TCR with a relatively high dissociation rate compared to other receptor-ligand 
interactions, rapidly rebind to the same or other pMHC to repeat the process of triggering 
to the point that enough short signals accumulate to produce a sufficiently strong signal to 
reach a threshold that initiates T cell activation208. Evidence supporting this model are 
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delays found between several TCR-pMHC engagements and markers of T cell activation 
such as calcium flux. The Zhu lab found that accumulation of binding events over a 
course of a minute resulted in intracellular calcium flux20 and was corroborated by 
another group who found that T cells require less than 3 minutes to signal after TCR and 
pMHC were thought to first engage213. Not mutually exclusive from the kinetic 
proofreading model which focuses on a series of molecular steps under an overall 
reaction rate, the serial triggering model shifts focus on the population of TCR-pMHC 
interactions. An entire sequence of kinetic proofreading steps may occur within each unit 
of bond lifetime followed by dissociation and rebinding. However, rebinding between 
TCR and pMHC can occur on time-scale so short that they are masked from bulk affinity 
values and are difficult to discern even for single molecule bond lifetime measurements. 
Since the present results found stabilization by CD4 cooperativity, the role of both TCR-
pMHC and coreceptor rebinding in the accumulation of units toward a threshold is 
considered in section 3.3.3.  
 On the surface of APCs are MHC which are loaded mostly with self-peptide214. 
Whereas T cells highly reactive to self-peptide were removed during negative selection, 
other T cells must be mildly reactive to self-peptides in order to be positively selected in 
the thymus. Interestingly, when T cells were engaged with an in-situ mimicking surface 
made up of a mixture of both cognate and non-cognate peptide loaded on the same 
pMHC, T cell activation was found to be enhanced214,215. A possible explanation for this 
phenomena is proximity of Lck-engaged coreceptors to the cognate TCR-pMHC 
interaction enables efficient signaling. Based on results from the present study, 
coreceptors could bind to MHC with or without TCR engagement. It would follow 
therefore, that even if coreceptor-bound pMHC engaged transiently with a non-cognate 
TCR, Lck would still be readily available to transfer to association with a TCR bound to 
a cognate pMHC since TCR were shown to exist in nanoclusters149. By this model, co-
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agonism relies on coreceptor binding to MHC, which was shown in the present study, and 
could pay an important role in the sensitivity of TCR triggering.   
3.3.3 T cell machinery signaling loop 
 Transfer of extracellular information to intracellular signaling is termed outside-in 
signaling and describe the case of pMHC ligation resulting in signal inside the T cell 
through the TCR36. The opposite transfer also exists, whereby intracellular signaling 
events can alter how the molecules behave outside the cell, termed inside-out signaling. 
Such a process has been documented for the integrins where calcium flux inside the cell 
will lead to drastic conformational changes of the integrin’s ectodomain which modulate 
its affinity to its ligands. A similar process can be applied to the TCR, CD3, pMHC, and 
CD4 complex which has been previously described as a pseudo dimer of dimers19. 
Recognizing that Lck can associate with CD3 ITAMs, a recent study investigated 
whether the Lck-ITAM interaction can have a functional role in maintaining association 
between TCR-pMHC in the ectodomain. To support this idea, they found that preventing 
association between ITAM and Lck by using an Lck inhibitor, caused the lifetimes 
between TCR-pMHC to shorten. This may be due to the fact that without the support 
from Lck-ITAM rebinding between TCR-pMHC is less likely. Conversely, by increasing 
the association between Lck and the intracellular domain of the coreceptor, they were 
also able to achieve longer bond lifetime. Results from the present study support similar 
conclusions by confirming CD4 is indeed stably binding to MHC, thereby opening the 
possibility that the pseudo-dimer-of-dimers is self-stabilizing especially under tensile 
force as seen in the present study’s BFP bond lifetimes results. 
3.3.4 Implications toward T cell receptor signaling 
 The general consensus prior to the present study was that the predominant role for 
coreceptors was to recruit Lck into proximity of CD3 ITAMs for phosphorylation by 
binding to MHC84. Without characterizing kinetics of CD4-MHC binding, it is difficult to 
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understand how the kinetics of phosphorylation of ITAMs by free Lck can differ from 
phosphorylation by coreceptor-bound Lck. Considering less than 7% of Lck were found 
to be bound to CD4 coreceptors but up to 40% are constitutively active79, the stability of 
Lck-ITAM association modulated by the coreceptor binding to MHC is pertinent to 
understanding the role of coreceptors. This question is underscored by studies 
demonstrating a functional role of CD4 since antibody blockade is sufficient to reduce T 
cell activation by 30-fold63. The TCR system used in the present study is unique in that 
the wild type TCR could not be detected to bind to pMHC204. Indeed, the wild type triose 
isomerase peptide derived from melanoma is not recognized by the E8 TCR, which 
results in immune evasion. A naturally occurring point residue mutation does not change 
the affinity with pMHC but resulted in a T cell response 5 orders of magnitude greater. 
Thus, despite indistinguishable 3D kinetics, the E8 TCR was very sensitive to changes in 
its interaction with pMHC which was characterized by distinct structural differences from 
its interaction with the wild type TPI peptide. It is therefore less surprising that this TCR 
was sensitive to coreceptor cooperativity which was not detected in previous studies, 
including those using the micropipette adhesion frequency assay. It is possible that the 
relatively stronger TCR-pMHC interactions used in previous studies masked the 
contribution of CD4 to stabilization.  
 While this suggests that CD4 stabilization can occur for all other TCR-pMHC 
interactions, the contribution of stabilization toward successful TCR triggering remains 
unanswered. For instance, as shown in previous studies, CD4 stabilization may play a 
minimal role for strong TCR-pMHC interactions, some of which have been shown to 
trigger TCR in absence of coreceptor208. However, for other weaker TCR-pMHC 
interactions such as the E8 TCR-TPI MHC interaction, CD4 stabilization may provide a 
means for baseline signaling to maintain cell survival. The functional results in this study 
support such a view. The percentage of cells that fluxed calcium in response to the 
“cryptic” wild-type TPI pHLA was very low compared to when anti-CD3 was used to 
 83 
crosslink CD3 and bypass TCR. However, for cells that did flux calcium, the time 
required for flux and the degree of flux was enhanced with CD4 inclusion. The 
enhancement in the magnitude of calcium flux correlated well to the prolonging of bond 
lifetime due to CD4 which demonstrates a direct relation between the synergy 
experienced at a single molecule scale to cell effector functions. Consistent with previous 
studies20, an accumulation of these long lifetimes (in this scenario, facilitated by CD4) 
over a course of a few minutes may have led to calcium flux in only in a small percentage 
of cells, without the risk of over-activating cells which would lead to autoimmunity. The 
parameters solved for by the mathematical model suggest that tremendous enhancement 
is occurring for CD4 association with HLA between the bimolecular and trimolecular 
scenarios. Enhancement is on the other hand, not observed for the TCR-pHLA 
interaction. But in both pathways, stabilization by the trimolecular complex is evident. 
This suggests that a conformational changes occur in the pHLA molecule upon 
engagement with TCR, which makes CD4 association much more amenable. Although 
such a conformational change has not been reported, it has been well documented that 
minor changes in the residues anchoring peptides can have profound impacts on the 
binding interfaces of pHLA. Thus, it is not unreasonable to speculate that binding with 
TCR can reciprocate conformational changes. The development of this model represents 
the first analytical solution for a simultaneous association between three different 
molecules. It builds on previous models for cooperativity such as the Hill, Koshland-
Némethy-Filmer, and Monod-Wyman-Changeux models. These three models rely on 
logarithmic coefficients that may be related to multiple binding sites of a substrate for 
one ligand and elegantly encompass allosteric changes. Overall, the results from this aim 
clearly demonstrate that CD4 synergizes with the TCR-pHLA interaction to yield 
enhanced on-rates and off-rates resulting in a stabilized trimolecular complex which 
contributes to TCR triggering toward more efficient T cell activation. 
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CHAPTER 4  Aim 2 
Quantify the effect of H2O2 environment on T cell receptor binding. Interactions 
between TCR, pMHC, and CD4 are constrained by the membranes of their respective 
cells which migrate through dynamic soluble microenvironments. DC-mediated T cell 
activation occurs within peripheral lymph nodes which is a distinct microenvironment 
from where TCR recognition of pMHC on infected cells occur. In such inflamed 
environments, ROS has been shown to play a convoluted role on T cell function96. In 
some cases, H2O2 was determined to be necessary for signal transduction and effector 
functions112-114, while in other cases, H2O2 was suggested to cause impairment in 
recognition leading to disease progression116,216. Since membrane bound CD4 has been 
shown to be sensitive to dimerization upon reduction of cysteines in its D2 domain which 
alters is binding properties132, the focus of study in this aim will be on CD8, which has 
not been reported to be ROS-sensitive. By studying the CD8 coreceptor, influence of 
ROS on TCR-associated components other than the TCR-pMHC-CD8 interaction can be 




 CD8 purification kit was purchased from Stemcell Technologies (Vancouver, 
Canada). HBSS and PBS was purchased from Corning (Corning, NY). Quantibrite beads 
and PE-antibodies were purchased from BD Biosciences (San Jose, CA). J.T. Baker 
brand H2O2 was purchased from Avantor (Allentown, Pa). Amplex Red enzymatic kit 
was purchased from ThermoFisher (Waltham, MA). Calbiochem-brand Latrunculin A 
and biotin-NHS polymers were purchased from Millipore Sigma (Burlington, MA). 
Recombinant biotin-tagged OT1-TCR was generously gifted by David Margulies at the 
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National Institutes of Health. Recombinant CD4 generously gifted by Roy Mariuzza at 
the University of Maryland. Peptides were synthesized by Genscript (Piscataway, NJ) 
and loaded onto MHC by the Yerkes National Institutes of Health Tetramer Core facility 
(Atlanta, GA).  All other materials including cholesterol oxidase and the Lck specific 
ATP-competitive inhibitor, 7-Cyclopentyl-5-(4-phenoxyphenyl)-7H-pyrrolo[2,3-
d]pyrimidin-4-ylamine53, were purchased from Sigma Aldrich (St. Louis, MO).  
4.1.1.1 T cells 
 Naïve CD8+ T cells were isolated from spleens of OT1 transgenic mice according 
to a Georgia Institute of Technology IACUC-approved protocol. T cells were purified 
using a Stemcell Technologies CD8+ negative purification kit, according to the 
manufacturer’s protocols. Briefly, spleens isolated from mice were stored in ice cold 1X 
HBSS no longer than 1 hour until ready for purification. Spleens were physically grinded 
through a 100µm filter in the presence of ice cold 1X PBS without calcium or 
magnesium. RBCs were lysed and remaining cells were coated with an antibody cocktail 
that excludes coating CD8+ T cells. Coated cells were magnetically removed using 
streptavidin magnetic beads leaving only CD8+ naïve T cells. Cells were resuspended in 
R10 and stored in a 37°C incubator with 5% CO2 until ready for injection in a 
micropipette experimental chamber. 
4.1.1.2 Preparation of RBCs for adhesion frequency 
 Whole blood was isolated by phlebotomists from healthy volunteers at the Stamps 
Health Center at the Georgia Institute of Technology according to a Georgia Institute of 
Technology IRB-approved protocol. Histopaque-1077 was added to the bottom of the 
tube of RBCs and the suspension was centrifuged. Supernatant containing all cells except 
for RBCs were discarded and the RBCs were washed and resuspended in ice cold 1X 
PBS. Following buffer exchange into EAS-45, aliquots of RBCs were mixed with biotin-
3400-NHS at a pH of 7.2 for 30 minutes at room temperature. The ratio between RBCs 
 86 
and biotin-3400-NHS were varied to increase the site density of biotin on the surface of 
RBCs. Controlled biotin sites allowed for defined sites of biotinylated protein when 
saturating concentrations of proteins were incubated with biotinylated RBCs. 2 mg/mL 
tetravalent streptavidin was incubated with RBCs for 20 minutes at room temperature. 
Following exhaustive washing of RBCs with ice cold EAS-45, biotinylated OT1-TCR or 
OVA-MHC-I at a concentration of 20 µg/mL were incubated with RBCs for 30 minutes 
at room temperature. RBCs were washed twice with ice cold 1X PBS + 2% BSA and 
aliquots would be taken for site density measurements by flow cytometry. Also 
conjugated with OT1-TCR or OVA-pMHC were glass beads. Beads were etched with 
NaOH, mercaptopropyl-silanated in an acidic reaction, and covalently conjugated to 
malemide-streptavidin in an overnight reaction with phosphate buffer at a pH of 6.5. 
Beads would be incubated with sub-saturating concentrations of protein (2 ng/mL) for 2 
hours at 4°C, washed with 1X HBSS + 2% BSA, and taken for site density measurements 
by flow cytometry. 
4.1.1.3 Measurement of site density by flow cytometry 
 Beads or RBCs were incubated with antibodies corresponding to their protein 
functionalized surfaces (PE-conjugated anti-mouse TCR Vα chain for OT1-TCR, and PE-
conjugated anti-mouse OVA for the pMHC) for 30 minutes at room temperature using a 
saturating antibody concentration. Following three washes and resuspension in 1X PBS + 
2% BSA, beads and RBCs were analyzed using the BD Accuri Flow Cytometer FL2 
channel for PE excitation and detection. Fluorescence measurements were compared with 
BD Quantibrite PE calibration beads in order to calculate the number of proteins on the 
surface of beads. Briefly, fluorescence from beads of four different sizes and with 
different known number of PE-fluorochromes were used to create a well-fitted (R2 > 
0.97) linear regression between the log of mean fluorescence intensity and the log of PE 
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molecule count. The regression was used to back-calculate the fluorescence from PE-
stained beads and RBCs. 
4.1.2 Optimizing conditions for adhesion frequency 
 H2O2 is well-documented to be cytotoxic, dependent on the concentration used. 
These range from no detectable effects on intracellular proteins when concentrations used 
are sub-nanomolar, transient and permanent stunting of cell metabolism in the 
micromolar range, to induction of apoptosis and necrosis of the cell in the millimolar 
range106. However, cytotoxic effects also depend on the duration of H2O2 exposure
106. A 
concentration of H2O2 representative of an inflamed environment was optimized based on 
literature values217, the timing of experiment, condition of cells, and quality of adhesion 
frequency.  
4.1.2.1 Consumption of hydrogen peroxide 
 To measure H2O2 concentrations in cell suspensions, an Amplex Red enzyme-
based fluorescence indicator of H2O2 was employed according to manufacturer’s 
protocols. Briefly, Amplex Red was dissolved in DMSO and mixed with a horse radish 
peroxidase solution and the manufacturer’s reaction buffer. Cells were allowed to react 
with H2O2 at various times in a solution representative of the experimental micropipette 
chamber which was made up of cells at a specific density, RBCs, and 2% BSA in 1X 
PBS. Following the completion of reaction time, supernatant removed from cells by 
centrifugation was collected and mixed with the Amplex Red reaction solution for 30 
minutes at room temperature away from light. The 96 well plate was inserted into a 
BioTek Synergy H4 microplate reader plate reader to measure fluorescence signal using 
560 nm excitation and detecting 590 nm emission. Fluorescence intensities were 
normalized against a calibration curve using four different known concentrations of 
manufacturer-provided H2O2. 
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4.1.2.2 Production of hydrogen peroxide by glucose oxidase 
 After testing several different concentrations, 0.135 U/mL of glucose oxidase 
(GOx) was used in all experiments. First, the production of H2O2 by this amount of GOx 
was characterized by absorbance monitoring at the 240-280 nm wavelength using a 
Thermofisher nanodrop spectrophotometer. Solutions of the same concentration of GOx 
and varying concentration of glucose were monitored for increased amplitude of the peak 
at 240-280 nm over the course of 1 hour. This rate of change in absorbance was assumed 
to be the rate of H2O2 production and plotted against glucose concentration to yield a 
linear regression. An optimized glucose concentration was determined by matching the 
integrated H2O2 produced with the integrated H2O2 consumed. A representative 
experimental solution of cells, glucose, H2O2, GOx, and 2% BSA in 1X PBS was tested 
for pH changes using a calibrated Thermofisher pH meter over the course of 30 minutes. 
4.1.3 Real-time adhesion frequency 
 Beyond the closer correlation between TCR-pMHC affinity and peptide potency 
compared to SPR measurements21, the micropipette adhesion frequency assay is 
advantageous for the ability to measure binding between molecules on live, functional 
cells. This was clearly demonstrated in a study that imaged calcium flux in T cells 
concurrently with cycles of pMHC contact20. Typically, affinity values would be obtained 
from 30-50 contacts and averaged between tens of cell pairs. Since changes in adhesion 
frequency have been documented to occur in a temporal fashion during this period of 
repeated contacts218, quantifying the TCR-pMHC 2D affinity in real-time would describe 
the propensity of the T cell to recognize antigen at a given time in response to an external 
perturbation. Herein, a modification to the protocol described in section 3.1.2 to be 
conducted in real time is described. 
 The micropipette chamber was prepared as follows: four well-separated droplets 
of 35 µL of 1X PBS + 2% BSA were placed on a coverslip. Another coverslip was used 
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as a top which held droplets in place, and the droplets were sealed with mineral oil to 
prevent osmotic changes. Before the experiment, T cells and RBCs were stained with 
their respective antibodies and analyzed on flow cytometry as described in section 3.1.1. 
This ensured the presence of molecules to be tested. Additionally, site density 
measurements will later be used to calculate 2D affinity values as described in section 
3.1.2.  
 Injected into each media droplet within the chamber was 1 µL of T cell 
suspension directly from the 37°C incubator at a concentration of 4 x 105 cells/mL to 
ultimately provide a final cell concentration of 1 x 105 cells/mL (after addition of ROS 
for a final volume of 40 µL). In the field of view under the microscope, the right pipette 
forged to specifically hold a bead (2 µm diameter bead was aspirated by a 1.5um 
diameter pipette) or a T cell (6 µm diameter naïve T cell was aspirated by a 3 µm 
diameter pipette and aspirated until the tail of the T cell within the pipette was no longer 
than 1 µm). The pipette on the left, forged to 1 µm in diameter was used to aspirate the 
RBC and was programmed to approach the target cell over a distance of 10 µm in 0.5 
seconds, remain in contact with the target cell for 2 seconds, retract 10 µm in 0.5 
seconds, and remain at the 0 µm reference point for 0.5 seconds, before the next cycle 
begins. This was repeated for 30 cycles for each cell pair aspirated. 
 One cell pair was used to confirm binding occurred between cell pairs. 
Accounting for cell-to-cell variability, this first cell pair was used to optimize an 
appropriate adhesion frequency (10-50%) by optimizing the site densities on the RBC, 
and this procedure was conducted for all experiments. For experiments that were found to 
decrease gradually in adhesion frequency, a higher baseline frequency was used such as 
60%, to ensure the lowest level of adhesion frequency was still captured by the 
experiment.  
  Following the first cell pair, 4 µL of freshly diluted 100 µM H2O2 in PBS was 
injected into the experimental droplet for a final concentration of 10 µM and a timer was 
 90 
initiated. Adhesion events would be collected in a Microsoft Excel file in correspondence 
with the time by recording the time at which the first contact was made, and the last 
contact. When a new cell pair was aspirated, the 30-contact cycle was repeated but the 
timer continued through the course of about a 30-minute experiment. This process was 
repeated with new cell pairs until 30 minutes was reached, at which point the experiment 
ended with the 30th contact of the cell pair tested at that point. Through the entire process, 
data for one time-course was collected. This experiment was repeated at least 8 times to 
calculate mean values between cell pairs at corresponding time courses. Nine cell pairs 
were tested across a time course. 
4.1.3.1 Caveats 
 Probability of adhesion is a function of the contact time between two surfaces 
expressing a receptor-ligand pair. A saturation of contact time can be reached at which 
point probability of adhesion no longer increases with longer contact times. However, 
this saturation value varies greatly between different ligands.  
 A set of adhesion frequency collection per cell for real-time experiments included 
30 cycles of contact and retraction. Given previous studies that have predicted TCR 
triggering by pMHC can occur within 1-3 minutes of pMHC engagement20,213, durations 
of 2-6 seconds per cycle would be appropriate for the total number of cycles within the 
window. A receptor-ligand pair with relatively fast on-rates and long bond lifetimes is the 
OT1 TCR-OVA pMHC. Previous studies have found saturation contact times to be 
achieved within 2 seconds21, suitable for the requirement of this assay. Altogether, each 
cycle consisted of 0.5 seconds of approaching, 2 seconds of contact, 0.5 seconds of 
retraction, and 0.5 seconds of delay before the next cycle, totaling 3.5 seconds for 30 
cycles. A combined time of 1 minute and 45 seconds for the total test duration between 
one cell pair fits well within the few minutes of TCR triggering, at which point 
downstream signaling may convolute measurements.  
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 This real-time adhesion frequency assay is not conducive to studying receptor-
ligand interactions with low on-rates and fast off-rates, such as the E8 TCR-TPI MHC 
pair used in aim 1. The saturation contact time was measured to be more than 4 seconds 
and therefore, a total cycle of 30 contacts between cell pairs may extend beyond the time 
T cell signaling will remain untriggered.  
 Capturing binding within early stages of TCR triggering is desired because the 
signaling cascade that ensues may influence the degree of binding213. The goal of this aim 
is to capture effects of extracellular soluble environment on receptor-ligand binding 
constrained by a membrane anchored microenvironment. Recently, the Zhu lab has 
shown that kinase activity can influence binding at a bond-to-bond basis53. Unlike BFP 
which measures single bond lifetimes, the micropipette adhesion frequency assay 
captures affinities at an overall cellular scale (which can be used to calculate bulk values 
of on- and off-rates but are not necessarily single molecule measurements). Thus, even if 
kinase activity is changing, this assay will lump those changes into cellular-scale 
measurements of affinity between receptor-ligand species.  
4.1.3.2 Statistics 
 In purified TCR-pMHC experiments, each time-binned affinity distribution 
(conducted in at least triplicate) was tested against the distribution of all time-binned 
values using parametric one-way ANOVA tests. The null-hypothesis in these tests was 
that the TCR-pMHC interaction is not sensitive to ROS as it is exposed to H2O2 over the 
one variable of time. Significant differences between distributions of each time point 
would indicate that the null-hypothesis is proven false. Unless specified otherwise, the 
remainder of experiments in this aim were analyzed using non-parametric two-way 
ANOVA tests for significant differences between experimental groups. Specific null-
hypotheses varied between experiments, but generally they were testing whether the 
TCR-pMHC interaction is sensitive to ROS and if that difference depended on time, 
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coreceptor binding, or a pharmacologic perturbation. To analyze the dynamics of affinity 
changes, other statistical approaches were used. For results that displayed a decrease and 
increase of affinity values, separate linear regressions were taken for descending and 
ascending portions of data19. These slopes were compared to a zero slope and tested for 
significance. The null-hypothesis for these tests were that the slopes did not deviate 
significantly from zero-slope. For results using glucose oxidase, only one linear 
regression for each experimental group was used and those slopes were compared were 
tested for significance against zero slope. To test for statistical significance in the delay 
of time to decrease in affinity between the experimental groups upon injection of glucose 
oxidase cocktail, distributions of time were tested against each other using a parametric 
one-tailed student’s t-test. The null-hypothesis for this test was that the time point at 
which the mtOVA plot significantly decreased (as tested by a student’s t-test from its 
baseline values) did not differ from the time point at which the wtOVA plot significantly 
decreased. *, **, and *** described statistically significant differences with p-values 
smaller than 0.05, 0.005, and 0.0005, respectively. T-tests were not conducted on 
individual affinity value points along the time axis because, although these points are 
experimentally matched, they occurred at different time points and could not be directly 
statistically compared. Therefore, one- and two- way ANOVA tests were opted to test for 
significant differences between affinity values across experimental groups. All statistics 
were performed using GraphPad Prism 5. 
4.1.4 Pharmacologic perturbations 
 For Lck inhibition experiments, OT1 T cells in R10 were incubated with 5 µM 
Lck inhibitor for 30 minutes at 37°C in a 5% CO2 incubator53. Cells were injected into 
the micropipette chamber supplemented with 5 µM Lck inhibitor. For actin inhibition 
experiments, OT1 T cells in R10 were incubated with 1 µM latrunculin A for 30 minutes 
at 25°C21,219. Adhesion frequencies were noticeably changing over the course of the 
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experiment. Therefore, they were divided between ‘early’ events which were calculated 
from cell pairs during the first 15 minutes of the experiment, and ‘later’ events which 
were calculated from cell pairs during the last 15 minutes of the experiment. Mean values 
between groups were tested using unpaired student’s t-tests with ** and *** representing 
significant differences between groups with p-values smaller than 0.005 and 0.0005, 
respectively. To robustly oxidize membrane cholesterol, OT1 T cells in R10 were 
incubated with 5 U/mL of cholesterol oxidase for 30 minutes at 37°C in a 5% CO2 
incubator21. Cells were then injected into the micropipette chamber media, with no 
further supplemented cholesterol oxidase. Mean values across the entire time course were 
compared between cholesterol oxidized and non-cholesterol oxidized groups using a two-
way ANOVA with a null-hypothesis that the two groups did not statistically differ in 
affinity values. 
4.2 Results 
4.2.1 Optimization of hydrogen peroxide concentration 
 Literature values for H2O2 concentrations used to incubate T cell range from sub-
micromolar to 1 mM. To begin optimizing the concentration of H2O2 to use for these 
experiments, cells were incubated with H2O2 at various concentration within a solution 
representative of the experimental micropipette chamber. After 30 minutes of suspension 
in PBS supplemented with 2% BSA (to minimize nonspecific adhesion) at 25°C, the vast 
majority of cells in the chamber (86%) did not experience apoptosis or necrosis (Figure 
16). When treated with a 10 µM of H2O2 bolus for 30 minutes, the distribution of cells 
was very similar, with 85.2% of cells not experiencing cell death. However, when treated 
with a 100 µM bolus for the same duration, roughly 16% of cells underwent apoptosis as 
indicated by positive Annexin V staining. Finally, with treatment of 1 mM of H2O2 for 30 
minutes, almost half of the cells underwent apoptosis, and up to 16% of the cells 
exhibited markers for both apoptosis and necrosis which was indicated by positive 
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propidium iodide staining. The bolus concentration of 10 µM of H2O2 was used for 
subsequent experiments since it exhibited negligible differences in cell viability from the 







Figure 16: Optimization of hydrogen peroxide concentration.  
(A-D) Contour plots from flow cytometry depicting cells undergoing apoptosis (x-axis 
as measured by Annexin V staining) or necrosis (as measured by propidium iodide 
staining) after 30 minutes incubation at 25°C in the stated concentrations of H2O2 in 
PBS supplemented with 2% BSA. (A) No H2O2. (B) 10 µM H2O2. (C) 100 µM H2O2. 




Table 3: Optimization conditions for micropipette experimental chamber buffer 
Component Optimized Experimentally 
H2O2 
Concentration 
10 µM 10-fold lower exhibited no changes 
in affinity for TCR-mtOVA, while 
10-fold higher yielded poor cell 
quality 
Chamber media PBS + 2% BSA, with or 
without glucose oxidase 
2% BSA yields negligible change in 
H2O2 concentration but is necessary 
to minimize nonspecific adhesion 
Cell concentration 100,000/mL When 1 million cells/mL was used 
no significant change in affinity was 
observed 
Amount of RBC 
inside chamber 
< 0.5 µL Does not yield any changes in H2O2 
concentration at volumes used 
Receptor-Ligand 
density 
Combined ~2000/µm4 for 
TCR and pMHC 
Provides enough adhesion frequency 




30 minutes Observed drop and recovery in this 
time frame, viability, TCR surface 
expression 
Cell type Naïve CD8+ T cells Activated CD8 T cells were 
attempted with less prominent effect 
Type of 
micropipette test 
Many cells in one 30-
minute test as opposed to 
one cell for 30 minutes 
Examines "early" recognition, larger 
number of cells tested 
Nonspecific Negligible No nonspecific adhesion between 
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0.135 units/mL Highest concentration where no 
change in RBC stiffness was 
detected 
pH No change Buffer prevents changes in pH 
 
4.2.2 Purified OT1 TCR binding to OVA pMHC is not influenced by H2O2 
 There are no documented cases of CD8 restricted TCR losing binding affinity to 
pMHC in response to H2O2. To confirm this is the case, a mutant variation of pMHC-I 
was employed that prevents binding between CD8 and MHC-I, thereby only testing the 
interaction between TCR and the binding region where peptide is loaded onto MHC-I. 
Recombinant OT-1 TCR was coated on a bead and probed against mutant OVA pMHC 
coated on an RBC yielding 2D effective affinity values that are consistent with values 
from previous studies21 (Figure 17). Upon injection of H2O2, no changes in 2D affinity 
were observed over the course of 30 minutes. By calculating the 2D affinity values for 
each cell-pair over the time course of the experiment, each cell pair acted as time bins in 
real-time, thereby affording the observation of affinity in real-time on live cells. The lack 
of change in 2D affinity over time supports the concept that the bimolecular interaction 
between the TCR molecule and pMHC molecule are not influenced by oxidation by 
H2O2. 
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Figure 17. TCR affinity to pMHC in response to H2O2 exposure.  
Each point represents affinity values between TCR coated on beads and pMHC coated on 
RBCs, in triplicate. Error bars represent standard error. An unpaired student’s t-test was 
conducted between distributions for every point against distributions of the trace. 
4.2.3 OT1 TCR binding to OVA is weakened in the presence of H2O2 
 Translating the lack of change in binding affinity into a cell system where TCR is 
expressed on OT1 transgenic T cells, the same micropipette adhesion frequency 
experiment was conducted with live cells instead of beads. In stark contrast to the 
purified system, 2D affinity values dropped within a minute of H2O2 introduction, 
reached a minimum at about 10 minutes, and gradually increased back to baseline levels 
attained before the introduction of H2O2 (Figure 18). Affinity values are normalized 
against the site densities of mutant pMHC on RBCs and TCR on T cells, and these values 
did not change over the time course of the experiment. Thus, despite TCR being 
monoclonal and the T cells being genetically identical, the 2D affinity can change in 
response to H2O2. 
 Injection of H2O2 into the chamber was administered as a bolus at 0 seconds. One 
explanation for the rebound in 2D affinity after about 10 minutes was that the effect of 
H2O2 diminished over time due to a loss in concentration. H2O2 was reported to consume 
H2O2 in fibroblasts
106, and therefore consumption was investigated for the OT1 T cells 
used in this system. Using different cell densities in solution, H2O2 concentration was 
monitored by fluorescence using the Amplex Red enzyme-facilitated conversion into 
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resorufin in response to H2O2 (Figure 19). These consumption profiles were fitted to a 
first order decay rate, and these functions were integrated to determine the dependence of 
rate of consumption on cell concentration. With an increase in concentration, molar 
amount of H2O2 consumed increased proportionally, as indicated by a well-fitting linear 
regression. Therefore, OT1 T cells were indeed consuming H2O2 and the loss in 
concentration may be responsible for the rebound in 2D affinity after 10 minutes.  
 To prevent the loss of H2O2, a solution of glucose oxidase and glucose was 
developed to balance the depletion of H2O2 by T cells with generation of H2O2 from 
glucose. This was conducted within the experimental buffer which would prevent small 
changes in pH due to the glucose oxidase reaction and resulted in an experimental 
chamber predicted to be a constant concentration of H2O2 (Figure 20). Using this system, 
the 2D affinity values between TCR and mutant OVA gradually decreased and appeared 
to remain at a lower 2D affinity value (Figure 21). For the mtOVA trace, affinity values 
decreased upon injection to the same levels as in the bolus scenario. The wtOVA trace 
did not follow the same trend as the bolus scenario as discussed in section 4.2.4. These 
results suggests that continuous production of H2O2 by glucose oxidase can different 



















Figure 18. Hydrogen Peroxide effect on 2D affinity in OT-1 T cells.  
(A) Surface expression of OT-1 TCR measured by flow cytometry over the time course 
of the experiment in the presence of H2O2. (B) Plot of 2D affinity over time for wtOVA 
(green) and mtOVA (red) against OT1-TCR on live cells. Lines between points are visual 
connectors and not fittings. (C) Plot of same points from B but with overlaid linear 
regressions depicting significant differences from zero-slope. Error bars represent 
standard error. ** represents p < 0.005 using a two-way ANOVA test between red and 
green groups. 
Figure 19. Consumption of hydrogen peroxide over time.  
(A) Concentration of H2O2 over time in the presence of a specified cell density. Solid 
curved are first order decay functions fitted to the data with a starting point of 5 µM of 
H2O2. (B) Plot of area under the curve from panel B against cell concentration. Solid line 








Figure 20. Hydrogen peroxide production facilitated by glucose oxidase.  
(A) Diagram depicting chemical reaction indicating stoichiometry between glucose, 
oxygen, and H2O2. (B-D) Plots representing absorbance readout by 
spectrophotometer at  240 nm peak fitted to linear regression. (E) Linear regression 
between slopes of lines from B-D to indicate the relationship with glucose 
concentration. The R2 value is displayed. (F) pH monitoring of the optimized 
experimental chamber buffer. 
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4.2.4 CD8 coreceptor rescues diminished binding between OVA and OT1 TCR 
 To understand the extent of this reduced affinity towards pMHC, the wild-type 
pMHC was employed which allows binding to the CD8 coreceptor also expressed on the 
T cell. Therefore, in this experiment, both TCR and CD8 can bind to the pMHC on the 
surface of the RBC. By allowing CD8 binding, the reduction was completely abrogated, 
where the 2D affinity values between TCR and pMHC did not decrease over the course 
of 30 minutes of H2O2 bolus exposure (Figure 18). Interestingly, the affinity appeared to 
increase slightly immediately following bolus injection of H2O2. Sine the only difference 
between experimental set-ups was the molecular make-up of the MHC molecule, it was 
concluded that CD8 binding was responsible for rescuing otherwise diminished binding 
in response to ROS.  
 When glucose oxidase was employed to generate a constant concentration of 
H2O2, the 2D affinity values between TCR and wtOVA persisted longer at the same value 
than the mtOVA, but eventually began to decrease to a level almost as low as the case for 
mtOVA (Figure 21). The 2D affinity values also appeared to increase after 20 minutes, 
but not to baselines levels before injection and was not monitored after 30 minutes. 
Linear regressions fitted to both traces reveal negative slopes for both data sets unlike the 
case of bolus injections. These results suggest that continuous production of H2O2 by 
glucose oxidase can influence CD8 incorporated TCR-pMHC binding in a fashion that a 









Figure 21. Effect of continuous hydrogen peroxide production on 2D affinity. 
(A) Plot depicting 2D affinity between TCR and wtOVA or mtOVA over time. * above 
the green trace represents p < 0.05 using an unpaired student’s t-test to test for significant 
differences between the time point at which the affinities significantly decrease 
(described in more detail in the statistics section 4.1.3.2). * to the immediate right of the 
traces represents p < 0.05 using an unpaired t-test between the lowest and baseline point 
distributions on the green trace, ** represents p < 0.005 tested in the red trace. ** to the 
far right of the traces represent p < 0.005 using a two-way ANOVA between traces. Solid 
lines between points are visual connectors and not fittings. (B) the same plots from A but 
with linear regressions fitted to each trace and statistically compared to a slope of zero. 
Error bars represent standard error. 
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4.2.5 Lck activity regulates coreceptor rescue of TCR binding 
 While the TCR-pMHC interaction was shown here to not be sensitive to oxidation 
by H2O2, other components of the TCR machinery have been documented to be sensitive 
to ROS. One example that has been widely documented to be ROS-sensitive is the Lck 
kinase. Since this kinase can act as a bridge between CD3-ITAMs which are associated 
with TCR and the CD8 coreceptor, we hypothesize that this this kinase may be 
responsible for stabilizing the wtOVA-TCR interaction in response to ROS.  
 Cells were incubated with an ATP-competitive Lck inhibitor and underwent 
binding with wtOVA. Without Lck inhibition (DMSO vehicle treated cells), 2D affinity 
values remained stable over 30 minutes as shown earlier, as previously shown without 
DMSO vehicle (Figure 22). However, upon Lck inhibition, the TCR-wtOVA interaction 
displayed sensitivity to H2O2 bolus injection, as indicated by a decrease and increase 
similarly seen with mtOVA in response to H2O2. The value that the affinity reduced to 
was also similar to values when mtOVA-TCR binding was exposed to a bolus of H2O2. 
Additionally, as observed before, there was a slight increase in affinity for the non-treated 
wtOVA-TCR interaction upon bolus injection, but this increase was not observed when 
Lck was inhibited. These data suggest that Lck is regulating the resistance to decrease in 
2D affinity in response to ROS exposure.  
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Figure 22. The role of Lck activity on 2D effective affinity. 
Plots depicting 2D effective affinity in response to a bolus injection off H2O2 when cells 
were either left untreated (green trace) or pre-treated with an Lck inhibitor (red trace). 
Lines between points are visual connectors and not fittings. Error bars represent standard 
error. ** represents p < 0.005 using a two-way ANOVA between the red and green 
traces. 
4.2.6 Lipid raft oxidation and actin inhibition reduce 2D affinity 
 Another species susceptible to ROS is membrane cholesterol. Since it has been 
suggested recently that TCR associates with cholesterol to present itself in an active and 
inactive state, cholesterol oxidase was used here to examine the effect on 2D affinity. 
Cells were preincubated with cholesterol oxidase which oxidizes cholesterol to 
cholestenone and prevents association with TCR. The progression of cholesterol 
oxidation was therefore not tested in this experiment. Here, the mtOVA system was used 
to only observe the interaction between TCR and loaded peptide (without convolution of 
coreceptor protection effect). Cells treated with a vehicle exhibited the decrease and 
increase in 2D affinity in response to H2O2 injection shown before. Cells that were 
pretreated with cholesterol oxidase, however, exhibited a much lower 2D affinity to the 
baseline non-treated mtOVA scenario, and this value did not change over the course of 
H2O2 exposure for 30 minutes (Figure 23). Interestingly, the 2D affinity value shown by 
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cells here is very similar to the values reached and maintained at when glucose oxidase is 
continually generating H2O2, for both the mtOVA and wtOVA cases. 
The actin cytoskeleton is known to be closely associated with lipid rafts, necessary for 
robust 2D binding, and responsible for TCR-mediated pMHC pulling. Therefore, binding 
under H2O2 exposure with inhibited actin polymerization was examined to understand the 
interplay between oxidation and actin remodeling mechanisms. Both wtOVA and 
mtOVA binding to MHC was greatly inhibited upon pretreatment with latrunculin A 
while H2O2 was injected as a bolus (Figure 24). While the values of affinity did not 
change from before the bolus injection to after the bolus injection, after 15 minutes of 
exposure without further inhibition by Latrunculin A, they appeared to show small 
increases. This experiment displayed potential relationships between oxidation and actin 
polymerization with regards to TCR binding to pMHC. 
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Figure 23. The role of cholesterol in regulating binding. 
Plots depicting 2D effective affinity in response to a bolus injection off H2O2 when cells 
were either left untreated (green trace) or treated with cholesterol oxidase (red trace). 
Lines between points are visual connectors and not fittings. Error bars represent standard 
error. *** represents p < 0.0005 using a two-way ANOVA tested between the green and 
red traces two test for significant differences between the cholesterol oxidized group and 







4.3 Discussion and conclusions 
 Excessive presence of ROS has been well documented in inflammatory 
environments associated with autoimmunity90, cancer220, and airway diseases87. Since T 
cells play a central role in these pathologies, the effects of ROS on T cell function have 
also been long well studied, albeit with discrepant conclusions96. For instance, T cell 
proliferation was found to be both inhibited and promoted by ROS. Further complicating 
investigation was that T cells produce a burst of ROS in response to TCR triggering, 
which also serves as a mode to release calcium from the mitochondria in a feed-forward 
fashion. Finally, many (but not all) TCR-associated molecules have been documented to 
be sensitive to oxidation which can alter the efficiency by which TCR is triggered96. The 
complexities in the interplay between endogenous and exogenous ROS, as well as the 
specific oxidative sensitivities of kinases, phosphatases, cholesterol, and actin, prompted 
Figure 24. Effect of cytoskeleton on 2D affinity in the presence of hydrogen peroxide. 
Plot depicting 2D effective affinity between TCR and wild-type OVA (WO) or mutant 
OVA (MO) under a bolus of H2O2 after cells were pre-treated with Latrunculin A. Early 
plots represent affinity from the first 15 minutes, while later plots represent affinity from 
the next and last 15 minutes of the experiment. Error bars represent standard error. ** and 
*** represent p-values less than 0.005 and 0.0005 respectively by an unpaired t-test. 
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treating the T cell as a black box. In this approach, TCR binding to pMHC was monitored 
in real-time while all the effects of ROS on the T cell were ongoing. The input into the T 
cell black box (with or without CD8 coreceptor binding) was H2O2, and the readout was 
the degree of TCR-pMHC binding. Through this dissection, it was determined that the 
degree of binding in response to ROS was regulated by the presence of coreceptor 
binding, Lck kinase activity, and membrane cholesterol organization. This is the first 
direct demonstration of how these mechanisms can regulate TCR binding to pMHC on 
live cells in real-time which provides novel insights into how TCR recognize antigen in 
pathological environments. 
4.3.1 Model for oxidation of TCR-pMHC-CD8-Lck signaling loop 
 To test whether TCR-pMHC binding is sensitive to oxidation by H2O2, a real-time 
micropipette adhesion frequency assay was developed which monitors the 2D effective 
affinity of interactions on live cells in real-time. This approach leveraged the observation 
that TCR is triggered within 1-3 minutes, at which point signaling cascades may occur 
which could enhance binding through further recruitment of TCR, kinases, and adaptor 
molecules. The time resolution of this method is therefore the duration of one cell pair 
interacting for 30 contact which would occur over no longer than 3 minutes. Using this 
method, recombinant OT1 TCR was probed against mtOVA pMHC which prevents CD8 
binding. While, there is no CD8 on the RBC coated with TCR, this condition served as a 
control for future experiments using primary OT1 T cells which express high levels of 
CD8. Additionally, this interaction focused the attention only on TCR-pMHC sensitivity 
to ROS. As expected, the interaction was found to remain at a stable affinity throughout 
the 30 minutes of ROS exposure, clearly indicating that the TCR-pMHC interaction does 
not experience binding-altering oxidation to a mild 10 µM treatment of H2O2, which was 
found in pathological environments106. This was not, however, the case when mtOVA 
was probed against primary OT1 T cells.  
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 Without contribution of CD8, TCR-pMHC binding underwent a period of 
diminishing affinity followed by a recovery. While the specific mechanisms by which the 
changes occurred may differ, they are likely both due to oxidation of a T cell intrinsic 
factor since no change in affinity was observed before injection of H2O2, and no changes 
in affinity were observed for the purified protein interaction over the same time course. 
The recombinant TCR-mtOVA interaction displayed roughly the same affinity as those 
measured in the cell system, as previously shown. For the decreasing regime between the 
time of H2O2 injection and about 10 minutes, oxidation of a variety of TCR-binding-
associated molecules may have reduced the on-rate between TCR and pMHC, which will 
be discussed further later. To rationalize the recovery regime which began around 15 
minutes after H2O2 injection and ended at the at the conclusion of the experiment at 30 
minutes, two possibilities were proposed: 1) cells consumed H2O2 and the TCR-binding-
molecules that were sensitive to oxidation returned to their reduced state as H2O2 was 
gradually depleted; or 2) cells underwent an adaptation phase in which the cell exerted 
compensatory mechanisms to recover binding to baseline levels in response to an 
unchanging H2O2 concentration. Interestingly, using wtOVA abrogated changes in TCR-
pMHC binding affinity. Since the only difference in the experimental set-up compared to 
the mtOVA case was the molecular make-up of the MHC molecules which either allowed 
or prevented CD8 binding, it was concluded that the coreceptor rescued diminished 
binding in response to ROS. 
 To test the two possibilities for why a recovery period was experienced in the case 
of mtOVA binding, H2O2 consumption was measured. Indeed, it was discovered that T 
cells were consuming H2O2 at a cell density dependent rate. However, it was found that 
consumption of H2O2 plateaued for T cells over time, as opposed to a profile exhibiting 
continual consumption to zero. While it was clear that T cells do indeed consume H2O2, a 
possible explanation or the plateauing profile was that T cells may produce ROS in 
response to activation by ROS. It was previously suggested that nonphagocytic NADPH 
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Duox1 produced ROS in response to T cell activation as indicated by calcium flux as 
means to sustain TCR signaling. This model is consistent with the current data whereby 
low cell densities are activated by H2O2 more readily and may produce ROS as measured 
by the Amplex Red assay. For the intermediate cell density, cells first consume H2O2 by 
their antioxidants but sufficient H2O2 is present to activate H2O2 generation which 
together with exogenous H2O2 would eventually deplete antioxidants preventing any 
further consumption. In contrast, cells in the highest density tested may have consumed 
most of the H2O2 before generating activation-mediated ROS. Altogether, these findings 
clearly demonstrate H2O2 consumption which precludes the second possibility for the 
affinity recovery, which was based on the assumption that H2O2 concentration was not 
changing. Therefore, it was assumed that the effects of H2O2 were wearing off on TCR-
binding-associated molecules. To test this assumption, an optimized solution with 
constant production of H2O2 by GOx was developed and it was found that the reduction 
of affinity was prolonged for the mtOVA and strikingly, a reduction in affinity was 
observed for the wtOVA case as well. This supports a model where any rescuing capacity 
of the CD8 coreceptor could only sustain an extent and duration of H2O2 oxidation, 
before itself being prone oxidation.  
 As discussed earlier, several TCR-binding-associated molecules are sensitive to 
oxidation. The difference in binding profiles between mtOVA and wtOVA in response to 
H2O2 bolus provided a first speculation into what could be important for TCR binding in 
an oxidative environment. Since Lck associates with the coreceptor, testing its role was a 
logical progression. By maintaining Lck in an inactivated state, TCR-wtOVA binding 
was found to resemble TCR-mtOVA binding in response to a H2O2 bolus. These data are 
consistent with a model described by a recent study discussed in Section 3.3.3, which 
proposed a TCR signaling loop between the TCR-CD3 complex, the Lck-CD8 coreceptor 
complex, and the pMHC on the APC. In the referenced study, the coupled trans-cis 
heterodimeric interactions were proposed to amplify discrimination between positive- 
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and negative-selecting ligands19. Association between CD8-bound Lck and the CD3 
ITAMs played a central role in this discrimination. The same Lck inhibitor used in that 
study was used in the present study and it appeared to play a similar role in stabilizing 
TCR-pMHC interactions in the presence of H2O2, although direct measurements of bond 
lifetimes were not measured in the present study. This is due to observations made during 
optimization of the present study where H2O2 induced stiffening of the RBC. This 
phenomena occurs due to oxidation of Fe2+ in the hemoglobin prosthetic group to Fe3+ 
which creates methemoglobin. Such an alteration is incompatible with the BFP assay 
which is centered around the stiffnesses of carefully modified and calibrated RBCs. 
Using RBCs in the micropipette adhesion assay in the presence of H2O2 was carefully 
optimized, however, the requirement of stiffness is far less important. The only necessary 
feature for RBCs was qualitative deformability that could be observed with 40X 
magnification and did not change quantitatively in response to H2O2. This was confirmed 
to be the case when the purified protein system was tested. No reduction in affinity was 
found in this case which is in support of both no change in the receptor-ligand interaction 
and no change in RBC deformability monitoring. Had bond lifetimes been measured, it 
was hypothesized that H2O2 bolus would reduce bond lifetimes in a similar fashion to 
how Lck inactivation altered select catch-bonds into slip bonds. It was concluded that 
exposure to H2O2 (continuously produced by GOx) resulted in inactivation of Lck and 
reduced affinity which mirrored the effect seen when the coreceptor was not engaged to 
mtOVA. These findings underscore the importance of the Lck-engaged coreceptor in 
stabilizing TCR-pMHC interactions. 
 Whether H2O2 directly or indirectly inactivates Lck could not be directly 
determined from the available data. Previous studies suggest that critical cysteines 
mediate the association between Lck and the coreceptor137. Under H2O2 exposure of the 
present study, these cysteines could undergo oxidation and association to the coreceptor 
could be prevented. This would abrogate the mechanotransduction loop which could 
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result in reduced binding in response to H2O2 even if the CD8 coreceptor was present to 
interact with pMHC. It is important to note that Lck would still be bound to the 
membrane, and this scenario does not reveal anything about the activation state of Lck. 
However, without its association to CD8, Lck would not serve as a bridge between TCR-
CD3 and CD8 regardless of its activation state and therefore it is reasonable to posit that 
oxidation-modified Lck would effectively serve equivalent roles in the context of TCR-
pMHC binding.  
 An alternative possibility to the importance of Lck in TCR-pMHC binding is that 
H2O2 is indirectly influencing Lck by inactivating phosphatases which are known to be 
sensitive to oxidation. Both CD45 and Shp1 have been shown to be critical in the 
regulation of TCR proximal signaling96. CD45 has been shown to be able to 
dephosphorylate both the activating Y394 and the inhibitory Y505, thereby deactivating 
and activating Lck, respectively. Additionally, CD45 has been extensively studied for its 
role in the kinetic segregation model for TCR triggering29. Accordingly, it is thought that 
CD45 is largely excluded from sites of TCR-pMHC-CD8 binding, therefore implying 
that CD45 must exert its effects on Lck away from these sites. In contrast, it is clear that 
Shp1 is a negative regulator for TCR signaling because Shp1 deficiency has been shown 
to lead to T cell hyperresponsiveness. Accordingly, it was found that Shp1 
dephosphorylates the inhibitory tyrosines for both Lck and Zap-70. Both these 
phosphatases were shown to be inactivated by H2O2. Interestingly, the ROS burst 
resulting from TCR triggering was sufficient to cause sulfenylation in Shp1 and Shp2 
phosphatases. This suggests that even transient oxidation was capable of inactivation, 
which would consequently lead to prolonged activation of Lck. However, an 
enhancement in activation of Lck due to phosphatase inactivation should result in higher 
affinity interactions, assuming the converse effect of the mechanotransduction loop, and 
was therefore concluded to not play a role in the reduction in affinity. Upon closer 
inspection of the data however, a small increase in affinity was observed for all the 
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wtOVA cases. While not significantly different from the baseline, the increase does 
indeed consistently coincide with a response to a transient change in ROS concentration. 
Taken together, both direct and indirect oxidation effects on Lck by H2O2 are plausible 
based on observations of real-time data. 
 
 
4.3.2 Cholesterol and actin dependencies 
 All of the aforementioned proteins are anchored in the plasma membrane which 
contains microdomains rich in cholesterol144. Referred to as lipid rafts, these 
microdomains are also densely populated with surface proteins. TCR has long been 
associated with lipid rafts and it has been suggested to play role in TCR triggering by 
multimerizing TCR and increasing its avidity. More recently, cholesterol that associates 
with the TCR β-chain transmembrane region has been suggested to lock the TCR into a 
resting state which prevents phosphorylation of the CD3 ITAMs by active kinases221. 
Figure 25. Model for effect of H2O2 on TCR binding 
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Upon dissociation with cholesterol, the TCR is in a primed active state which can be 
stabilized by binding to pMHC. This allosteric model, however, does not encompass 
binding kinetics between TCR and pMHC when influenced by cholesterol association. In 
fact, a previous study by the same group provided evidence that cholesterol association 
with TCR did not influence the affinity between TCR and pMHC, however it did play a 
role in increasing the avidity of the interaction149. Another study determined that 
displacement of cholesterol by its naturally occurring derivative, cholesterol sulfate 
(which does not bind to the TCR β-chain transmembrane region), reduced CD3 ITAM 
phosphorylation155. By disrupting TCR nanoclusters, analogously to how cholesterol 
oxidase can disrupt nanoclusters, TCR triggering was inhibited. These studies underscore 
the importance of cholesterol in CD3 ITAM phosphorylation and provide insight into 
how a drastic reduction in TCR-pMHC affinity were observed in cell systems using 
micropipette assays. One possibility is that TCR adopt organizations or conformations 
that are stabilized by pMHC interaction which is a model consistent with aforementioned 
literature positing a TCR primed state. Monte Carlo simulations support this concept by 
demonstrating that once a single TCR is primed, it can propagate the same conformation 
to the surrounding TCR within the nanocluster218. The phenomena of propagating 
increased binding to other TCR could be quantified using a memory index, which 
examines enhancement of bond formation relative to prior bond formations. In the 
present study, a positive memory index would be expected for the unperturbed 
interactions between OT1 TCR and mtOVA due to the presence of TCR nanoclusters. 
However, upon oxidation by H2O2 or by cholesterol oxidase, the memory index would 
be expected to be closer to zero since the nanoclusters would be more dispersed, thereby 
preventing the TCR-pMHC bond to serve as a scaffold for future bond formations. The 
degree of reduction in affinity due to cholesterol oxidase, coincides closely with the 
trough experienced by the TCR-mtOVA interaction in response to the H2O2 bolus, as 
well as for both mtOVA and wtOVA interactions when treated with continuous H2O2. 
 115 
These data support a model whereby oxidation of cholesterol by H2O2 disrupts 
nanoclusters, altering the primed state of TCR which preferentially binds to pMHC, 
resulting in reduced 2D effective affinity to pMHC. 
 A similar response was imagined for the influence of actin polymerization on 
affinity values. Previous studies have shown that preventing actin polymerization by 
latrunculin A results in a drastic reduction of affinity between OT1 TCR and OVA 
pMHC21. Interestingly in this study, it was found that regardless of the incorporation of 
CD8 binding to pMHC, affinity values were still greatly reduced upon treatment with 
latrunculin A. Since exposure of H2O2 did not decrease either of the affinity values 
between TCR and mtOVA and wtOVA, it was concluded that the ability for actin to 
reorganization played the most dominant role in TCR binding regardless of the oxidative 
state. Nevertheless, actin components have been previously shown to be sensitive to 
oxidation153. Cofilin is kept in an inactive form in the plasma membrane by binding to 
phosphatidylinositol 4,5‐bisphosphate. Upon Ras-dependent dephosphorylation, cofilin 
adopts an activated state which can mediate actin polymerization which was shown to be 
important for SMAC formation. This activated state was also shown to be sensitive to its 
redox environment, whereby oxidation keeps cofilin insensitive to dephosphorylation. 
Another study using DNA force probes have shown that inhibition of actin reorganization 
prevents TCR-mediated pulling on pMHC212,222, thereby clearly demonstrating that the T 
cell is capable of generating force through the TCR and that the force is actin-dependent. 
These forces have been previously shown to play a central role in amplifying the 
discriminatory power of the TCR when scanning pMHC. These studies indicate that actin 
plays a central role in TCR recognition of pMHC, and inhibition by oxidation could 
abrogate its dominance. The results in the present study do not support this concept, 
however. The main piece of data that argues against oxidation of cofilin and prevention 
of membrane proximal actin reorganization is the unchanging affinity values of TCR-
wtOVA in response to H2O2 bolus exposure. Supporting this are affinity values that did 
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diminish never reaching the remarkably low affinity values seen when actin 
polymerization was inhibited by latrunculin A. Thus, both membrane proximal oxidation 
of cofilin and global oxidation-mediated inhibition of actin reorganization, respectively, 
were unlikely. In conclusion, as depicted in Figure 25, oxidation of cholesterol 
nanoclusters rapidly reduces affinity of TCR-pMHC but can be rescued by the quaternary 
molecular signaling loop between TCR, CD3, Lck, and CD8. However, after a threshold 
of H2O2 concentration is reached without counter from antioxidants, the quaternary- 
signaling loop stabilization is disrupted possibly due to critical cysteine mediated 
dissociation of Lck from CD8. These conclusions derived from the real-time analysis 
afforded by the micropipette adhesion frequency assay. 
4.3.3 Role of post-translational modifications in TCR recognition 
 The cancer microenvironment contains a soluble milieu of proinflammatory 
cytokines, chemokines, ROS, and reactive nitrogen species. It is incompletely understood 
how these various soluble species can modulate one another, but it has long been 
appreciated that together, they can have an inhibitory effect on infiltrating T cells 
recognizing tumor antigen. Myeloid derived suppressor cells (MSDCs) were suggested to 
be the predominant cell type in the microenvironment to promote tumor-associated CD8+ 
T cell tolerance223-225 by directly contacting CD8+ T cells220,223,226. It was reported that 
MSDC-upregulated superoxide reacted with constitutive levels of nitric oxide to yield 
peroxynitrite which could induce structural modification of TCR and CD8 molecules216. 
Based on molecular modeling, the relatively stable227 and disruptive228 nitrotyrosine 
resulted in an impaired TCR-pMHC-CD8 interaction which explained their observed 
induction of antigen-specific non-responsiveness of peripheral CD8 T cells and could be 
reversed by prophylactic treatment of peroxynitrite-neutralizing uric acid216. This study 
clearly demonstrated how post- translational modifications on TCR and CD8 could lead 
to impaired TCR recognition of antigen ultimately resulting in tumor tolerance. However, 
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the study relied on adoptive transfer of large amounts of MSDCs which may induce 
exaggerated levels of peroxynitrite, as suggested by further results in their studies with 
very limited levels of nitrotyrosine in CD8+ T cells, far from enough to reflect tumor 
tolerance. Instead, present in much higher levels than effects of nitrotyrosine are 
oxidative effects due to ROS generated from a variety of inflammatory cells, including 
MSDCs226. Due to the ubiquitous nature of oxidation sensitive kinases and phosphatases 
in inflammatory cells, it is reasonable to speculate that ROS may play a more significant 
role in tumor tolerance than nitrotyrosine. Thus, this study provides a complementary 
mechanism to altered recognition of antigen by CD8+ T cells.  
4.3.4 Cell- and tissue-scale effects of ROS and antioxidants  
 The role of ROS in T cell function is convoluted, with many signaling molecules 
important for T cell activation being sensitive to oxidation in both positive and negative 
regulatory fashions, and functions such as cytokine secretion and proliferation reflecting 
the same discrepancies. These conflicting conclusions could be a result of different 
antioxidant capacities of T cells at its various developmental and activation stages, as 
well as the presence of antioxidants in different anatomical compartments. For example, 
activated CD8+ T cells were shown to have a higher antioxidant capacity than naïve 
CD8+ T cells; and in asthma studies investigating the role of oxidative stress on T cell 
function, T cells in peripheral blood experienced no deficiencies while those in the 
oxidative environment of the lung exhibited impaired effector function. Additionally, 
regulation of TCR binding and signaling itself can be dynamic based on its location in the 
body, as previously shown during viral infections.  
 Nevertheless, there is a wealth of studies that suggest that ROS plays a central 
role in tumor initiation and progression. To protect against these purported deficiencies in 
immune surveillance due to ROS, Ando and colleagues229 transduced catalase into CD4+ 
and CD8+ T cells. Indeed, expression of catalase were concluded to improve function 
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and proliferation of CD4+ T cells, rescue CD8+ T cells from cell death, and improve 
CD8+ T cell capacity to recognize antigen all in excessive presence of H2O2 (between 
100 and 200 µM bolus administration). An alternative possibility, consistent with results 
in the present study, is that catalase improved the viability of T cells, affording them their 
baseline effector functions.  In a subsequent study230, they co-expressed catalase with a 
chimeric antigen receptor (CAR) and that the bicistronic expression was found to 
improve targeted killing compared to only CAR expressed T cells, mainly at the 12.5 µM 
which is a more reasonable H2O2 concentration to model a pathological 
microenvironment without convoluting effects of apoptosis or necrosis. Interestingly, the 
improved killing was more pronounced with bystander T- and natural killer cells. Thus, 
the protection mediated by antioxidants appeared to play a more important role in T cells 
where the mechanisms for TCR specific recognition were not bypassed by the CAR. 
Those findings are consistent with conclusions from the present study whereby signaling 
molecules important for TCR recognition of antigen may be impaired by H2O2.  
 Administration of antioxidants for the goal of preventing cancer has demonstrated 
conflicting clinical outcomes. Some studies have provided evidence of antioxidants as an 
effective strategy to prevent the initiation or progression of some cancers231-233, while 
others have found that they increase the likelihood of initiation for other contexts of 
cancer234-236. Generally, dietary antioxidants did not reduce the incidence of cancer and in 
fact there is experimental evidence that they increased the incidence and death from lung 
and prostate cancers237. Supporting these clinical data were two recent complementary 
studies that showed oxidative stress in fact plays a role in limiting metastasis of 
melanomas238,239. They found systemic antioxidants directly improved the migratory 
properties of cancer cells and enabled prolonged survival through circulation that 
otherwise would have been detrimentally oxidative. Therefore, administration of 
antioxidants leading to a systemic reduced environment must be considered with caution 
for cancer therapy. It is important to note, however, that neither of these studies examined 
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the role of antioxidants in the initiation of cancer. Rather, they relied on examining fully 
developed cancers of a highly tumorigenic mouse melanoma model. The results of the 
present study are focused on immune surveillance prior to the point where metastases 
occur but following the generation of an oxidative microenvironment which may impair 
TCR recognition. It was shown for the first time herein, that continuous presence of 
H2O2 does indeed reduce binding between TCR and its cognate pMHC which would 
impair its activation and effector function in killing target cells. This dysfunction was 
likely accomplished by oxidation of membrane cholesterol and Lck cysteines. 
Genetically modifying CD8+ T cells to express catalase may be a viable system to 





CHAPTER 5  Aim 3 
Determine the role of TLR4-LPS binding in ROS-impaired function. ROS generation 
by NOX proteins and TLR4-LPS signaling interact in a positive feedback fashion187,188. 
Meanwhile, upregulation of ROS generation induced by ethanol exposure impairs 
macrophage differentiation and phagocytosis183. These discrepant findings may be a 
reflection of the temporal scale of oxidative stress experienced by macrophages, as well 
as the plasticity in macrophage responses to its immediate microenvironment. Together 
with the fact that TLR4 ligates LPS in concert with other proteins including soluble MD-
2 and membrane bound CD14, formidable questions surrounding the role of oxidative 
stress in macrophage signaling may be reasonably approached using the framework 
developed in Aim 1 and 2 of this thesis. Specifically, the real-time adhesion frequency 
assay allowed for monitoring of binding between TLR4, LPS, and associated proteins in 
a temporal scale previously not studied. Additionally, these experiments were conducted 
while macrophages endogenously produced ROS. This method could reciprocally inform 
the study of T cells in oxidative stress. 
5.1 Methods 
5.1.1 Materials 
 Ultra-pure biotin-LPS from EB was purchased from InvivoGen (San Diego, CA). 
Antibody for LPS-core was purchased from Hycult Biotech Inc. (Wayne, PA). Fc-block 
antibody cocktail was purchased from Bio-Rad Technologies (Hercules, CA). All other 
antibodies were purchased from Biolegend (San Diego, CA). Calibration beads for 
Alexa488 were purchased from Bangs Laboratories/Polysciences (Warrington, PA). MH-
S alveolar macrophage cell line was generously gifted by Lou Ann Brown at Emory 
University. All other reagents were purchased from Sigma Aldrich.  
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5.1.2 Development of Oxidative stress 
 Macrophages were cultured in R10 + penicillin/streptomycin for 24 hours. 
Afterward, cells were scraped from the flask an added into wells of a 12-well plate at a 
seeding density of 105 cells/mL with or without 0.08% ethanol in RPMI1640 
supplemented with 2% FBS. Overall, four conditions were established for the two sets of 
cells as shown in Figure 26. One group was the control group with no treatments, the 
second group was treated with 500 µM reduced glutathione (GSH) for the duration of 
ethanol exposure, the third group was treated with 10 ng/mL LPS only for the third day 
of ethanol exposure, and the fourth group was treated with both 500 µM GSH and 10 
ng/mL LPS. For the fourth condition, GSH was present for the duration of ethanol 
exposure while the LPS was only added on the third day. GSH was added to cells directly 
from frozen stock solutions of 50 mM which were prepared no longer than one month in 
advance. Altogether, each 12-well plate was placed inside a modular incubation chamber 
(Billups, Del Mar, CA) with a water supply of the same ethanol concentration within the 
cell media to provide an ambient environment matching that immersing cells. Both 
modular incubation chambers were placed entirely in 37°C incubators with 5% CO2. 
These conditions were refreshed, and the modular incubation chamber flushed, every day, 
for 3 days. On the third day of incubation, 10 ng/mL LPS were added to the appropriate 
wells. On the fourth day, cells were scraped from wells and replenished against with 
corresponding media. Fractions of cells were allocated for the micropipette assay, 




5.1.3 Real-time Micropipette Assay 
 A modification of the real-time adhesion frequency method described in section 
4.1.3 was employed to observe binding kinetics in real-time. Available SPR data for 
Figure 26. Schematic depicting conditions of macrophage culture in incubator 
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interactions between TLR4 and LPS suggested that the method was appropriate since the 
kinetics were similar to those between OT1 TCR and OVA pMHC. However, upon 
unsuccessful attempts in obtaining binding data, the method was further modified as 
follows: RBCs were coated with LPS-biotin using the same method described in section 
3.1.2.1.1. Briefly, RBCs with the highest possible biotinylation capacity were coated with 
tetravalent streptavidin for 30 minutes at 25°C. After extensive washing, LPS-biotin was 
added to RBCs at a final concentration of 100 µg/mL and incubated 30 minutes at 25°C. 
The presence of LPS on RBCs and TLR4 on macrophages were confirmed by antibody 
staining quantified analysis using the BD Accuri flow cytometer as described earlier. 
Antibody against the LPS conserved core region bound to LPS coated on RBCs, which 
was further conjugated to an Alexa488 secondary antibody. Following blocking using an 
Fc-blocking antibody cocktail, TLR4 on macrophages were coated with antibody against 
mouse TLR4, and a secondary conjugated with an Alexa488 stained the primary. 
Quantification of the sites was conducted using Alexa488 calibration beads and as 
described in section 3.1.2. 
5.1.3.1 Binding 
 Protocols for micropipette adhesion frequency from Aim 1 and Aim 2 were 
combined to investigate binding between TLR4 and LPS. Briefly, macrophages and 
coated RBCs were placed in the experimental chamber. Pipettes were used to aspirate and 
probe the cells against each other, and adhesion frequency was monitored over time. The 
real-time micropipette method requires that the binding interaction achieves a saturation 
as a function of early contact times (roughly 2 seconds), for sufficient sampling of data. 
Contact times of 2 seconds were used, but this did not achieve binding distinguishable 
from nonspecific binding. Longer contact times such as those used in Aim 1 were then 
used, and even further constant contact time throughout the experiment was tested. Data 
is presented for 8 second contact times which did not differ from constant contact. 
 124 
Experiments in all cases occurred over a course of 15 minutes in the micropipette 
chamber at 25°C.  
5.1.3.2 Morphological changes 
 The pixels on the monitor for micropipette were calibrated to translate 
measurements on the monitor into the metric scale. Sizes of macrophages were measured 
before the first contact with LPS-coated RBC. At the end of 15 minutes, the following 
measurements were made and are depicted in Figure 29: the size of the macrophage from 
the opening of the pipette as the origin, the distance macrophage reaching onto the pipette 
from the opening of the pipette as the origin, the size of the macrophage in along the y-
axis at the center of the macrophage along the x-axis. Using these measurements, the 
following normalized morphology changes for the macrophage were measured: The 
normalized distance macrophages traveled onto the pipette; and the distance traveled by 
the RBC-facing cell edge. Both of these measurements were normalized by the size of 
cells and were based on a reference point of the pipette opening. 
5.1.4 Intracellular cytokine staining 
 Following 3-day development of oxidative stress across 4 conditions, cells were 
replenished in fresh corresponding media supplemented with 10 ng/mL LPS and BD 
Golgiplug to prevent cytokine secretion. Cell were incubated for 6 hours in a 37°C 
incubator with 5% CO2, and then scraped off. Cell were fixed using Biolegend fixation 
buffer for 20 minutes at room temperature in the dark. After washing, cells were 
permeabilized using 0.1% triton-X100 in PBS for 5 minutes on ice. For each condition of 
cells, unstained control, isotype control, blocking control, as well as PE-anti mouse TNF-
α and PE-anti-mouse IL-6 antibodies were tested. Permeabilized fixed cells were 
incubated with Fc-blocking antibody cocktail for 30 minutes, then with fluorophore-
conjugated antibody for 30 minutes at 25°C in the dark. For the case of the blocking 
control, fluorophore-unconjugated anti-mouse IL-6 or anti-mouse TNF-α was incubated 
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with cells for 30 minutes, and then added with the corresponding fluorophore conjugated 
antibodies. Staining was analyzed by flow cytometry on the BD Accuri flow cytometer. 
5.1.5 Confocal imaging 
 Coverslips were prepared to present a gradient of LPS on its surface in order to 
allow macrophages to ‘sense’ changes of concentration of surface bound LPS over 
cellular size distance scales. Coverslips were sonicated with ethanol for 15 minutes and 
washed extensively with water. 1 M sodium hydroxide was added to coverslips and 
allowed to clean surface for 2 hours at room temperature. Coverslips were washed 
extensively with water and then buffer exchanged with PBS. Tetravalent streptavidin in 
PBS (100 µg/mL) were added to each coverslip and incubated at room temperature for 1 
hour. Coverslips were washed with 1X PBS supplemented with 2% BSA 3 times and 
then incubated with 1X PBS + 2% BSA for 30 minutes at room temperature. All buffer 
was aspirated, only leaving a wet surface. At one end of the coverslip, 1 µL of 1 mg/mL 
LPS-biotin was added slowly. Coverslips were incubated at 4°C for 1 hour. To wash, 1X 
PBS +2% BSA was added at the opposite end in a direction toward the center of 
coverslip. Buffer was removed slowly at the same end where the LPS was added. This 
one directional washing process was repeated two more times. Finally, 200 µL of cells 
suspended in R10 (cell concentration of 104/mL would be added to each newly aspirated 
coverslip, and cells would be incubated at 37°C for 6 hours. At the end of 6 hours, cells 
would be fixed in 4% PFA for 10 minutes, washed, and then analyzed under confocal 
microscopy for cell density distributions and LPS distribution. Cell distribution, LPS 
distribution by Alexa488 staining, and F-actin distributions were imaged under an LSM 
710 NLO confocal microscope using 488 and 594 nm laser lines and a 20X / 0.8 NA 
Plan-Apochromat air objective or a 63X / 1.4 NA oil-immersion Plan Apochromat 
objective (when imaging F-actin distributions). The main system consisted of a Zeiss 710 
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confocal scan head mounted on an AxioObserver Z1 inverted microscope stage with 
motorized stage. 
5.2 Results 
5.2.1 Macrophages secrete less cytokines when supplemented with antioxidants 
 Ample evidence exists for the deficiency in macrophage phagocytosis and 
differentiation upon ethanol exposure. However, there is also evidence for enhancement 
of macrophage function in an oxidative environment. To draw a more direct comparison 
between effector functions studied elsewhere, cytokine generation in this ethanol induced 
oxidative stress model was monitored by Golgi-inhibited intracellular cytokine staining in 
flow cytometry. Three-day supplementing with antioxidants appeared to reduce 
generation of both TNF-α (Figure 27A) and IL-6 (Figure 27B), consistent with previous 
studies that showed that inhibition of antioxidant production led to higher IL-6 
generation. Ethanol treatment purported to upregulate ROS generation, appeared to yield 




Figure 27. Cytokine secretion is inhibited by antioxidants.  
(A) Plots depicting effect of 3-day glutathione supplement on TNF-α generation for 
various conditions. (B) Plots depicting effect of 3-day glutathione supplement on IL-6 
generation for various conditions. 
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5.2.2 TLR4:LPS bimolecular binding is not a good predictor of ethanol induced 
derangement 
 To reconcile the variable macrophage effector functions in response to oxidative 
stress, the initial trigger for macrophage activation- binding- was tested against its 
cognate ligand. TLR4 is a toll like receptor that ligates LPS and triggers a signaling 
cascade ultimately leading to cytokine secretion. To test TLR4 functionality under 
ethanol exposure, macrophages were probed against a surrogate cell coated with LPS at a 
high density. Whether or not macrophages experienced ethanol exposure, binding to LPS 
at high concentrations and for prolonged contact times, yielded about 5% binding (Figure 
28). When the cells were pretreated with soluble LPS for 24 hours, the binding frequency 
increased to almost 15% but there were no differences between the ethanol or no-ethanol 
treated macrophages. These data indicate that binding frequency of TLR4 to LPS did not 
correlate with the dysfunctional state of the macrophage. 
 
 
Figure 28. Binding assay between macrophages and LPS.  
(A) Microscopic view of RBC coated with LPS (left cell) interacting with macrophage 
expressing TLR4 (right cell). Scale bar 4 µm. (B) Plot depicting adhesion frequency 
between RBC and macrophages not conditioned or conditioned with 0.08% ethanol for 
three days. Control condition was not treated with LPs while + LPS condition was pre-
treated for 24 hours. Error bars represent standard error and an unpaired t-test was 
employed for significance.  
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5.2.3 Cell morphology predicts ethanol induced deficiency 
 During the binding frequency experiments, cell morphology visibly changed over 
the course of the 15-minute experiment while the macrophage was repeatedly contacted 
with the LPS and was therefore monitored and quantified (Figure 29 A and B). 
Strikingly, by the end of the experiment, macrophage was seen on the pipette distal from 
the RBC. Cells were observed enveloping the pipette (not on one side or the other of the 
pipette). This effect was abrogated if the macrophages were treated with ethanol and was 
partially rescued if the cell experienced concurrent conditioning with the glutathione. 
Another morphology change observed was movement toward or away from the RBC 
coated with LPS. While the movements were not as drastic as seen with the movement 
onto the micropipette, cells that were pretreated with LPS moved toward the RBC, while 
those that did not experience pretreatment of LPS moved away from the RBC. In contrast 
to the rescuing nature of the glutathione conditioning for movement onto the pipette, 
glutathione appeared to prevent movement toward or away from LPS at the cell edge 
facing LPS, from the frame of reference of the pipette. No morphological changes were 
seen with control RBCs, which were only coated with streptavidin (Figure 29 C and D). 
Thus, since LPS was the only molecule presented to the macrophages, these data suggest 









5.2.4 Chemotaxis in response to LPS is inhibited upon ethanol treatment 
 To extend these findings to a more high-throughput fashion and to observe 
consequences of LPS-induced movements over a longer period of time which is 
representative of macrophage activation from LPS, macrophages were plated on surface 
coated with LPS in a gradient fashion. Over the diameter of the coverslip, LPS 
concentration increased and depleted gradually with concentration changes occurring at 
Figure 29. Morphological changes in response to LPS 
(A) Microscopic view of macrophage engulfing aspirating pipette. Scale bar 4 µum. (B) 
Microscopic view of macrophage elongation toward the LPS-coated RBC. Scale care 4 
µm. (C) Plot depicting quantification of morphological changes of crawling on pipette 
seen in A. Error bars represent standard error and *** represents p < 0.0005 using a two-
tailed t-test. (D) Plot depicting quantification of morphological changes of polarization 
toward LPS seen in B. Error bars represent standard error and * represents p < 0.05 using 
a one-tailed t-test. 
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the distance scale of the macrophage size (Figure 30A). After 30 minutes of allowing 
cells to reach the surface, the fraction of cells across a cross-section of the coverslip 
relative to corresponding LPS density was determine. By relating these values to the 
‘chemotactic’ index of the control setting which was without a surface coating or with 
any treatment of the macrophages to account for the general distribution of cells on a 
coverslip, cells pretreated with LPS clearly moved toward greater concentrations of LPS, 
while those that were not pretreated with LPS moved away from greater concentrations 
of LPS (Figure 30B). These results suggest that macrophages can undergo chemotaxis in 






5.2.5 Actin reorganization influenced by ethanol treatment 
 Since cellular motility is associated with actin reorganization, cells across all 
conditions were stained with a phalloidin to observe the density of filamentous actin. This 
was achieved by calculating the ratio of fluorescence intensities between intracellular F-
actin staining and the overall cellular actin staining (Figure 31). For the cells not treated 
Figure 30. Gradient of LPS is sensed by macrophages 
(A) Traces that depict mean fluorescence intensity of LPS coating on a glass surface 
over the same distances. (B) Plots displaying the effects of conditioning and pre-
treatment of macrophages on their polarization toward LPS. Positive values for the 
chemotactic index represent skewing of macrophage adhering toward greater LPS 
concentrations, while negative values represent adhering toward less LPS. 
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with ethanol, glutathione appeared to reduce the actin ratio, indicative of less actin within 
the cell. This was rescued by LPS pretreatment but again diminished when LPS 
pretreatment was supplemented with glutathione. For the cells conditioned with ethanol, 
glutathione pretreatment appeared to lead to higher intracellular actin. LPS pretreatment 
did not lead to any changes compared to the control ethanol condition, even when 
supplemented with ethanol. Importantly, when cells not pretreated with glutathione or 
LPS were conditioned with ethanol, intracellular actin decreased. Overall, these results 
mirror those observed in the micropipette assay and indicate that ethanol exposure leads 

























































Figure 31. Extent of actin remodeling for various macrophage conditions. 
Plot displaying how different treatments on macrophages influence the ratio between 
intracellular and overall actin staining. 
5.3 Discussion and conclusions 
 Oxidative stress and TLR4 signaling have been reported to be mutually 
beneficial186,189. On one hand, removing Nox components which produce ROS will 
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diminish TLR4 signaling187. The opposite will occur if endogenous antioxidant 
production is removed187. On the other hand, inhibiting TLR4 signaling can limit the 
macrophage production of ROS188. Furthermore, the presence of ROS can accelerate 
recruitment of existing TLR4 to the cell surface189. It is possible that these mechanisms 
promote robust detection of LPS while macrophages are bombarded by a complex 
inflammatory milieu. After all, macrophages make up the majority of cell mass in the 
alveolus and therefore are present from initiation through the recession of inflammation, 
experiencing the effector functions of a variety of immune cells156. Although, 
overactivation of TLR4 signaling can lead to excessive macrophage effector functions 
including ROS production and TGF-β secretion, which have been shown to directly 
contribute to injuries such as renal hypertension188. At the same time, oxidative stress 
induced by chronic ethanol exposure has been shown to impair macrophage function and 
differentiation- a process directly related to TLR4 recognition of LPS181. These 
discrepant findings are reminiscent of those reported for T cells, whereby hydrogen 
peroxide can promote and diminish T cell effector function96. A difference between the 
two systems is that ROS has been previously shown to contribute to abrogation of TCR 
recognition while it appears to have had the opposite effect for macrophages, at least 
specifically for TLR4 signaling. Additionally, there has not been as extensive of study on 
the effects of ROS on various macrophage signaling molecules compared to those in T 
cells. The lack of such information aligns well with the black box approach undertaken in 
aim 2 of this thesis. Accordingly, investigation of critical metrics of macrophage 
recognition of LPS were measured in this aim using the micropipette adhesion frequency 
assay while the macrophages were endogenously generating ROS in response to ethanol 
exposure182. 
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5.3.1 Novel chemotaxis of macrophages in response to LPS 
 Previous work using the present alveolar macrophage cell line found that 
differentiation and phagocytosis were impaired in response to ethanol exposure which 
coincided with upregulation of ROS production by Nox1 and Nox2182. However, a major 
axis of macrophage function tied to differentiation is TLR4 signaling165. To begin 
exploring how TLR4 responds to the ethanol regimen applied to these macrophages, 
cytokine production in response to LPS was analyzed. When treated with ethanol, 
macrophages appeared to release more TNFα and IL-6, a finding that was observed even 
when cells were previously activated with LPS. Based on these functional results it was 
clear that oxidative stress played a role in macrophage sensing of LPS, consistent with 
previous studies that suggested a mutually beneficial relationship187,189.  The cells were 
then monitored under the real-time adhesion frequency assay for binding between TLR4 
and LPS. It is accepted that TLR4 requires MD-2 to form a stable complex with LPS, and 
prior to that, CD14 is involved for lateral transfer after it extract LPS from the cell wall 
with the assistance of LBP196. Nevertheless, binding was attempted using the present 
method because SPR had previously measured kinetics between purified LPS and 
TLR4198. Despite detecting binding above a nonspecific level, the adhesion frequency 
was outstandingly low and did not differ between cells exposed and not exposed to 
ethanol. This was likely due to the fact that MD-2 was not present in the experimental 
chamber to form a stable complex with TLR4 and LPS, as shown in the crystal structure. 
It is curious, however, how these macrophages were able respond to LPS in functional 
assays. A likely explanation is that the macrophages secreted sufficient MD-2 over the 
hours-long durations necessary to induce effector functions in response to LPS, which 
may have not been captured in the 15 minutes duration of the adhesion frequency assay. 
Indeed, adhesion frequency improved if the macrophages were activated with LPS prior 
to testing binding, but still did not significantly correlate to macrophage dysfunction. It is 
also possible that the purified LPS used in this experimental system is not conducive to 
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binding compared to those used in other studies198. Previous studies have shown that 
minor alterations in LPS structure have can greatly influence macrophage 
response196,240,241. 
 Interestingly, morphological changes were consistently observed over the course 
of real-time adhesion frequency assay. Therefore, metrics describing the interaction with 
the aspirating micropipette and the LPS-coated RBC were developed. It was found that 
over the course of 15 minutes of repeated contact with high densities of LPS, 
macrophages moved away and crawled onto the micropipette in a uniform fashion. Since 
this movement did not occur with blank RBCs that were only coated with LPS, it is clear 
that the morphological change was specifically due to LPS. Although, it is unclear how 
such a low adhesion frequency had such a profound specific impact on macrophages. A 
possible explanation for this is that pattern recognition by TLR4 was sufficient to induce 
signaling but not binding. Indeed, analogous to the weak interactions between the E8 
TCR with mutant TPI, binding was not detected by SPR but robust recognition between 
T cells and APCs was demonstrated198,204. Additionally, TLR4 is well-documented to be 
N-terminal glycosylated when expressed on cells which may further accelerate 
dissociation207,242. These difficulties may explain why there were no documented cases of 
in situ binding kinetics between TLR4 and LPS before the results presented in this aim198. 
It is important to note that these cells may not necessarily be “moving away” from LPS. 
It is possible that upon actin reorganization, macrophages crawl onto the only solid 
surface available, which is the micropipette. Thus, this isolated observation may only be a 
reflection of the activation of actin reorganization in response to LPS, which is still a 
novel characterization at this time frame. A contrasting morphological change was 
observed for macrophages that were pre-treated with LPS for 24 hours. These activated 
macrophages bound to LPS with 3-fold higher adhesion frequency and after 15 minutes, 
moved closer to the LPS-coated RBC. This finding is consistent with previous studies 
that demonstrated prostaglandin-mediated chemotaxis toward LPS169. However, similarly 
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to the prior morphological change, chemotaxis has not been previously shown to occur in 
such a short time frame. Furthermore, movement directly toward LPS supports the idea 
that macrophages are capable of morphological polarization. In other words, the bi-
directional movements of the macrophage suggest that it possesses mechanisms to 
respond to LPS in a rapid manner. In this vein, it is reasonable to speculate that 
macrophages may possess a protective mechanism to evade infection by escaping 
excessive concentrations of LPS before it is activated to respond. To examine this 
phenomena in a higher throughout fashion, surfaces coated with a gradient of LPS were 
developed. As they arrived onto the surface, macrophages appeared to respond to the 
changing LPS density and navigated their adhering to the surface either away from high 
LPS concentrations if they were not pre-treated with LPS, or toward the high 
concentrations if they were pretreated.  
 Cellular morphological changes and mobility are mediated by acto-myosin 
reorganizations243. As shown in aim 2, inhibition of actin polymerization can also greatly 
inhibit receptor-ligand binding. Additionally, as previously discussed, components of 
actin are sensitive to oxidation and therefore may play a role in the macrophage 
impairment96,244. After the three-day regimen of ethanol treatment, the amount of fully 
formed actin fibers was diminished compared to untreated cells as measured by 
fluorescently-tagged phalloidin. It is possible that membrane proximal cofilin was 
oxidized by the upregulation of ROS182, which prevented actin reorganization and 
manifested in the lack of morphological changes observed under the real-time adhesion 
frequency assay.  
5.3.2 Implications for ethanol induced deficiencies 
 These actin-based deficiencies may explain the impairments in phagocytosis and 
differentiation in response to ethanol exposure, since those processes are related to actin 
reorganization. Specifically, both Fc receptor- and complement receptor-based 
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phagocytosis require actin reorganization to form the phagocytotic cup, which could be 
susceptible to oxidation170. Similarly, CD14-mediated endocytosis of LPS, which 
represents an alternative activation pathway for macrophages, relies on actin 
polymerization245. The relation between actin reorganization and differentiation is less 
direct although from a lens of actin-dependent internalization, CD14 and TLR4 signaling 
can steer differentiation165,170. Another possible mechanism actin can dictate 
differentiation is through selective viability. It was recently shown that perturbing 
nucleation of actin polymerization using chondramide A led to depletion of M2 
differentiated macrophages while the M1 macrophages upregulated their effector 
functions246. Furthermore, there are have been documented changes in stiffness of cells 
through the differentiation process, suggesting that the process may be susceptible to 
impairment or delaying if actin reorganization were perturbed247. Interestingly, when 
cells not treated with ethanol or LPS were supplemented with the antioxidant glutathione, 
actin reorganization was also slightly diminished. This was reflected in the morphological 
changes as well. Thus, it is possible that the excess of antioxidants may interfere with 
intracellular signaling processes in a redox dependent fashion244. This was expected in 
the case of TLR4 signaling, since that cascade has been strongly suggested to be mutually 
tied to ROS signaling187. But the finding that the presence of antioxidants also led to 
impairment in morphological changes was not expected. It is not clear from the data 
whether the changes in actin due to oxidative stress directly cause less formation of actin 
fibers as measured by phalloidin staining, or whether it induces a different macrophage 
phenotype which may possesses a less stiff morphology that does not require as extensive 
of a actin cytoskeleton network, consistent with previous studies that present profound 
plasticity in macrophage phenotype247. 
 Administration of glutathione to alveolar macrophages in vitro and in vivo led to 
downregulation of Nox expression and ROS generation, improved macrophage 
phagocytosis, and ultimately led to greater bacterial clearance of LPS releasing K. 
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pneumoniae183,248. The results from that study provide an elegant validation of previous 
literature that show introduction of LPS leads to generation of ROS. However, other 
studies and results in this thesis suggest that other macrophage functions such as cytokine 
secretions may thrive in oxidative stress environments187,188. First, it must be noted that 
the results examining actin reorganization in this thesis were not shown to be directly 
linked to earlier functional studies. Notwithstanding that premise, the mechanism for 
deranged cytokine secretion in response to ethanol treatment in this thesis is not clear. 
Could generation of ROS in response to LPS recognition reach a point that will 
detrimental to the cellular source itself? It is clear that phagocytosis is improved when 
glutathione is present183, and the results in the present work support this notion. However, 
the maintenance of a reduced environment may also result in collateral phenotypic 
changes in the macrophages which may not have an impact over the course of prolonged 
phagocytosis but may be worth investigating with respect to other effector functions such 
as pro-inflammatory cytokine secretions165. Overall, the results in this thesis support a 
model where chronic ethanol exposure impairs macrophage phagocytosis and 
differentiation by oxidizing the cytoskeleton while maintaining LPS triggered TLR4 
signaling. 
5.3.3 Mechanosensitive macrophages 
 Rapid actin remodeling may be impaired under an environment of oxidative 
stress. Indeed, ethanol treatment prevented macrophages from crawling onto the pipette 
or morphologically polarize toward LPS after prior activation by LPS. While the results 
in this thesis were the first presentation of morphological changes occurring on such a 
short time scale, a recent study employed a damage associated molecular pattern, 
PRDX5, to specifically bind to TLR4 and ultimately found that stiffening of the 
macrophage occurred over the course of 40 minutes201. The time course of stiffening 
presented by their work was similar to that of seen in the present study with direct 
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ligation of LPS to TLR4. Importantly, the LPS presented to TLR4 expressing 
macrophages in this study were conducted in two different fashions. One was by 
repeatedly contacting macrophages with LPS-coated RBCs and the other was by allowing 
macrophages to plate on LPS-coated glass surfaces. It has long been appreciated that 
substrate stiffness can influence the degree to which macrophages cooperatively with the 
biochemical signals it receives247,249. Recently, advances in the fields of biomaterials and 
nanopatterning have shown that substrates can also influence function and differentiation 
of macrophages with applications in immune modulation and regenerative medicine 
(reviewed elsewhere247). Therefore, despite similar results observed between the rigid 
glass and elastic RBC presentation of LPS, it is possible that different responses not 
monitored in the present experiments resulted. One difference observed was the degree to 
which cells polarized toward LPS, which was largely attributed to the fact that cells could 
only change morphology to the extent of its cell volume for the case of the micropipette 
assay. Nevertheless, minor changes in morphology can result in drastic outcomes since it 
was recently shown that patterning LPS on gold nanorods of varying axis anisotropy, but 
equal ligand density were able to skew macrophage differentiation between M1 and 
M2250. It was suggested that polarization resulted from changes in ligand presentation 
geometry in an actin dependent fashion, further supporting results in this thesis where 
remodeling can greatly influence differentiation250. Overall, the results presented herein 
reveal potential cell regulatory mechanisms that are susceptible to oxidation in response 
to ethanol exposure and provide a reconciliatory concept in understanding the 
relationship between macrophage function and oxidative stress by considering the 




CHAPTER 6  CONCLUSIONS AND FUTURE DIRECTIONS  
 The results presented in this thesis inform how conserved and hypervariable 
receptor-ligand interactions navigate their highly sensitive pathogen recognition in a 
different environments. Investigation began with a systematic characterization of multi-
molecular interactions thought to contribute to discrimination of antigen. In the case of 
conserved recognition of LPS found in the cell wall of gram-negative bacteria, TLR4 
associates with secreted MD-2 and works in concert with CD14 to achieve sensitive 
recognition. For the hypervariable and adaptive recognition of abnormal antigen 
expressed on infected or cancer-transformed cells, the TCR may depend on intrinsic 
force-regulated structural alterations to ensure discrimination from self-peptides and 
prevention of autoimmunity. There is reason to believe that T cell activation may also 
rely on CD4 and CD8 coreceptors that associate to the antigen presenting pMHC 
simultaneously but independently from TCR, since they can recruit phosphorylation-
initiating kinases19. Additionally, CD4 and CD8 coreceptors are expressed during 
development of T cells and the difference in their individual expression demarcates T cell 
effector function54. Thus, despite their importance, evidence of a stable TCR-pMHC-CD4 
trimolecular complex is scant, due to the postulated weak interaction between CD4 and 
MHC75. Whereas delicate conformational changes have been shown to be important in 
ligand discrimination53,216, cooperativity between several molecules may also play a role 
in specialization of these innate and adaptive immune receptors toward modulating 
conserved signaling cascades for appropriate cell activation and pathogen clearance. 
6.1.1 Development of a mathematical model for multi-molecular interactions 
 A two-pronged approach was undertaken in this thesis to measure CD4-MHC 
binding. First, an ultra-sensitive micropipette adhesion frequency assay was employed 
which has previously detected binding of the CD8-MHC interaction and has enabled a 
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larger dynamic range of affinity measurements that correlate better to pMHC potency 
compared to measurements made by SPR21. Interestingly, the adhesion frequency assay 
was previously used to distinguish trimolecular TCR-pMHC-CD4 binding from TCR-
pMHC binding using an antibody blockade for CD4, to no avail49. To circumvent 
potential problems with limited efficacy of antibody blockade, a minimalist system of 
purified TCR, CD4, and pHLA was used. Additionally, the TCR used in these 
experiments was previously found to not bind to its cognate pHLA unless tetramerized204 
and was therefore hypothesized herein to minimize the dominant binding of TCR to 
pHLA which could potentially mask any CD4-HLA binding. First, in contrast to SPR 
measurements, E8 TCR-TPI pHLA was readily detected by the adhesion frequency 
assay. Then, despite hovering close to the detection limit of the assay, CD4 binding to 
HLA was also detected, yielding the first documented characterization of CD4-MHC 
kinetics. Furthermore, when TCR and CD4 were mixed on the same surface interacting 
with pHLA, CD4 was observed to stabilize TCR-pHLA interactions in a synergistic 
fashion. By analyzing the contribution of CD4 to form observed bonds, a mass-action 
based analytical solution describing a trimolecular interaction was developed which 
reasonably fits the nonlinearities exhibited by the experimental results. This is the first 
instance of a mathematical model describing cooperativity exhibited by a trimolecular 
interaction and can be used to extend models that describe bimolecular hemoglobin 
cooperativity such as the Hill, Koshland-Némethy-Filmer, and Monod-Wyman-
Changeux models.  
 A limitation of the trimolecular model is that it was built on kinetic parameters 
determined from the adhesion frequency assay which represent two-dimensional kinetics, 
and therefore may not be appropriate using kinetics determined from three-dimensional 
techniques such as ITC or SPR which do not always demonstrate strong correlations 
between cell function and binding between membrane anchored receptor-ligand pairs21. 
However, these results and mathematical model have many implications for TCR 
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triggering models such as kinetic proofreading and serial engagement which can broadly 
be applied to triggering of other cell surface receptors208. Specifically, detectable CD4-
MHC binding and synergy suggest that CD4 contribution cannot be neglected when 
considering dwell-times of TCR-pMHC interactions which eventually lead to ITAM 
phosphorylation. In fact, functional studies in this thesis demonstrated that CD4 inclusion 
led to more efficient T cell activation. Importantly, enhancement found herein may only 
be the case since the specific TCR-pHLA pair used in these experiments is a very weak 
interaction, thereby amplifying the role CD4 may play. Therefore, immediate future work 
for this aim include testing the contribution of CD4 in synergistic stabilization for a 
system that uses the same TCR but a pHLA that possesses a point residue mutation which 
has been previously shown to greatly enhance its potency204. Interestingly, the 3D 
affinities between the wild-type and mutant peptides could not be distinguished which 
poses a relevant challenge for the adhesion frequency assay. Preliminary studies found in 
Appendix Figure 32 have shown that this assay could in fact detect binding between TCR 
and both peptides and can distinguish their affinities. Therefore, analysis of CD4 synergy 
using the mathematical framework developed in this aim could be a facile approach to 
understand what role TCR-pHLA bimolecular affinity plays in trimolecular bond 
formation. Error in the mathematical model compared to observed data seems to largely 
stem from nonlinearities with pHLA density. Testing a greater range of pHLA densities- 
from limiting to excess- could reveal an additional factor that may need to be included in 
the model. Specifically, this could be determined by creating an expression that relates 
the errors in the model directly to the pHLA densities. Beyond the aforementioned point 
residue mutations, additional mutations could be determined through molecular dynamic 
simulations which could abolish the catch-slip bond profile exhibited by the TCR-pHLA 
bimolecular interaction. Such mutations could pose the question of whether CD4 
stabilization can occur with a TCR-pHLA interaction that exhibits a slip-bond profile, 
and if so, to what degree and can it change bond profile from slip to catch-slip? The same 
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analysis can be conducted for the CD4-HLA interaction. In fact, mutations in CD4 which 
greatly enhances CD4-HLA association was tested in early in this thesis. While using a 
mutant CD4 may not be as physiologically relevant as the naturally occurring point 
residue mutation in HLA, understanding even strong CD4 contribution relative to TCR-
pHLA binding can inform TCR triggering and be exploited for protein engineering 
studies. Indeed, a recent study expressed the mutant CD4 on cell lines prone to false 
negative screenings and improved TCR signaling to the point of being as robust as in 
primary cell lines251. Next, since Lck associates with coreceptors, the possibility of Lck 
inhibition in current Jurkat system abrogating bond lifetime synergy would corroborate 
the model describing a pseudodimer of dimers between TCR, CD3, pMHC, and 
coreceptor19. Finally, functional studies examining activation of membrane proximal 
signaling components may provide a more detailed picture of how CD4 is contributing 
directly to triggering compared to calcium flux. Specifically, total internal reflection 
microscopy can be employed to observe phosphorylation events of kinases proximal to 
signaling motifs on CD3. Together, these future studies would provide a more detailed 
understanding of how TCR, pHLA, and CD4 cooperate to afford the outstanding 
sensitivity and specificity exhibited by T cells in recognizing foreign antigen amid an 
abundance of self-antigen. 
6.1.2 Reconciliation of oxidative effects on T cell function 
 The precise interplay between multiple molecules for signaling specialization 
must withstand the soluble influences between varying tissue compartments each with its 
own microenvironment milieu. For example, the difference in cytokine presence between 
circulation and tissue compartments can modulate T cell function and fate in the context 
of viral infections252. More explicitly, ROS has been suggested to mediate T cell 
dysfunction by oxidizing critical signaling molecules in both activating and inhibiting 
fashions96. The results presented in the second aim of this thesis are the first instance 
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where TCR-pMHC binding was monitored in real-time in response to ROS. In doing so, 
the convoluted findings of previous studies were reconciled, and a model was proposed to 
explain how the various effects of ROS on TCR machinery components can lead to a 
scenario of impaired binding, which has been shown to be a good predictor of T cell 
function. Early observations of this project found that mtOVA binding to TCR on 
primary naïve T cells was reduced in response to a pathologically representative 
concentration of H2O2. Yet, the reduction could have been due to a litany of signaling 
molecules associated with the TCR and shown to be sensitive to oxidation96. The 
technique developed in this aim enabled in situ monitoring of an amalgamation of 
potential effects manifesting in the critical metric of binding while carefully comparing 
only one molecular difference between two systems. Together with the quantitative 
nature of the method, this approach ultimately led to parsing out which molecules were 
likely playing a role in the reduced binding. The model proposed has its limitations in 
that the activity of oxidation sensitive phosphatases were not directly analyzed. CD45 
and Shp1 directly modulate Lck proximal activity100 but their role in T cell function in 
response to oxidation is not completely understood. It is thought that inactivation of Shp1 
by oxidation of critical cysteines leads to overactivation of Lck and this should represent 
an increase in binding based on the pseudodimer of dimers model. Although the model 
did indeed incorporate such an increase, examining the redox state of cysteines in these 
phosphatases in response to the concentrations of H2O2 used in the adhesion frequency 
experiment by mass spectrometry-based techniques developed by Hogg and colleagues132 
could provide necessary validation.  
 The major limitation of these results was the in the optimization of the system. 
Only naïve T cells were used in this system, and immediate future studies should 
investigate the effect on other developmental stages of T cells253,254. Effector T cells 
would be an instructive system to study because it has been postulated that survival of 
these cells is prolonged due to their increased antioxidant capacity compared to naïve T 
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cells. In what could be an evolutionarily conserved mechanism to survive the harsh 
environment of inflammatory sites, this difference could also corroborate the implication 
of the present results which posit that the redox state of T cells is important for sensitive 
and specific TCR recognition. With an appropriate level of protection afforded by 
endogenous antioxidants, it is hypothesized that TCR on effector cells would not 
experience reduced binding in response to pathological concentrations of H2O2. 
However, if binding is reduced, a more quantitative understanding for how ROS can alter 
TCR recognition in the tumor environment could be achieved. What must be developed 
to approach such a problem is a mathematical black box model that incorporates H2O2 
concentration (which includes an initial presence of ROS, as well as consumption and 
generation), experimentally derived information surrounding TCR-pMHC 2D affinity, 
and the endogenous antioxidant capacity of a given T cell. Thus, by inputting ROS 
context and surface molecule expression levels while assuming constant expression 
signaling molecules which may or may not be ROS-sensitive, an idea for TCR 
recognition can be outputted.  
 Quantitative information like this would inform rational design of genetically 
modified T cells that express catalase for antioxidant protection in two ways. The first is 
that global expression of catalase may be optimized to determine the degree of 
antioxidant production that will maximize TCR binding. Once such a value is obtained, 
exploration of compartmentalized expression of catalase can be pursued to ensure that T 
cell signaling cascades known to depend on oxidation are not perturbed. Rather than use 
binding as a metric at this stage, T cell effector functions such as proliferation and 
cytokine secretion would be monitored for maximization. However, the first step in these 
sequence of experiments would be to test TCR-pMHC binding in the exact same manner 
as done in this thesis, except for surface expression of catalase as previously described229. 
In the case of a H2O2 bolus, it is hypothesized that the reduction in binding between 
TCR and mtOVA would be minimized or abrogated. For the case of continuous 
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production of ROS, it is hypothesized that the catalase generation would protect both 
wtOVA and mtOVA binding.  To circumvent the byproducts and consequences of 
continuous artificial production of H2O2 by glucose oxidase, it would be worth exploring 
whether T cells can upregulate ROS production via Nox proteins as macrophages have 
been shown to182. While the molecular mechanism for the upregulation in macrophages 
has yet to be determined, it is not unreasonable to suggest the same phenomena can be 
exerted by T cells because they have been shown to upregulate expression and activity of 
Nox proteins upon TCR triggering120. If such a mechanism exists for T cells, a system 
consisting of endogenously produced ROS at physiologically relevant concentrations 
could be implemented in the proposed mathematical framework for ROS effects. These 
future studies would greatly inform the convoluted nature of antioxidant therapeutics 
which have suffered from poor outcomes and represent a promising avenue to 
understanding a major facet of how tumors escape immune surveillance239. 
6.1.3 Toward understanding multi-molecular interactions in macrophages 
 The challenges in studying the effects of ROS also plague the field of macrophage 
immunobiology with some studies describing detrimental effects on macrophages182 
while others providing evidence for the requirement of ROS in effective TLR4 
signaling189. Furthermore, sensitivities of macrophage intracellular signaling molecules to 
ROS have not been catalogued as extensively as for T cells, which prompted using the 
black box approach developed in this thesis to delineate oxidation sensitives manifested 
in macrophage trimolecular binding. These methods resulted in the first documented in 
situ binding kinetics between macrophage cell surface molecules and LPS and 
description of a novel morphological polarization in response to LPS at short time scales. 
Supporting evidence came from the development of a gradient of LPS coated on a glass 
surface. Together, the findings in the third aim of this thesis suggested that actin played a 
role in macrophage impairment under oxidative stress induced by ethanol exposure. 
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Addressing this hypothesis were confocal images of actin fibers which appeared to be 
less prevalent when under oxidative stress. Conclusions from this aim align well with 
previous studies and have implications in various pathologies and regenerative medicine 
as macrophages are often the predominant tissue surveilling immune cell156. On one 
hand, TLR4 signaling was indeed enhanced with ROS as measured by cytokine 
secretions while on the other hand they may be effectively decoupled from other 
functions such as phagocytosis and differentiation which rely more on the actin 
cytoskeleton organization170. Notwithstanding the decoupling, a compelling narrative 
emerges from the data: TLR4 triggering by LPS generates a positively reinforcing 
generation of ROS which can continue in excess until inducing macrophage dysfunction 
which predisposes patients to infection and tissue damage. Unlike the response of T cells 
studied in this aim with mild concentrations of ROS, it is likely that sufficient 
concentrations were present to impair actin reorganization. Immediate future studies 
would develop a ratio between antioxidant capacity and ROS generation by macrophages 
to more directly compare actin susceptibility between macrophages and T cells in this 
thesis which were exposed to exogenous ROS and did not appear to experience actin 
machinery oxidation.  
 The major limitation of this thesis chapter was the inability to comprehensively 
measure binding kinetics between TLR4 and LPS. One difficulty stemmed from the 
expression of both CD14 and TLR4 on the surface of macrophages, which without 
antibody blockade of either of the receptors, specificity could not be clarified. However, 
due to the low baseline adhesion frequency, blockade was not immediately pursued. 
Since binding frequency improved after LPS mediated pre-activation of macrophages, 
consistent with improved MD-2 secretion, adding soluble MD-2 and LBP into the 
micropipette experimental chamber may assist in stabilizing bond formation according to 
crystal structures. The challenge of this approach is to ensure purification tags of soluble 
proteins do not lead to nonspecific anchoring, but this may be circumvented by antibody 
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blockade such as for the Fc-receptor. Once improved binding is detected, several future 
experiments are envisioned. The first, most relevant to the goal of this thesis, is to 
understand the contribution of each molecular player in formation of bonds, using the 
model developed in aim 1 between TLR4, MD-2, and LPS. Differences to expect 
between systems are the docking geometries and soluble nature of MD-2, both of which 
may necessitate changes in the mathematical model. Monitoring the stability of this 
complex in response to oxidative stress by systematically parsing through each molecular 
player as in aim 2 would reveal whether any of them are sensitive to ROS. This approach 
could serve as an initial step toward cataloging susceptibilities of macrophage surface and 
intracellular signaling molecules to ROS, in addition to cholesterol and actin determined 
through this thesis. Ultimately, an application of this work is to lay the framework for a 
systems-level model that encompasses ROS-sensitive signaling proximal and receptor-
ligand interactions to predict the antigen recognition phase of activation for a variety of 
cell types. 
 The methods developed in this thesis can be extended to further predict 
downstream signaling processes. It has long been established that activation of 
macrophages through TLR4 requires about hours of stimulation with soluble LPS in 
culture255. However, the dynamics of binding between TLR4 and LPS through this 
process is unexplored and is important to understand for design of therapeutics and since 
the soluble environment surrounding the macrophage in vivo is dynamic upon initiation 
of inflammation. In lieu of distinct difference in adhesion frequency between naïve and 
activated macrophages, monitoring binding in real-time over the course of 6 hours 
necessary for activation could reveal the threshold of activation and the dynamics of MD-
2 secretion if the surface expression of TLR4 is characterized over time (a facile task 
separately determined at various time points of LPS stimulation using flow cytometry). A 
corresponding experiment could be conducted for the chemotaxis of macrophages in 
response to LPS, which would reveal the temporal threshold by which macrophages 
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switch between polarizing away and toward LPS. A transwell system would be more 
effective in capturing long term migration patterns (in a digital fashion) than the gradient 
surface method because the latter appeared to only capture early adhering behaviors. 
Comparing the temporal thresholds between these two experiments could elucidate 
mechanisms that occur between the establishment of activation and effector functions 
such as migration. In other words, a difference between temporal thresholds would 
indicate that MD-2 secretion and migration occur in a specific sequence. Finally, 
throughout this thesis, oxidation of signaling molecules was inferred from binding 
experiments. To complement results presented herein, fluorescent reporters of ROS could 
be implemented in T cells and macrophages which would determine with high resolution 
the localization of ROS experienced by cells and further inform the rational design of 
compartmentalized expression of antioxidant protections. 
6.1.4 Final Remarks 
 The overall goal of this thesis was to contextualize well-established bimolecular 
interactions into physiologically relevant biophysical and biochemical environments. By 
developing a mathematical model that predicts cooperation between many molecules, a 
conceptual model that explains how those interactions can be perturbed under an 
oxidative environment, and experimental methods to quantify binding and cell behaviors 
in real-time, a novel understanding of immune recognition by different cell types under 
pathological conditions was achieved. Results of this thesis align well with existing 
literature and provide inspiration for future studies that aim to more comprehensively 
















































Figure 32. Mutant TPI binds to E8 TCR with much higher affinity. 
The wild-type TPI pHLA is a ‘cryptic peptide’ in that it is capable of immune evasion. A 
point residue mutation in the peptide greatly enhances its immune detection, however, its 
binding affinity is indistinguishable from SPR when E8 is tetramerized, while neither can 
be detected when E8 is monomeric. Using the micropipette adhesion frequency assay, not 
only the wild-type TPI-TCR interactions detected with monomeric TCR, but the mutant 
peptide clearly demonstrated a much higher affinity value with TCR than with the wild-




A.2. Derivation of mathematical model for trimolecular interaction 
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